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ABSTRACT 
This thesis presents the development of bismuth(III) triflate-promoted conjugate 
additions of electron-rich heteroarenes to b,b-disubstituted enones, regioselective 1,6-
additions of electron-rich heteroarenes to dienones, and 1,2-addition of nucleophilic 
heteroarenes to progesterone, 17a-hydroxyprogesterone acetate and andrenosterone. 
Additionally, this dissertation describes the first examples of intermolecular alkene 
carboacylation triggered by amide C-N bond activation.          
Chapter II discusses the development of catalytic conjugate additions of 
heteroarenes to b,b-disubstituted enones. Additions of a range of heteroarene nucleophiles, 
including furans, indoles, pyrroles, and thiophenes to a variety of b,b-disubstituted enones 
occur to form heteroarylated all-carbon quaternary centers in up to 90% yield. These 
reaction occur under mild reaction conditions in the presence of low loadings of 
bismuth(III) triflate.  
Chapter III describes the development and optimization of bismuth(III) triflate-
promoted regioselective 1,6-additions of electron-rich heteroarenes to dienones. 
Regioselective 1,6-additions of a range of electron-rich heteroarenes, including furan, 
thiophene, pyrrole, and indole nucleophiles to 3-vinyl-2-cyclohexenone occur to produce 
a variety of d-heteroarylated, b,b-disubstituted enones in up to 93% yield. The high 1,6-
selectivity for these reactions is attributed to the increased steric bulk at the b-position 
relative to the d-position, and no competing 1,4-conjugate addition is observed.  
Chappter IV describes 1,2-additions of heteroarenes to hormone steroids. 
Additions of a range of electron-rich heteroarene nucleophiles, including indoles, a 
pyrrole, and a thiophene, to a variety of commercially available steroids and subsequent 
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dehydration occur to form 3-heteroarylated steroidal dienes in up to 93% yield. This 
atom-economical reaction sequence occurs under mild reaction conditions in the presence 
of catalytic bismuth triflate. 
Chapter V discusses studies toward nickel-catalyzed intermolecular carboacylation 
of alkenes with amides and tetraarylborates. Bicyclic alkenes are readily functionalized 
with a variety of N-benzoyl-N-phenylbenzamides and triarylboranes, which are generated 
in situ from the corresponding tetraarylborates, to synthesize ketone products in up to 91% 
yield. This reaction manifold is initiated by activation of the amide C-N bond via oxidative 
addition by a Ni(0) catalyst. Preliminary mechanistic studies suggest that migratory 
insertion precedes transmetalation, and that reductive elimination is the turnover-limiting 
step. These reactions occur with excellent chemoselectivity and diastereoselectivity in the 
absence of a directing/chelating group and further demonstrate amides as practical acyl 
electrophiles for alkene functionalization reactions.   
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CHAPTER 1.    INTRODUCTION 
General Introduction 
The development of new and novel reaction manifolds to forge new C-C bonds is 
essential to the advancement of organic chemistry. Given that alkenes are widely abundant and 
ubiquitous building blocks, devising improved methods for the construction of new C-C bonds 
through alkene functionalization is a particularly important challenge. Catalytic 
hydrofunctionalization reactions constitute a valuable subset of alkene functionalization 
reactions to construct new C-C bonds.1,2 This broad area of research encompasses 
hydrovinylation,3 hydroacylation,4,5,6 and hydroarylation,7 amongst others. Building upon 
these hydrofunctionalization reactions, forays into three-component conjunctive cross-
coupling reactions have emerged as a promising platform to construct two new C-C bonds in 
a single step.8 This thesis describes the discovery of new catalytic methods for formal 
hydroheteroarylation and intermolecular alkene carboacylation reactions. The development of 
formal hydroarylations encompass bismuth(III) triflate-promoted regioselective 1,2-, 1,4-, and 
1,6-additions reactions of electron-rich heteroarenes. In addition, this thesis will discuss the 
development of a nickel catalyst for intermolecular, three-component alkene carboacylation 
reactions initiated by amide C-N bond activation. 
Transition-metal catalyzed conjugate addition of aryl boron nucleophiles is a well-
established method for the construction of benzylic and bis-benzylic quaternary centers.9 In 
comparison, transition metal-catalyzed conjugate additions of heteroaryl boron nucleophiles 
to construct related heteroarylated all-carbon quaternary centers remains challenging, likely 
due to the relative instability of these heteroarylboron nucleophiles.10  The use of Lewis or 
Brønsted acid catalyst to promote the direct attack of nucleophilic heteroarenes is an alternative 
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approach to construct heteroarylated all-carbon quaternary centers, and bypasses challenges 
associated with transition metal-catalyzed conjugate addition with heteroarylboron 
nucleophiles.  
The majority of catalytic conjugate additions of electron-rich heteroarenes to b,b-
disubstituted enones involve additions of furan and indole nucleophiles to 4-methyl-3-penten-
2-one.11-15 In general, these conjugate additions occur under mild reaction conditions in the 
presence of low loadings of Lewis acid catalyst. In comparison, additions to cyclic, b,b-
disubstituted enones remain challenging (Scheme 1.1).  
Scheme 1.1: Current Challenges in Conjugate Additions of Heteroarenes to Cyclic b,b-
Disubstituted Enones 
 
 
In 1996, Kerr and co-workers reported high pressure, Yb(OTf)3-catalyzed conjugate 
additions between N-methylindole and a select few b,b-disubstituted enones to construct 
heteroarylated all-carbon centers.12  This study constituted one of the first examples of 
conjugate additions between electron-rich heteroarenes and cyclic, b,b-disubstituted enones 
and formed the corresponding heteroarylated quaternary centers where synthesized in 3-15% 
yield. Building from this seminal report, Kwiatkowski and co-workers reported a high 
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3 
pressure-accelerated asymmetric conjugate addition of indole to b,b-disubstituted enones.16   
These high-pressure reactions utilized a chiral, non-racemic bifunctional organocatalyst. The 
addition of indole to a series of activated b,b-disubstituted enones generated heteroarylated 
quaternary stereogenic centers in 57-72% yield and 48-80% ee. The most efficient approach 
to direct conjugate additions of heteroarenes to b,b-disubstituted enones involves 
diastereoselective addition of indole and pyrrole nucleophiles to progesterone in the presence 
of a Ru(III) catalyst.17 Prior to this study, conjugate additions between furan and cyclic, b,b-
disubstituted enone required stoichiometric amounts of Lewis acid catalyst.18 Despite these 
advances, current conjugate addition reactions between electron-rich heteroarenes are limited 
to additions between a few heteroarenes and  b,b-disubstituted enones and require either high 
reaction pressures, up to 13 kbar, or require stoichiometric amounts of catalyst.  
This thesis presents studies toward the development of a bismuth(III) triflate-promoted 
conjugate additions of electron-rich heteroarenes and b,b-disubstituted enones to construct 
heteroarylated all-carbon quaternary centers. During studies to assess the substrate scope for 
these conjugate additions, we made two key observations: (1) additions of electron-rich 
heteroarenes to b,b-disubstituted enones was exceptionally sensitive to the size of the b-
substituent and (2) under the guise of applying our model conjugate addition reactions to 
include biologically active enones, such as progesterone, no conjugate addition reaction was 
observed. Serendipitously, we discovered that this reaction manifold promoted a sequential 
1,2-addition and dehydration pathway to generate heteroarylated steroidal dienes.  These key 
observations serve as the bases for Chatpers III and IV in this dissertation. 
Catalytic 1,4-addition reactions of carbon nucleophiles to a,b-unsaturated ketones have 
emerged as a powerful tool for the construction of new C-C bonds.19 Despite the large body 
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of work describing catalytic 1,4-additions, analogous 1,6-addition reactions are 
underdeveloped.20 The presence of multiple electrophilic sites results in poor regioselectivity  
and has hindered the advancement of catalytic 1,6-additions. One approach to promote 
regioselective 1,6-additions is to utilize dienones which bear a bulky b-substituent relative to 
the d-postion.21  
During studies to assess the scope for the conjugate additions of electron-rich 
heteroarenes to b,b-disubstituted enones we observed that this reaction manifold was sensitive 
to the size of the b-substituent (Scheme 1.2).22 We envisioned that we could leverage this 
sensitivity to develop regioselective 1,6-additions of electron-rich heteroarenes to dienones 
bearing a bulky b-substituent relative to the d-postion.  
Scheme 1.2: Impact of the Identity of the b-Substituent on Bismuth(III) Triflate-Promoted 
Conjugate Addition 
 
The most common approach to 1,6-additions of electron-rich heteroarenes to dienones 
involve the addition of indoles to para-quinone methides (Scheme 1.3a).23, 24 It is important to 
note that these reactions do not generate heteroarylated products that retain the electrophilic 
enone functionality, but instead isomerize to generate the corresponding triarylmethane.  The 
only direct method for the 1,6-addition to generate d-heteroarylated, b,b-disubstituted enones 
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involve the Lewis acid-catalyed addition of furan nucleophiles to steroidal dienones (Scheme 
1.3b).25 This thesis describes the development of a catalyst system for the regioselective 1,6-
addition of electron-rich heteroarenes to 3-vinyl-2-cyclohexenone. This process generates d-
heteroarylated, b,b-disubstituted enones products. This thesis describes the development and 
optimization of bismuth(III) triflate-promoted regioselective 1,6-additions of electron-rich 
heteroarenes to dienones to generate generates d-heteroarylated, b,b-disubstituted enones. 
Scheme 1.3: Regioselective 1,6-Additions of Electron-Rich Heteroarenes 
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alkynylanilines,26 Stille cross-coupling reactions,27, 28 and Ullman coupling reactions.29 These 
reactions require prefunctionalization of the parent steroid to the corresponding halogenated 
or pseudohalogenated derivative. The only example of direct addition of indole to steroids 
involves Ru(III) catalyzed, diastereoselective addition of indoles to progesterone (Equation 
1.1).17 During studies to assess the scope for our bismuth(III) triflate-promoted conjugate 
 
additions of electron-rich heteroarenes to steroidal b,b-disubstituted enones, we observed that 
the expected conjugate addition reaction does not occur. Instead, we were surprised to discover 
this reaction manifold formed 3-heteroarylated steroidal dienes (Equation 1.2). This thesis 
presents a method for the direct synthesis of 3-heteroarylated  
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7 
steroidal dienes. These reactions occur under mild reaction conditions in the presence of 
catalytic amounts of bismuth(III) triflate.  
Tremendous progress has been made in recent years in the area of transition metal-catalyzed 
cross-coupling reactions of amides.30-32 These cross-coupling reactions are initiated by 
activation of an amide C-N bond via oxidative addition to generate an acyl-metal-amido 
complex. Subsequent transmetalation with an organometallic nucleophile produces an acyl-
metal-aryl or acyl-metal-alkyl intermediate, and reductive elimination forms a ketone. While 
there have been many developments in this advancing area of amide activation, methods that 
exploit alkene insertion into the corresponding acyl-metal complexes are rare (Scheme 1.4). 
Scheme 1.4: Intramolecular Alkene Functionalization Reactions Triggered by Amide C-N 
Bond Activation.  
 
 
  In 2015, Murakami and co-workers reported Pd-catalyzed aminoacylations initiated by 
C-N bond activation of strained b-lactams (Scheme 1.4a).33 Recently, Garg and co-workers 
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reported Mizoroki-Heck cyclization of o-allybenzamides (Scheme 1.4b).34 During parallel 
studies, our group reported Ni-catalyzed alkene carboacylation between o-allylbenzamides and 
arylboronic acid pinacol esters. (Scheme 1.4c).35 These processes begin to demonstrate the 
synthetic potential of amides as acyl electrophiles in the context of alkene functionalization 
reactions. However, these methods are limited to intramolecular reactions, delivering cyclized 
products from preassembled starting materials. The development of intermolecular alkene 
functionalization reactions is poised to expand the synthetic utility of amides.  
To date, most alkene carboacylation proceed in an intramolecular fashion to form 
cyclized products.36-38 As a consequence, alkene carboacylation reactions have been limited to 
single-component reactions, and a select few examples of transition metal-catalyzed two- and 
three-component alkene carboacylation have been reported.36-38  Current approaches to 
intermolecular alkene carboacylation encompass (1) reactions triggered by the directed 
activation of a C-C bond, and (2) three-component conjunctive cross-coupling reactions 
between a carboxylic acid derivative, an alkyl radical or organometallic nucleophile, and an 
alkene (Scheme 1.5) 
A vast majority of carboacylation reactions are triggered by C-C bond activation.39-41 In 2009, 
Douglas and co-workers reported a Rh-catalyzed intramolecular alkene carboacylation 
initiated by quinoline-directed C-C bond activation of 8-acylquinolines bearing a pendent 
alkene.39 Building upon their intramolecular carboacylation reaction, the Douglas group 
reported a Rh-catalyzed two-component alkene carboacylation between strained bicyclic 
alkenes and 8-acylquinolines (Scheme 1.5a).36 
 A mechanistically different approach to three-component carboacylation via Ni-
catalyzed radical relay was recently reported (Scheme 1.5b).37 This radical relay process is 
triggered by acyl chloride C-Cl bond activation to generate the key acyl-nickel complex. 
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While this report provides a practical entry into three-component alkene carboacylation 
reactions, this method is limited to the addition of perfluoroalkyl radicals. In 2002, the first 
example of a fully intermolecular, three-component alkene carboacylation was reported 
(Scheme 1.5c).38 This Rh-catalyzed three-component conjunctive coupling reaction occurs 
between acid anhydrides, strained bicyclic alkenes, and sodium tetraphenylborates to generate 
ketone products. While three-component carboacylation has the potential to be highly modular, 
this approach suffers from limited substrate scope and poor chemoselectivity. The products of 
this alkene carboacylation reaction are often accompanied by benzophenones, the product of 
Suzuki-Miyaura coupling, in nearly a 1:1 ratio. This thesis discusses the development the first  
Scheme 1.5: Current Strategies for Intermolecular Alkene Carboacylation 
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examples of intermolecular, three-component alkene carboacylation reaction initiated by 
amide C-N bond activation (Scheme 1.5d). 
Thesis Organization 
 This thesis is comprised of six chapters that contain both work that has been published 
in peer-reviewed journals and research results that are in preparation for publication. Chapter 
I introduces catalytic alkene hydrofunctionalization and dicarbofunctionalization in the context 
of acid-catalyzed 1,2-, 1,4-, and 1,6-addition of electron-rich heteroarenes and transition metal-
catalyzed intermolecular alkene carboacylation reactions. Chapter II and III are adapted from 
papers published in Organic Letters and Tetrahedron. Chapter IV is adapted from a paper 
published in The Journal of Organic Chemistry. Chapter V discusses research results that are 
currently in preparation for submission to Journal of the American Chemical Society. This 
chapter also describes work that will not be published in the manuscript. Chapter VI serves as 
a general summary and conclusion of the present research.  
Chapter II describes catalytic conjugate additions of electron-rich heteroarenes to b,b-
disubstituted enones and is a modified version from work published in Organic Letters and 
Tetraheron in 2017.  The work included in this chapter encompasses the additions of furan, 
thiophene, pyrrole, and indole heterocycles to a variety of  b,b-disubstituted enones to form 
the corresponding b-heteroarylated ketone products bearing an all-carbon quaternary centers 
in up to 90% yield. These reactions occur under mild reaction conditions in the presence of 
low loadings of bismuth(III) triflate. Joshua Evans was an undergraduate student at Iowa State 
University who helped establish the substrate scope for the addition of indole nucleophiles to 
3-methyl-2-cyclohexenone.  
Chapter III discusses the development and optimization of bismuth(III) triflate-
promoted regioselective 1,6-additions of electron-rich heteroarenes to dienones and is 
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modified from a published paper in Tetrahedron in 2017. This chapter discusses regioselective 
1,6-additions of a range of electron-rich heteroarenes, including furan, thiophene, pyrrole, and 
indole nucleophiles to 3-vinyl-2-cyclohexenone occur to produce a variety of d-heteroarylated, 
b,b-disubstituted enones in up to 93% yield. The high 1,6-selectivity for these reactions is 
attributed to the increased steric bulk at the b-position relative to the d-position, and no 
competing 1,4-conjugate addition is observed. Mingwan Leng was a visiting summer 
undergraduate student from Beijing Normal University and helped establish the substrate scope 
for this reaction manifold.  
Chapter IV describes 1,2-additions of heteroarenes to hormone steroids containing an 
a,b-unsaturated ketone and is modified from a paper published in The Journal of Organic 
Chemistry.  The work discussed in this chapter encompasses addition of a range of electron-
rich heteroarene nucleophiles, including indoles, a pyrrole, and a thiophene, to a variety of 
commercially available steroids and subsequent dehydration occur to form 3-heteroarylated 
steroidal dienes in up to 93% yield. This atom-economical reaction sequence occurs under mild 
reaction conditions in the presence of catalytic bismuth triflate. Grace A. Lutovsky was an 
undergraduate student at Iowa State University that helped established the substrate scope for 
the addition of indole nucleophiles to progesterone.  
Chapter V discusses the development of nickel-catalyzed three-component alkene 
carboacylation initiated by amide C-N bond scission. The chapter contains modified sections 
of a paper in preparation for submission to Journal of the American Chemical Society, as well 
as additional data that will not be included in the submitted manuscript. This chapter discusses 
the development of a nickel-catalyzed intermolecular, three-component alkene carboacylation 
reaction triggered by activation of an amide C-N bond. This nickel-catalyzed conjunctive 
cross-coupling encompasses reactions of a variety of bicyclic alkenes, amides, and 
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tetraarylborates to generate highly functionalized ketone products in high yields and excellent 
diastereoselectivity. Abhishek A. Kadam is a graduate student in the Stanley lab who helped 
develop the alkene carboacylation reaction protocol and helped establish the substrate scope 
for carboacylation reaction of norbornene with a range of amide and tetraarylborates. 
Chapter VI discusses general conclusions from the work presented and proposes new 
directions for further research in the Stanley Lab.  
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CHAPTER 2.                                                                                                         
CATALYTIC CONJUGATE ADDITION OF ELECTRON-RICH HETEROARENES 
TO b,b-DISUBSTITUTED ENONES 
Modified from a paper published in Organic Letters1 and Tetrahedron2 
Tanner L. Metz, Joshua Evans, and Levi M. Stanley 
Abstract 
Here we report catalytic conjugate additions of electron-rich heteroarenes to b,b-
disubstituted enones. Additions of furan, thiophene, pyrrole, and indole heterocycles to a 
variety of  b,b-disubstituted enones occur to form the corresponding b-heteroarylated ketone 
products bearing an all-carbon quaternary centers in up to 90% yield. These reactions occur 
under mild reaction conditions in the presence of low loadings of bismuth(III) triflate. 
Introduction 
Conjugate additions of aryl and heteroaryl nucleophiles to b,b-disubstituted enones 
enable rapid generation of arylated and heteroarylated quaternary carbons centers. Transition 
metal-catalyzed conjugate additions of aryl nucleophiles to b,b-disubstituted enones are 
established methods to generate benzylic and bis-benzylic quaternary centers.3 However, 
transition metal-catalyzed conjugate additions of heteroarylated nucleophiles to b,b-
disubstituted enones to construct related heteroarylated all-carbon centers remains challenging. 
For example, the conjugate addition reaction of 2-furylboronic acid to 3-methyl-2-
cyclohexeneone in the presence of a previously reported palladium(II) catalyst does not occur,4 
likely due to protodeboronation of the heteroarylboronic acid.5 The use of Lewis or Brønsted 
acid catalyst to promote the direct attack of nucleophilic heteroarenes provides an alternative 
approach to construct heteroarylated all-carbon quaternary centers that circumvents this 
pathway for deactivation of the heteroarylboronic acid. 
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Catalytic additions of indoles and furans to  b,b-disubstituted enones form 
heteroarylated all-carbon centers; however, these transformations are currently limited in terms 
of scope and efficiency. The majority of these reactions involve additions of indole or 2-
methylfuran to 4-methyl-3-penten-2-one,6 and additions to cyclic b,b-disubstituted enones 
remain challenging (Scheme 2.1). Lewis acid catalyzed conjugate additions of difuranyl 
cyanocuprate and 2-methylfuran to 3-methyl-2-cyclohexenone occur to form the 
corresponding cyclic ketone products in modest yields in the presence of a high loading of 
catalyst (Scheme 2.1a).7 
Scheme 2.1: Current Challenges in Conjugate Additions of Heteroarenes to Cyclic b,b-
Disubstituted Enones 
 
Conjugate additions of indole to cyclic b,b-disubstituted enones occur in low-to-
modest yields when the reactions are conducted at pressures in the presence of a Lewis acid 
catalyst or organocatalyst (Scheme 2.1b).6e,8 To the best of our knowledge, catalytic conjugate 
additions of thiophenes to b,b-disubstituted enones have not been reported. The most efficient 
approach to direct conjugate additions of heteroaryl to b,b-disubstituted enones involve 
diastereoselective addition of indole and pyrrole nucleophiles to progesterone in the presence 
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of a Ru(III) catalyst.9 Despite these advances, current catalyst of these transformations require 
high reaction pressures or high catalyst loadings, do not encompass a range of heteroaryl 
nucleophiles, or are limited to acyclic b,b-disubstituted enones. Herein, we report studies to 
identify a catalyst system that operates at ambient pressure with low catalyst loadings and 
encompasses a range of heteroaryl nucleophiles to enable the formation of ketone products 
bearing heteroarylated quaternary centers.  
Results and Discussion 
We began our studies by evaluating the model conjugate addition of 3-methyl-2-
cyclohexenone 1a and 2,3-dimethylfuran 2a to generate 3-(2,5-dimethylfuran)-3-
methylcyclohexanone 3a (Table 2.1). We initially evaluated RuCl3·cH2O as a catalyst based 
on the high activity of this catalyst in conjugate additions of indoles to progesterone. However, 
the model reaction catalyzed by RuCl3·cH2O formed 3a in 60% yield (entry 1). We were 
pleased to find that running the model reaction in the presence of scandium(III) and 
bismuth(III) triflate salts led to the formation of ketone product 3a in increased yields (74-76% 
yield, entries 2-3). Previous studies have established that triflic acid can be derived from the 
hydrolysis of bismuth(III) triflate, and the observed catalytic activates may be attributed to 
either Brønsted and/or Lewis acid activation(Scheme 2.2).10 We next carried out the model  
Scheme 2.2: Acidic Pathways for Bismuth(III) Triflate in the Presence of Water 
 
reaction in the presence of triflic acid to determine whether triflic acid derived from hydrolysis 
of bismuth(III) triflate is an active catalyst, and when the model conjugate addition reaction is 
run the presence of 10 mol % triflic acid, the ketone product 3a is formed in 67% yield (entry 
Bi(OTf)3 + H2O (TfO)3Bi O
H
H
(OTf)2BiOH + TfOH
Lewis acid-assisted
Brønsted acidity
Reversible formation
of TfOH
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4). This result suggests that bismuth(III) triflate is being hydrolyzed to triflic acid, and that the 
model reaction proceeds by Brønsted acid catalysis. To verify this mode of activation, we 
conducted our model reaction in the presence of catalytic amounts of bismuth(III) triflate and 
2,6-di-tert-butylpyridine. Under these reaction conditions ketone 3a was not generated, 
suggesting that triflic acid is serving as the active catalyst (entry 7). We chose to proceed with 
further studies using bismuth(III) triflate as a convenient source of triflic acid.  
Table 2.1: Evaluation of Catalyst for the Conjugate Addition Reaction Between 1a and 2aa 
 
entry catalyst additive yield b 3a (%) 
1 RuCl3·cH2O - 60 
2 Sc(OTf)3 - 74 
3 Bi(OTf)3 - 76 
4c TfOH - 67 
5 Bi(OTf)3 2,6-di-tert-butylpyridine 0 
a Conditions: Reactions were performed with 3-methyl-2-cyclohexenone 1a (0.25 mmol), 2,3-
dimethylfuran 2a (0.50 mmol), catalyst (0.013 mmol), acetonitrile/methanol (10:1, 0.5 mL), 60 °C for 
1h. b Determined by 1H NMR spectroscopy using dibromomethane as an internal standard. c Reaction 
run in the presence of 10 mol % TfOH. 
 
 
Identification of triflic acid derived from the hydrolysis of bismuth(III) triflate as a promising 
catalyst prompted us to investigate the effects of solvent on the yield of the model reaction. 
These results are summarized in Table 2.2. Unfortunately, variation of the identity of the aprotic 
and protic components of our binary solvent system did not lead to improved yields 
O
O catalyst (5 mol %)
additive (15 mol %)
+
60 °C, 1 h
MeCN:MeOH (10:1)
O
O1a 2a 3a
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Table 2.2: Evaluation of Reaction Solvents for the Conjugate Addition Reaction Between 1a 
and 2aa 
 
 
 
entry solvent protic co-solvent yield b 3a (%) 
1 acetonitrile methanol 76 
2 1,4-dioxane methanol 55 
3 dichloromethane methanol 48 
4 toluene methanol 44 
5 acetonitrile - 22 
6 acetonitrile ethanol 62 
7 acetonitrile 2-propanol 64 
8 acetonitrile phenol 21 
9 acetonitrile HFIP 34 
a Conditions: Reactions were performed with 3-methyl-2-cyclohexenone 1a (0.25 mmol), 2,3-
dimethylfuran 2a (0.50 mmol), Bi(OTf)3 (0.013 mmol), solvent/protic co-solvent (10:1, 0.5 mL), 60 °C 
for 1h. b Determined by 1H NMR spectroscopy using dibromomethane as an internal standard. 
  
of ketone 3a. Conducting the model reaction in the presence less polar solvents afforded the 
corresponding ketone product 3a in reduced yields (entries 2-4). Running the model reaction 
in the absence of a protic co-solvent had a deleterious impact on the reaction and led to the 
formation of 3a in only 22% yield. (entry 5). We also evaluated the effect of different protic 
co-solvents. Running the model reaction in the presence of ethanol or 2-propanol resulted in a 
slight decrease in yield of the corresponding ketone product 3a (entries 6-7).  However, the 
O
O
Bi(OTf)3 (x mol %)+
60 °C, 1 h
MeCN:MeOH (10:1)
O
O1a 2a 3a
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more acidic protic co-solvents, such as 3-hexafluoro-2-propanol and phenol, afforded ketone 
3a in significantly lower yields (entries 8-9). 
Table 2.3: Optimization of Substrate Concentrations and Catalyst Loading for the Conjugate 
Addition Reaction Between 1a and 2aa 
 
 
entry ratio 1a:2a Bi(OTf)3 (x mol %) yield b 3a (%) 
1 1:2 5 76 
2c 1:2 5 76 
3 1:1 5 62 
4 2:1 5 89 
5 3:1 5 98 
6 3:1 2.5 98 
7 3:1 1 82 
8c 3:1 1 98 
a Conditions: Reactions were performed with 3-methyl-2-cyclohexenone 1a (0.25-0.75 mmol), 2,3-
dimethylfuran 2a (0.50-25 mmol), Bi(OTf)3 (0.0025-0.013 mmol), acetonitrile/methanol (10:1, 0.5 
mL), 60 °C for 1h. b Determined by 1H NMR spectroscopy using dibromomethane as an internal 
standard. c Reaction ran for 2 h.  
 
To improve the yield of our model reaction, we investigate the impact of reaction time 
and substrate concentration. These results are summarized in Table 2.3. Running the model 
reaction for longer periods of time failed to deliver the corresponding ketone product 3a in 
increased yield (compare Table 3, entries 1 and 2). This observation led us to hypothesize that 
inhibition of the catalyst by ketone 3a may be significant as the reaction progresses. With this 
O
O
Bi(OTf)3 (x mol %)+
60 °C, 1 h
MeCN:MeOH (10:1)
O
O1a 2a 3a
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hypothesis in mind, we examined the impact of increasing the concentration of 3-methyl- 2-
cyclohexenone 1a relative to 2,3-dimethyl furan 2a. We found that running the reaction in the 
presence of excess enone enabled the construction of the desired ketone product 3a in good-
to-excellent yields (89-98%, entries 3-5). In the presence of excess enone, the loading of 
bismuth(III) triflate can be lowered to 2.5 mol % without impacting the yield of 3a (entry 6).  
Scheme 2.3: Catalytic Conjugate Addition of Heteroarenes to Enone 1aa 
 
a Conditions: Reactions were performed with 3-methyl-2-cyclohexenone 1a (0.75 mmol), heteroarene 
2a-2e (0.25 mmol), Bi(OTf)3 (0.0063 mmol), acetonitrile/methanol (10:1, 0.5 mL), 60 °C for 1h. b 
Reaction ran with 1a (1.25 mmol) for 3 h. 
Upon lowering the catalyst loading to 1 mol %, the model reaction generated 3a in 82% yield; 
however, if the reaction time is increased, product 3a is generated in 98% yield (entries 7 and 
8). 
To establish the scope of heteroarene nucleophiles, additions of a variety of electron-
rich heteroarenes to 3-methyl-2-cyclohexenone 1a were conducted under the reaction 
conditions identified in entry 6 of Table 2.3. These results are summarized in Scheme 2.3. As 
noted above, the addition of 2,3-dimethyl furan 2a to 1a occurs in high yield and 3a was 
isolated in 88% yield. The addition of 2-methylfruan 2b to 1a occurs to form product 3b in 
O
Bi(OTf)3 (2.5 mol %)
60 °C, 1 h
MeCN:MeOH (10:1)
O
X
R1
R2
heteroarene O
N
H
or
3 equiv
O
O
3a 88% yield
O
NH
3d 70% yield
O
S
OMe
3c 70% yield
O
N
H
3e 63% yield 
(84% yield)b
O
O
3b 90% yield
1a 3a-3d 3e
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90% yield. Additions were not limited to furan derivatives, and the reactions of 2-
methoxythiophene 2c and 2-methypyrrole 2d to 1a formed ketones 3c and 3d in 70% yield. 
The conjugate addition of indole 2e to 3-methyl-2-cyclohexenone 1a generated the 
corresponding ketone product 3e in 63% yield. The modest yield of 3e led us to further 
investigate reaction conditions, and we found that the reaction of 2e with 5 equivalents of 1a 
formed ketone 3e in 84% yield when the reaction was run for 3 hours. Additions of less 
nucleophilic heterocycles such as, benzofuran, benzothiophene, 2-bromofuran, and 2-
methylthiophene did not occur.  
The lower yields observed for conjugate additions of more nucleophilic 2-
methylpyrrole 2d and indole 2e compared to additions of less nucleophilic 2,3-dimethylfuran 
2a and 2-methylfruan 2b were unexpected. We conducted a series of competition experiments 
between 2-methylfuran, indole and 2-methylpyrrole to gain insight into these results (Scheme 
2.4) The competition between 2-methylfuran and indole formed product 3e, the product of 
indole addition, exclusively. The observed relative rates of addition between 2-methylfruan 
and indole are consistent with nucleophilicity parameters associated with these heterocycles.11 
In addition, the competition between 2-methylfuran and 2-methylpyrrole formed ketone 3d, 
the product of 2-methylpyrrole addition, exclusively. Competition between indole (1.5 
equivalents) and 2-methylpyrrole (1.5 equivalents) formed ketone product 3d exclusively, 
again these results are consistent with nucleophilicity parameters for these heterocycles. 
Surprisingly, the competition between indole (3 equivalents) and 2-methylpyrrole (3 
equivalents) did not occur to form the products of conjugate addition. Based on this observation 
we hypothesized that 2-methylpyrrole and/or indole nucleophiles can inhibit the active acid 
catalyst. To test our hypothesis, we evaluated the conjugate addition reactions of 2-
methylprryole 2d and indole 2e nucleophiles with enone 1a catalyzed by TfOD. The conjugate  
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Scheme 2.4: Competition Experiments Between 2-Methylfuran, Indole, and 2-Methylpyrrolea 
 
a Yields determined by 1H NMR spectroscopy using dibromomethane as an internal standard. 
addition reaction between 2-methylpyrrole 2d and 3-methyl-2-cyclohexenone 1a catalyzed by 
in situ generated TfOD led to the fomration of ketone product 3d in 62% yield. We observed 
significant deuterium incorporation (86% D) at the nucleophilic 5-postion of the remaining 2-
methylpyrrole (Equation 2.1). The analogous TfOD-catalyzed conjugate addition reaction  
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between indole 2e and enone 1a generated ketone product 3e in 42% yield, and 88% deuterium 
incorporation was observed at the 3-position of the remaining indole in the reaction mixture 
(Equation 2.2). These results support our hypothesis and provide further evidence that these 
nucleophilic heterocycles such as indole and 2-methylpyrrole do interact with the active TfOH 
catalyst. 
 With practical reaction conditions identified for the conjugate addition of indole 2e to 
3-methyl-2-cyclohexenone 1a, we next evaluated the conjugate additions of a variety of 
substituted indole nucleophiles. These results are summarized in Scheme 2.5. As noted above, 
the addition of indole 2e to 3-methyl-2-cyclohexenone 1a occurred to form ketone 3e in 84% 
yield. Reactions of indoles bearing electron-donating and electron-withdrawing substituents at 
the 5-postion with 1a occurred to form ketone products 3f-3h in moderate yields (46-58%). 
The addition of N-methylindole 2i to enone 1a generated product 3i in 67% yield. Reactions 
of 2-methylindole and 4-methylindole did not occur, likely due to the increased steric bulk 
adjacent to the C3 position of the indole. However, additions of 5-methyl, 6-methyl, and 7-
methylindole to 1a occurred to form ketone products 3j-3l in up to 77% yield.  
To further expand the scope of these conjugate addition reactions, we evaluated the 
conjugate additions of 2,3-dimethylfuran 2a, 2-methoxythiophene 2c, and indole 2e to a variety 
of 3-substituted enones (Scheme 2.6). The reactions of 3-ethyl-2-cyclohexenone 1b, 3-benzyl-
2-cyclohexenone 1c, and 3,5,5-trimethyl-2-cyclohexenone 1d with 2,3-dimethylfuran 2a 
occurred to form the ketone products 3m-3o in up to 69% yield. However, the conjugate  
O
+
O
MeCN-d3:MeOH-d4
(10:1), 60 °C
+
62% yield
H
N
H
N
NH
Bi(OTf)3  (2.5 mol %)
H/D
86% D
38% recovery
(2.2)
1a 2d
3d
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Scheme 2.5: Conjugate Addition of Indole Nucleophiles 2e-2l to Enone 1aa 
 
a Conditions: Reactions were performed with 3-methyl-2-cyclohexenone 1a (1.25 mmol), indole 2e-2l 
(0.25 mmol), Bi(OTf)3 (0.0063 mmol), acetonitrile/methanol (10:1, 0.5 mL), 60 °C for 1h. 
 
additions of 2,3- dimethylfuran 2a to cyclic enones containing bulkier b-substituents, such as 
3-isopropyl-2-cyclohexenone, 3-cyclohexyl-2-cyclohexenone, and 3-phenyl-2-cyclohexenone 
did not occur. The lack of reactivity observed for these enones bearing a bulky b-substituent is 
attributed to the increased steric bulk at the b-position Additions of 2,3-dimethylfuran 2a, 2-
methoxythiophene 2c, and indole 2e to 3-methyl-2-cyclopentenone 1e and 3-methyl-2-
cycloheptenone 1f occurred to form ketone products 3p-3u in 37-79% yield.  Additions of 
heteroarenes 2a, 2c, and 2e are not limited to cyclic b,b-disubstituted enones, and additions of 
these heteroarenes to 4-methyl-3-penten-2-one 1g occurred to form the conjugate addition 
products 3v-3x in in 66-79% yield.  
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Scheme 2.6: Conjugate Addition of Heteroarenes to b,b-Disubstituted Enones 1b-1ga 
 
a Conditions: Reactions were performed with enone 1b-1g (0.75 mmol), heteroarene 2a, 2c, 2e (0.25 
mmol), Bi(OTf)3 (0.0063 mmol), acetonitrile/methanol (10:1, 0.5 mL), 60 °C for 1h. b Reaction ran 
with enone 1e, 1f, or 1g (1.25 mmol) for 3 h. 
 
During studies to assess the scope for the conjugate additions of electron-rich heteroarenes to 
b,b-disubstituted enones we made two key observations: (1) additions of electron-rich 
heteroarenes to b,b-disubstituted enones was exceptionally sensitive to the size of the b-
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substituent. (2) under the guise of applying our model conjugate addition reactions to include 
biologically active enones, such as progesterone, no conjugate addition reaction was observed. 
Serendipitously, we discovered that this reaction manifold promoted a sequential 1,2-addition 
and dehydration pathway to generate heteroarylated steroidal dienes. 
Conclusions 
In conclusion, we have developed a series of conjugate additions of heteroarenes to 
b,b-disubstituted enones that form ketones bearing heteroarylated, all-carbon quaternary 
centers. These addition reactions occur under ambient pressures in in the presence of low 
loadings of bismuth(III) triflate. This method improves the reaction efficiency and expands the 
scope of heteroarene additions to b,b-disubstituted enones. Addition of furans, thiophenes, 
pyrroles, and indoles to a variety of cyclic and acyclic b,b-disubstituted enones occur to form 
ketone products in up to 90% yield.   
Experimental 
General Experimental Details. All air-sensitive procedures were conducted under 
inert atmosphere in a nitrogen-filled drybox or by standard Schlenk techniques. All reactions 
were performed under an atmosphere of nitrogen unless otherwise stated. All glassware for 
moisture sensitive reactions was dried at 140 °C in an oven. Dichloromethane, ether, and 
tetrahydrofuran were dried with a solvent purification system by passing through a one-meter 
column of activated alumina. Anhydrous acetonitrile and methanol was purchased from 
Sigma-Aldrich and used as received. Flash column chromatography was performed on 
SiliFlash® P60 silica gel (40-63μm, 60Å) or using a Teledyne Isco Combiflash® Rf system 
with RediSep GoldTM columns using hexanes/ethyl acetate or hexanes/diethyl ether. Reaction 
products were visualized on TLC by UV light or by staining with KMnO4. 
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HRMS (ESI) analysis was performed at the Iowa State University Chemical 
Instrumentation Facility on an Agilent 6540 QTOF spectrometer. NMR spectra were acquired 
on Varian MR-400 and Bruker Avance III 600 spectrometers at the Iowa State University 
Chemical Instrumentation Facility. Chemical shifts are reported in ppm relative to a residual 
solvent peak (CDCl3 = 7.26 ppm for 1H and 77.16 ppm. Coupling constants are reported in 
hertz. 
Materials. 3-Methylcyclohex-2-en-1-one 1a, 3-methylcyclopent-2-en-1-one 1d, 4-
methylpent-3-en-2-one 1f, 3,5,5-trimethylcyclhex-2-en-1-one 1g, 2-methylfuran 2b, and 2-
methoxythiophene 2c were purchased from TCI and used without further purification. 2,3-
Dimethylfuran 2a, 2-methyl-1H-pyrrole 2d, 1H-indole 2e, 5-methoxy-1H-indole 2f, N-
methylindole 2i, and 5-cyano-1H-indole 2h were purchased from AK Scientific and used 
without further purification. 5-Methyl-1H-indole 2j, and 6-methyl-1H-indole 2k were 
purchased from Combi-Blocks and used without further purification. 7-Methyl-1H-indole 2l 
were purchased from Sigma-Aldrich and used without any further purification. 5-Bromo-1H-
indole 2g was purchased from Frontier Scientific and used without further purification. 
Bismuth(III) trifluoromethanesulfonate was purchased from Strem Chemicals. 3-Ethyl-2-
cyclohex-2-en-1-one 1b was synthesized according to literature procedure.12 3-Benzyl-2-
cyclohex-2-en-1-one 1c was synthesized according to literature procedure.13 3-Methyl-2-
cyclohept-2-en-1-one 1d was synthesized according to literature procedure.14 
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General Procedure A: Acid-Catalyzed Conjugate Additions of Heteroarenes 2a-2d to 
Enones 1a-1g 
 
To a 1 dram vial was added Bi(OTf)3 (4.2 mg, 0.0063 mmol, 0.025 equiv), heteroarene 2a, 
2b, 2c or 2d (0.25 mmol, 1.00 equiv), enone 1a, 1b, 1c, 1d, 1e, 1f, or 1g (0.75 mmol, 3.00 
equiv), and acetonitrile and methanol (10:1) solution (0.5 mL). The vial was sealed with a 
PFTE/silicone-lined septum cap. The reaction was heated to 60 °C and allowed to stir at this 
temperature for 1h. The mixture was cooled and concentrated under reduced pressure. The 
crude reaction mixture was dissolved in CDCl3 (0.7 mL) and CH2Br2 (8.9 μL, 0.25 mmol) was 
added as an internal standard. NMR yields were determined by 1H NMR spectroscopy of the 
crude reaction mixture. The crude reaction mixture was purified by flash column 
chromatography on silica gel (hexane:EtOAc) or (hexane:ether) to yield the desired ketones 
3a-3d,3m-3s, 3v, and 3w. 
General Procedure B: Acid-Catalyzed Conjugate Additions of Indoles 2e-2l to Enones 
1a, 1e-1g 
 
To a 1 dram vial was added the appropriate Bi(OTf)3 (4.2 mg, 0.0063 mmol, 0.025 equiv), 
O
R1(  )n
heteroarene 2a-2d
Bi(OTf)3 (2.5 mol%)
n = 0, 1, 2
R1 = alkyl
1a-1g
O
R1
(  )n X
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MeCN:MeOH (10:1) 
60 °C, 1h
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R3
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(  )n
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heteroarene 2e-2l (0.25 mmol, 1.00 equiv), enone 1a, 1e-1g (1.25 mmol, 5.00 equiv), and 
acetonitrile and methanol (10:1) solution (0.5 mL). The vial was sealed with a PFTE/silicone-
lined septum cap. The reaction was heated to 60 °C and allowed to stir at this temperature for 
1-3 h. The mixture was cooled and concentrated under reduced pressure. The crude reaction 
mixture was dissolved in CDCl3 (0.7 mL) and CH2Br2 (8.9 μL, 0.25 mmol) was added as an 
internal standard. NMR yields were determined by 1H NMR spectroscopy of the crude reaction 
mixture. The crude reaction mixture was purified by flash column chromatography on silica 
gel (hexane:EtOAc) or (hexane:ether) to yield the desired ketones 3e-3l, 3t, 3u, 3x. 
Characterization Data for Ketones 3a-3x 
3-(4,5-dimethylfuran-2-yl)-3-methylcyclhexan-1-one (3a): Prepared 
according to General Procedure A from 3-methycyclohex-2-en-1-one 1a (84 
μL, 0.75 mmol) and 2,3-dimethylfuran 2a (26 μL, 0.25 mmol). The crude 
product was purified by flash column chromatography (80:20 hexanes:ether) 
to yield 3a (46.2 mg, 0.220 mmol, 88%) as a colorless oil. 1H NMR (600 MHz, CDCl3): δ 5.80 
(s, 1H), 2.74 (d, J = 14.4 Hz, 1H), 2.36-2.26 (m, 3H), 2.24-2.20 (m, 1H), 2.18 (s, 3H), 1.90-
1.86 (m, 4H), 1.76-1.62 (m, 2H), 1.32 (s, 3H). 13C NMR (150 MHz, CDCl3): δ 210.9, 156.5, 
145.9, 114.0, 108.3, 51.9, 40.7, 40.3, 35.9, 27.3, 22.1, 11.2, 9.8. HRMS (ESI) calcd. for 
C13H19O2+ [M+H]+ 207.1380, found 207.1381. 
3-(5-methylfuran-2-yl)-3-methylcyclhexan-1-one (3b): Prepared according 
to General Procedure A from 3-methycyclohex-2-en-1-one 1a (84 μL, 0.75 
mmol) and 2-methylfuran 2b (23 μL, 0.25 mmol). The crude product was 
purified by flash column chromatography (80:20 hexanes:ether) to yield 3b 
(43.9 mg, 0.228 mmol, 91%) as a colorless oil. 1H NMR (600 MHz, CDCl3): δ 5.86 (d, J = 2.4 
Hz, 1H), 5.81 (d, J = 2.4 Hz, 1H), 2.71 (d, J = 14.4 Hz, 1H), 2.36-2.16 (m, 4H), 2.24 (s, 3H), 
O
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1.90-1.81 (m, 1H), 1.76-1.58 (m, 2H), 1.30 (s, 3H).  (150 MHz, CDCl3): δ 210.9, 158.0, 150.9, 
105.8, 105.7, 52.0, 40.8, 40.6, 36.0, 27.3, 22.2, 13.6. HRMS (ESI) calcd. for C12H17O2+ [M+H]+ 
193.1223, found 193.1228.   
3-(5-methoxythiophen-2-yl)-3-methylcyclhexan-1-one (3c): Prepared 
according to General Procedure A from 3-methycyclohex-2-en-1-one 1a 
(84 μL, 0.75 mmol) and 2-methoxythiophene 2c (25 μL, 0.25 mmol). The 
crude product was purified by flash column chromatography (80:20 
hexanes:ether) to yield 3c (39.3 mg, 0.175 mmol, 70%) as a orange oil. 1H NMR (600 MHz, 
CDCl3): δ 6.38 (d, J = 3.6 Hz, 1H), 5.93 (d, J = 3.6 Hz, 1H), 3.83 (s, 3H), 2.77 (d, J = 14.4 Hz, 
1H), 2.39 (d, J = 14.4 Hz, 1H), 2.35-2.23 (m, 2H), 2.07-1.99 (m, 1H), 1.92-1.84 (m, 2H), 1.81-
1.73 (m, 1H), 1.35 (s, 3H). 13C NMR (150 MHz, CDCl3): δ 210.6, 164.7, 139.0, 120.6, 102.6, 
60.2, 53.6, 42.2, 40.7, 39.5, 31.2, 22.1. HRMS (ESI) calcd. for C12H17O2S+ [M+H]+ 225.0955, 
found 225.0952 
3-(5-methyl-1H-pyrrol-2-yl)-3-methylcyclhexan-1-one (3d): Prepared 
according to General Procedure A from 3-methycyclohex-2-en-1-one 1a (84 
μL, 0.75 mmol) and 2-methyl-1H-pyrrole 2c (22 μL, 0.25 mmol). The crude 
product was purified by flash column chromatography (80:20 hexanes:ether) 
to yield 3d (33.6 mg, 0.174 mmol, 70%) as a white solid. 1H NMR (600 MHz, CDCl3): δ 7.64 
(br, s, 1H), 5.79 (m, 1H), 5.75 (m, 1H), 2.74 (ddd, J = 14.4, 1.6, 1.6 Hz, 1H), 2.36 (d, J = 14.4 
Hz, 1H), 2.33-2.26 (m, 2H), 2.23 (s, 3H), 2.08-1.98 (m, 1H), 1.92-1.80 (m, 2H), 1.75-1.63 (m, 
1H), 1.32 (s, 3H). 13C NMR (150 MHz, CDCl3): δ 211.4, 136.4, 126.9, 105.8, 105.0, 53.1, 
40.9, 39.7, 38.0, 29.5, 22.4, 13.2. HRMS (ESI) calcd. for C12H18NO+ [M+H]+ 192.1394, found 
192.1390.   
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3-(1H-indol-3-yl)-3-methylcyclohexan-1-one (3e): Prepared according to 
General Procedure B from 3-methylcyclohex-2-en-1-one 1a (140 μL, 1.25 
mmol) and 1H-indole 2e (29.3 mg, 0.250 mmol). The crude product was 
purified with a CombiFlash system (12 g column, 95:5 to 85:15 
hexane:EtOAc) to yield 3e (48.1 mg, 0.210 mmol, 84%) as a white solid. 1H NMR (600 MHz, 
CDCl3): δ  8.03 (br, s, 1H), 7.76 (d J = 7.8 Hz, 1H), 7.37 (d J = 7.8 Hz, 1H), 7.19 (dd, J = 8.4, 
7.8 Hz, 1H), 7.10 (dd, J = 8.4, 7.8 Hz, 1H) , 6.96 (d, J = 2.4 Hz, 1H), 2.91 (d, J = 14.4 Hz, 1H), 
2.62-2.55 (m, 2H), 2.48 (d, J = 14.4 Hz, 1H), 2.36-2.24 (m, 2H), 1.96-1.79 (m, 3H), 1.53 (s, 
3H). 13C NMR (150 MHz, CDCl3): δ 212.8, 137.4, 125.1, 122.2, 122.0, 121.9, 120.9, 119.1, 
111.7, 54.4, 41.1, 40.2, 36.7, 29.4, 22.5. HRMS (ESI) calcd. for C15H18NO+ [M+H]+ 228.1394, 
found 228.1390. 
3-(5-methoxy-1H-indol-3-yl)-3-methylcyclohexan-1-one (3f): 
Prepared according to General Procedure B from 3-methylcyclohex-
2-en-1-one 1a (140 μL, 1.25 mmol) and 5-methoxy-1H-indole 2f (37.0 
mg, 0.250 mmol). The crude product was purified by flash column 
chromatography (70:30 hexanes:ether) to yield 3f (37.2 mg, 0.145 mmol, 58%) as a white 
solid. 1H NMR (600 MHz, CDCl3): δ 7.89 (br, s, 1H), 7.26 (d, J = 9.0 Hz, 1H), 7.19 (d, J = 
2.4 Hz, 1H), 6.94 (d, J = 2.4 Hz, 1H), 6.87 (dd, J = 9.0, 2.4 Hz, 1H) 3.87 (s, 3H), 2.89 (d, J = 
14.4 Hz, 1H), 2.60-2.53 (m, 1H), 2.47 (d, J = 14.4 Hz, 1H), 2.36-2.24 (m, 2H), 1.96-1.79 (m, 
2H), 1.59-1.41 (m, 4H). 13C NMR (150 MHz, CDCl3): δ 212.7, 153.4, 132.7, 125.5, 123.1, 
121.6, 112.2, 111.5, 103.8, 56.2, 54.4, 41.1, 40.1, 36.5, 29.1, 22.4. HRMS (ESI) calcd. for 
C16H20NO2+ [M+H]+ 258.1500, found 258.1493. 
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3-(5-bromo-1H-indol-3-yl)-3-methylcyclohexan-1-one (3g): Prepared 
according to General Procedure B from 3-methylcyclohex-2-en-1-one 1a 
(140 μL, 1.25 mmol) and 5-bromo-1H-indole 2g (49.0 mg, 0.250 mmol). 
The crude product was purified using a CombiFlash system (12 g 
column, 95:5 to 85:15 hexane:EtOAc) to yield 3g (41.1 mg, 0.134 mmol, 54%) as a white 
solid. 1H NMR (600 MHz, CDCl3): δ 8.39 (br, s, 1H), 7.88 (s, 1H), 7.29-7.25 (m, 2H), 6.98 
(d, J = 2.4 Hz, 1H), 2.89 (d, J = 14.4 Hz, 1H), 2.56-2.52 (m, 1H), 2.50 (d, J = 14.4 Hz, 1H), 
2.33-2.27 (m, 2H), 1.94-1.84 (m, 2H), 1.51 (s, 3H), 1.49-1.42 (m, 1H). 13C NMR (150 MHz, 
CDCl3): δ 212.7, 136.0, 126.8, 124.8, 123.5, 123.3, 121.6, 113.1, 112.4, 54.4, 41.1, 40.2, 36.7, 
29.5, 22.4. HRMS (ESI) calcd. for C15H17BrNO+ [M+H]+ 306.0488, found 306.0492.     
 3-(1-methyl-3-oxocyclohexyl)-1H-indole-5-carbonitrile (3h): 
Prepared according to General Procedure B from 3-methylcyclohex-2-
en-1-one 1a (140 μL, 1.25 mmol) and 5-cyano-1H-indole 2h (49.0 mg, 
0.250 mmol). The crude product was purified by flash column 
chromatography (70:30 hexanes:ether)  to yield 3h (29.0 mg, 0.115 mmol, 46%) as a white 
solid. 1H NMR (400 MHz, CDCl3): δ 8.42 (br, s, 1H), 8.11 (m, 1H), 7.43-7.42 (m, 2H), 7.10 
(d, J = 2.4, 1H), 2.89 (d, J = 14.4, 1H), 2.54-2.49 (m, 2H), 2.33-2.30 (m, 2H), 2.00-1.82 (m, 
2H), 1.51 (s, 3H), 1.48-1.34 (m, 1H). 13C NMR (100 MHz, CDCl3): 212.0, 139.0, 126.5, 125.0 
(2C), 124.5, 123.0, 120.9, 112.5, 102.6 54.3, 41.1, 40.3, 37.0, 29.8, 22.5. HRMS (ESI) calcd. 
for C16H17N2O+ [M+H]+ 253.1335, found 253.1335. 
3-methyl-3-(1-methylindol-3-yl)cyclohexan-1-one (3i): Prepared 
according to General Procedure B from 3-methylcyclohex-2-en-1-one 1a 
(140 μL, 1.25 mmol) and 1-methylindole 2i (31 μL, 0.250 mmol). The crude 
product was purified by flash column chromatography (80:20 
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hexanes:ether)  to yield 3i (42.5 mg, 0.176 mmol, 70%) as an orange oil. 1H NMR (600 MHz, 
CDCl3): δ 7.75 (d, J = 7.8 Hz, 1H), 7.30 (d, J = 7.8 Hz, 1H),  7.22 (ddd, J = 7.8, 7.2, 1.2 Hz, 
1H), 7.09 (ddd, J = 7.8, 7.2, 1.2 Hz, 1H), 6.80 (s, 1H), 3.73 (s, 3H), 2.90 (ddd, J = 14.4, 1.8, 
1.8 Hz, 1H), 2.62-2.55 (m, 1H), 2.47 (d, J = 14.4 Hz, 1H), 2.36-2.24 (m, 2H), 1.94-1.76 (m, 
2H), 1.59-1.41 (m, 4H). 13C NMR (150 MHz, CDCl3): δ 212.5, 138.0, 126.9, 125.5, 121.5, 
121.0, 120.5, 118.6, 109.7, 54.5, 41.1, 40.1, 36.9, 32.8, 29.6, 22.5. HRMS (ESI) calcd. for 
C16H20NO+ [M+H]+ 242.1539, found 242.1544. 
3-methyl-3-(5-methyl-1H-indol-3-yl)cyclohexan-1-one (3j): Prepared 
according to General Procedure B from 3-methylcyclohex-2-en-1-one 1a 
(140 μL, 1.25 mmol) and 5-methyl-1H-indole 2j (33.5 mg, 0.250 mmol). 
The crude product was purified using a CombiFlash system (12 g column, 
95:5 to 85:15 hexane:EtOAc) to yield 3j (35.0 mg, 0.145 mmol, 58%) as a white solid. 1H 
NMR (400 MHz, CDCl3): δ 7.91 (br, s, 1H), 7.53 (s, 1H), 7.26 (d, J = 8.4 Hz, 1H), 7.02 (dd, 
J = 8.4, 0.6 Hz, 1H), 6.92 (d, J = 2.4 Hz, 1H), 2.89 (ddd, J = 14.4, 1.8, 1.8 Hz, 1H), 2.62-2.52 
(m, 1H), 2.51-2.42 (m, 4H), 2.36-2.22 (m, 2H), 1.95-1.79 (m, 2H), 1.55-1.45 (m, 4H). 13C 
NMR (100 MHz, CDCl3): δ 212.7, 137.8, 131.9, 122.9, 121.9, 121.6, 120.9, 120.5, 111.6, 54.4, 
41.1, 40.2, 36.8, 29.4, 22.5, 21.7. HRMS (ESI) calcd. for C16H20NO+ [M+H]+  242.1539, found 
242.1545. 
3-methyl-3-(6-methyl-1H-indol-3-yl)cyclohexan-1-one (3k): Prepared 
according to General Procedure B from 3-methylcyclohex-2-en-1-one 1a 
(140 μL, 1.25 mmol) and 6-methyl-1H-indole 2k (33.5 mg, 0.250 mmol). 
The crude product was purified using a CombiFlash system (12 g column, 
95:5 to 85:15 hexane:EtOAc) to yield 3k (45.7 mg, 0.189 mmol, 76%) as a white solid. 1H 
NMR (600 MHz, CDCl3): δ 7.89 (br, s, 1H), 7.63 (dd, J = 8.4, 2.4 Hz, 1H), 7.16 (s, 1H), 6.94 
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(dd, J = 8.4, 2.4 Hz, 1H), 6.88 (m, 1H), 2.90 (d, J = 14.4 Hz, 1H), 2.61-2.53 (m, 1H), 2.50-
2.43 (m, 4H), 2.38-2.23 (m, 2H), 1.93-1.78 (m, 2H), 1.55-1.45 (m, 4H). 13C NMR (150 MHz, 
CDCl3): δ 212.7, 137.8, 131.9, 122.9, 121.9, 121.6, 120.9, 120.5, 111.6, 54.4, 41.1, 40.2, 36.8, 
29.4, 22.5, 21.7. HRMS (ESI) calcd. for C16H20NO+ [M+H]+ 242.1539, found 242.1540. 
3-methyl-3-(7-methyl-1H-indol-3-yl)cyclohexan-1-one (3l): Prepared 
according to General Procedure B from 3-methylcyclohex-2-en-1-one 1a 
(140 μL, 1.25 mmol) and 7-methyl-1H-indole 2l (33.5 mg, 0.250 mmol). 
The crude product was purified using a CombiFlash system (12 g column, 
95:5 to 85:15 hexane:EtOAc) to yield 3l (45.7 mg, 0.189 mmol, 76%) as a white solid. 1H 
NMR (600 MHz, CDCl3): δ 8.06 (br, s, 1H), 7.62 (d, J = 7.6 Hz, 1H), 7.08-6.94 (m, 3H), 2.92 
(d, J = 14.4 Hz, 1H), 2.63-2.56 (m, 1H), 2.51-2.45 (m, 4H), 2.34-2.25 (m, 2H), 1.94-1.78 (m, 
2H), 1.55-1.45 (m, 4H). 13C NMR (150 MHz, CDCl3): δ 212.8, 136.9, 124.6, 122.6, 122.5, 
121.9, 120.8, 119.4, 118.68, 54.5, 41.2, 40.2, 36.7, 29.4, 22.5, 16.8. HRMS (ESI) calcd. for 
C16H20NO+ [M+H]+ 242.1539, found 242.1544. 
3-(4,5-dimethylfuran-2-yl)-3-ethylcyclhexan-1-one (3m): Prepared 
according to General Procedure A from 3-ethylcyclohex-2-en-1-one 1b (99 
μL, 0.75 mmol) and 2,3-dimethylfuran 2a (26 μL, 0.25 mmol). The crude 
product was purified with CombiFlash system (12 g column, 100:0 to 90:10 
hexane:EtOAc) to yield 3m (35.2 mg, 0.163 mmol, 65%) as a colorless oil. 1H NMR (400 
MHz, CDCl3): δ 5.76 (s, 1H), 2.67 (dd, J = 14.4 Hz, 1H), 2.32-2.21 (m, 3H), 2.17-2.12 (m, 
4H), 1.85-1.78 (m, 4H), 1.77-1.68 (m, 2H), 1.58-1.50 (m, 2H), 0.70 (dt, J = 7.8, 2.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 211.2, 154.3, 146.1, 114.0, 110.8, 49.4, 44.3, 41.1, 34.4, 33.7, 
22.00, 11.4, 10.0, 8.4. HRMS (ESI) calcd. for C14H21O2+ [M+H]+  221.1539, found 221.1537. 
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3-benzyl-3-(4,5-dimethylfuran-2-yl)cyclhexan-1-one (3n): Prepared 
according to General Procedure A from 3-benzylcyclohex-2-en-1-one 1c (129 
μL, 0.75 mmol) and 2,3-dimethylfuran 2a (26 μL, 0.25 mmol). The crude 
product was purified by flash column chromatography (80:20 hexanes:EtOAc) 
to yield 3n (37.4 mg, 0.134 mmol, 53%) as a colorless oil. 1H NMR (600 MHz, CDCl3): δ 
7.23-7.15 (m, 3H), 6.81 (d, J = 6.5 Hz, 2H), 5.62 (s, 1H), 3.02 (d, J = 13.2 Hz, 1H), 2.85 (d, J 
= 13.2 Hz, 1H), 2.45 (d, J = 14.2 Hz, 1H), 2.33-2.23 (m, 3H), 2.20 (s, 3H), 2.22 (m, 1H), 1.89-
1.81 (m, 4H), 1.75 (m, 1H), 1.55-1.43 (m, 1H). 13C NMR (150 MHz, CDCl3): δ 211.0, 153.4, 
146.1, 137.0, 130.4, 127.9, 126.5, 114.3, 111.9, 49.0, 47.8, 45.0, 40.9, 34.3, 21.9, ll.4, 10.0. 
HRMS (ESI) calcd. for C19H23O2+ [M+H]+ 283.1693, found 283.1697 
3-(4,5-dimethylfuran-2-yl)-3,5,5-trimethylcyclohexan-1-one (3o): 
Prepared according to General Procedure A from 3,5,5-trimethylcyclohex-
2-en-1-one 1g (112 μL, 0.75 mmol) and 2,3-dimethylfuran 2a (26 μL, 0.25 
mmol). The crude product was purified with a CombiFlash system (12 g 
column, 95:5 to 85:15 hexane:EtOAc) to yield 3o (34.9 mg, 0.149 mmol, 60% yield) as a white 
solid. 1H NMR (600 MHz, CDCl3): δ 5.77 (s, 1H), 2.72 (d, J = 14.4 Hz, 1H), 2.29-2.25 (m, 
2H), 2.17-2.09 (m, 5H), 1.84 (s, 3H), 1.84 (d, J = 14.4 Hz, 1H), 1.30 (s, 3H), 1.02 (s, 3H), 0.51 
(s, 3H). 13C NMR (150 MHz, CDCl3): δ 211.0, 156.4, 145.3, 114.5, 108.5, 54.4, 50.7, 48.6, 
39.7, 35.7, 33.5, 31.7, 26.6, 11.4, 10.0. HRMS (ESI) calcd. for C15H23O2+ [M+H]+ 235.1693, 
found 235.1699. 
3-(4,5-dimethylfuran-2-yl)-3-methylcyclopentan-1-one (3p): Prepared 
according to General Procedure A from 3-methylcyclopent-2-en-1-one 1d (76 μL, 
0.75 mmol) and 2,3-dimethylfuran 2a (26 μL, 0.25 mmol). The crude product was 
purified by flash column chromatography (80:20 hexanes:EtOAc) to yield 3p 
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(36.2 mg, 0.188 mmol, 75%) as a yellow oil. 1H NMR (600 MHz, CDCl3): δ 5.80 (s, 1H), 2.65 
(d, J = 18.0 Hz, 1H), 2.39-2.28 (m, 3H), 2.20 (d, J = 18.0 Hz, 1H), 2.15 (s, 3H), 1.97-1.90 (m, 
1H), 1.88 (s, 3H), 1.41 (s, 3H). 13C NMR (150 MHz, CDCl3): δ 218.7, 157.0, 146.3, 114.2, 
107.3, 51.4, 40.7, 37.1, 35.3, 25.9, 11.4, 10.0. HRMS (ESI) calcd. for C12H17O2+ [M+H]+ 
193.1223, found 193.1227. 
3-(4,5-dimethylfuran-2-yl)-3-methylcycloheptan-1-one (3q): Prepared 
according to General Procedure A from 3-methylcyclohept-2-en-1-one 1e 
(99 μL, 0.75 mmol) and 2,3-dimethylfuran 2a (26 μL, 0.25 mmol). The 
crude product was purified by flash column chromatography (80:20 
hexanes:ether) to yield 3q (43.7 mg, 0.198 mmol, 79%) as a colorless oil. 1H NMR (600 MHz, 
CDCl3): δ 5.75 (s, 1H), 2.98 (d, J = 13.8 Hz, 1H), 2.62 (d, J = 13.8 Hz, 1H), 2.42 (dd, J = 6.0, 
6.0 Hz, 2H), 2.22-2.17 (m, 1H), 2.14 (s, 3H), 1.87 (s, 3H), 1.79-1.67 (m, 5H), 1.22 (s, 3H). 13C 
NMR (150 MHz, CDCl3): δ 213.4, 158.2, 145.7, 114.1, 107.0, 54.1, 44.3, 42.2, 37.6, 28.0, 
25.6, 24.1, 11.4, 10.0.  HRMS (ESI) calcd. for C14H21O2+ [M+H]+ 221.1536, found 221.1539. 
3-(5-methoxythiophen-2-yl)-3-methylcyclopentan-1-one (3r): Prepared 
according to General Procedure A from 3-methylcyclopent-2-en-1-one 1d (76 
μL, 0.75 mmol) and 2-methoxythiophene 2c (25 μL, 0.25 mmol). The crude 
product was purified with a CombiFlash system (12 g column, 95:5 to 90:10 
hexane:EtOAc) to yield 3r (29.7 mg, 0.141 mmol, 56%) as a yellow oil. 1H NMR (600 MHz, 
CDCl3): δ 6.41 (d, J = 3.6 Hz, 1H), 5.97 (d, J = 3.6 Hz, 1H), 3.85 (s, 3H), 2.64 (d, J = 18.0 Hz, 
1H), 2.40-2.24 (m, 4H), 2.14-2.04 (m, 1H), 1.47 (s, 3H). 13C NMR (150 MHz, CDCl3): δ 
218.17, 164.9, 139.2, 119.9, 103.0, 60.5, 53.7, 42.7, 38.3, 37.3, 29.2. HRMS (ESI) calcd. for 
C11H15O2S+ [M+H]+ 211.0787, found 211.0785. 
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3-(5-methoxythiophen-2-yl)-3-methylcycloheptan-1-one (3s): 
Prepared according to General Procedure A from 3-methylcyclohept-2-
en-1-one 1e (99 μL, 0.75 mmol) and 2-methoxythiophene 2c (25 μL, 
0.25 mmol). The crude product was purified by flash column chromatography (80:20 
hexane:EtOAc) to yield 3s (32.8 mg, 0.138 mmol, 55%) as a yellow oil. 1H NMR (600 MHz, 
CDCl3): δ 6.40 (d, J = 3.6 Hz, 1H), 5.95 (d, J = 3.6 Hz, 1H), 3.84 (s, 3H), 3.07 (d, J = 13.7 Hz, 
1H), 2.69 (d, J = 13.7 Hz, 1H), 2.47-2.35 (m, 2H), 2.16-2.07 (m, 1H), 1.92-1.65 (m, 5H), 1.30 
(s, 3H). 13C NMR (150 MHz, CDCl3): δ 213.0, 164.4, 140.4, 119.5, 102.7, 60.2, 56.2, 45.3, 
44.2, 39.3, 31.4, 25.7, 20.9.  HRMS (ESI) calcd. for C13H19O2S+ [M+H]+ 239.1100, found 
239.1106. 
3-(1H-indol-yl)-3-methylcyclopentan-1-one (3t): Prepared according to 
General Procedure B from 3-methylcyclopent-2-en-1-one 1d (127 μL, 1.25 
mmol) and indole 2e (29.3 mg, 0.250 mmol). The crude product was purified 
with a CombiFlash system (12 g column, 95:5 to 85:15 hexane:EtOAc) to 
yield 3t (19.8 mg, 0.093 mmol, 37%) as a colorless oil. 1H NMR (600 MHz, CDCl3): δ 8.01 
(br, s, 1H), 7.73 (d, J = 7.8 Hz, 1H), 7.39 (ddd, J = 7.8, 1.2, 1.2 Hz, 1H), 7.23 (ddd, J = 7.8, 
7.2, 1.2 Hz, 1H), 7.13 (ddd, J = 7.8, 7.2, 1.2 Hz, 1H), 6.94 (d, J = 2.4 Hz, 1H) 2.82 (d, J = 17.4 
Hz, 1H), 2.61-2.57 (m, 1H), 2.47 (d = J = 17.4 Hz, 1H), 2.40-2.36 (m, 1H), 2.33-2.27 (m, 1H), 
2.24-2.19 (m, 1H), 1.62 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 219.7, 137.5, 125.6, 122.9, 
122.2, 120.6, 120.2, 119.4, 111.7, 52.9, 40.0, 37.0, 35.8, 27.9. HRMS (ESI) calcd. for 
C14H16NO+ [M+H]+ 214.1226, found 214.1226. 
3-(1H-indol-yl)-3-methylcycloheptan-1-one (3u): Prepared according 
to General Procedure B from 3-methylcyclohept-2-en-1-one 1e (99 μL, 
1.25 mmol) and indole 2e (29.3 mg, 0.250 mmol). The crude product was 
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purified with a CombiFlash system (12 g column, 95:5 to 85:15 hexane:EtOAc) to yield 3u 
(27.6 mg, 0.115 mmol, 46%) as a white solid. 1H NMR (600 MHz, CDCl3): δ 8.05 (br, s, 1H), 
7.81 (d, J = 7.8 Hz, 1H), 7.37 (d, J = 7.8 Hz,1H), 7.19 (dd, J = 7.8, 7.2  Hz, 1H), 7.11 (dd, J = 
7.8, 7.2 Hz, 1H), 6.97 (s,  1H), 3.31 ( d, J = 13.8 Hz, 1H), 2.83 ( d, J = 13.8 Hz, 1H), 2.61-2.57 
(m, 1H), 2.50-2.41 (m, 2H), 2.00-1.95 (m, 1H), 1.83-1.74 (m, 4H), 1.43 (s, 3H) 13C NMR (150 
MHz, CDCl3): δ 214.7, 137.2, 125.4, 124.3, 121.9, 121.1, 120.4, 119.3, 111.6, 56.3, 44.4, 43.2, 
37.2, 29.1, 25.8, 24.3. HRMS (ESI) calcd. for C16H20NO+ [M+H]+  242.1539, found 242.1546. 
4-(4,5-dimethylfur-2-yl)-4-methylpentan-2-one (3v): Prepared 
according to General Procedure A from 4-methylpent-3-en-2-one 1f (84 
μL, 0.75 mmol) and 2,3-dimethylfuran 2a (26 μL, 0.25 mmol). The crude 
product was purified by flash column chromatography (80:20 hexanes:ether) to yield 3v (36.9 
mg, 0.189 mmol, 76%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 5.75 (s, 1H), 2.66 (s, 
2H), 2.16 (s, 3H), 1.88 (s, 3H), 1.85 (s, 3H), 1.31 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 
208.7, 158.2, 145.6, 114.3, 106.9, 54.6, 35.1, 31.4, 27.2, 11.4, 10.1. HRMS (ESI) calcd. for 
C12H19O2+ [M+H]+ 195.1380, found 195.1385. 
4-(5-methoxythiophen-2-yl)-4-methylpentan-2-one (3w): Prepared 
according to General Procedure A from 4-methylpent-3-en-2-one 1f 
(84 μL, 0.75 mmol) and 2-methoxythiophene 2c (25 μL, 0.25 mmol). 
The crude product was purified by flash column chromatography (80:20 hexanes:ether) to 
yield 3w (34.9 mg, 0.164 mmol, 66%) as a yellow oil. 1H NMR (400 MHz, CDCl3): δ 6.40 (d, 
J = 4.0 Hz, 1H), 5.96 (d, J = 4.0 Hz, 1H), 3.84 (s, 3H), 2.65 (s, 2H), 1.92 (s, 3H), 1.41 (s, 6H).  
13C NMR (100 MHz, CDCl3): 208.1, 164.3, 140.2, 119.6, 102.7, 60.2, 57.5, 36.9, 32.0, 29.7. 
HRMS (ESI) calcd. for C11H17O2S+ [M+H]+ 213.0944, found 213.0946.   
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4-(1H-indol-yl)-4-methylpentan-2-one (3x): Prepared according to 
General Procedure B from 4-methylpent-3-en-2-one 1f (140 μL, 1.25 
mmol) and indole 2e (29.3 mg, 0.250 mmol). The crude product was 
purified with CombiFlash system (12 g column, 95:5 to 85:15 hexane:EtOAc) to yield 3x (42.4 
mg, 0.198 mmol, 79%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 7.99 (br, s, 1H), 7.82 
(d, J = 8.0 Hz, 1H), 7.38 (ddd, J = 8.0, 0.8, 0.8 Hz, 1H), 7.20 (ddd, J = 8.0, 7.2, 1.2 Hz, 1H), 
7.13 (ddd, J = 8.0, 7.2, 1.2 Hz, 1H), 6.95 (d, J = 2.4 Hz, 1H). 2.96 (s, 2H), 1.73 (s, 3H), 1.55 
(s, 6H). 13C NMR (100 MHz, CDCl3): δ 209.4, 137.3, 125.6, 123.8, 121.8, 120.9, 120.6, 119.3, 
111.7, 55.2, 34.6, 31.9, 29.0. HRMS (ESI) calcd. for C14H18O2+ [M+H]+ 215.1310, found 
215.1314. 
Experimental Procedure for Competition Experiment Between 2-Methylfuran and 
Indole 
 
To a 1 dram vial was added Bi(OTf)3 (16.8 mg, 0.025 mmol, 0.10 equiv), 2-
methylfuran (69 μL, 0.75 mmol, 3.0 equiv), indole (87.9 mg, 0.75 mmol, 3.0 equiv), 3-methyl-
2-cyclohexenone (28 μL, 0.25 mmol, 1.00 equiv), and acetonitrile and methanol (10:1)  
solution (0.5 mL). The vial was sealed with a PFTE/silicone-lined septum cap. The reaction 
was heated to 60 °C and allowed to stir at this temperature for 1 h. The mixture was cooled 
and concentrated under reduced pressure. The crude reaction mixture was dissolved in CDCl3 
(0.6 mL) and CH2Br2 (8.9 μL, 0.25 mmol) was added as an internal standard. Yields were 
determined by 1H NMR spectroscopy of the crude reaction mixture.  
Experimental Procedure for Competition Experiment Between 2-Methylfuran and 2-
Methylpyrrole 
 
To a 1 dram vial was added Bi(OTf)3 (16.8 mg, 0.025 mmol, 0.10 equiv), 2-methyl 
furan (69 μL, 0.75 mmol, 3.0 equiv), 2-methylpyrrole (75 μL, 0.75 mmol, 3.0 equiv), 3-methyl-
2-cyclohexenone (28 μL, 0.25 mmol, 1.0 equiv), and an acetonitrile/methanol (10:1) solution 
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(0.5 mL). The vial was sealed with a PFTE/silicone-lined septum cap. The reaction was heated 
to 60 °C and allowed to stir at this temperature for 1 h. The mixture was cooled and 
concentrated under reduced pressure. The crude reaction mixture was dissolved in CDCl3 (0.6 
mL) and CH2Br2 (8.9 μL, 0.25 mmol) was added as an internal standard. Yields were 
determined by 1H NMR spectroscopy of the crude reaction mixture.  
Experimental Procedure for Competition Experiment Between Indole and 2-
Methylpyrrole 
 
To a 1 dram vial was added Bi(OTf)3 (16.8 mg, 0.025 mmol, 0.100 equiv), 2-
methylpyrrole (38 μL, 0.38 mmol, 1.50 equiv), indole (44.0 mg, 0.38 mmol, 1.50 equiv), 3-
methyl-2-cyclohexenone (28 μL, 0.25 mmol, 1.00 equiv), and acetonitrile and methanol (10:1)  
solution (0.5 mL). The vial was sealed with a PFTE/silicone-lined septum cap. The reaction 
was heated to 60 °C and allowed to stir at this temperature for 1 h. The mixture was cooled 
and concentrated under reduced pressure. The crude reaction mixture was dissolved in CDCl3 
(0.6 mL) and CH2Br2 (8.9 μL, 0.13 mmol) was added as an internal standard. NMR yields were 
determined by 1H NMR spectroscopy of the crude reaction mixture. 
Experimental Procedure for Catalyst Inhibition by Indole 
 
To a 1 dram vial was added Bi(OTf)3 (3.9 mg, 0.006 mmol, 0.10 equiv), indole (7.0 
mg, 0.06 mmol, 1.00 equiv), 3-methyl-2-cyclohexenone (34 μL, 0.30 mmol, 1.00 equiv), and 
acetonitrile-d3 and methanol-d4 (10:1) solution (0.1 mL). The vial was sealed with a 
PFTE/silicone-lined septum cap. The reaction was heated to 60 °C and allowed to stir at this 
temperature for 2 h. The mixture was cooled and internal standard CH2Br2 (2.1 μL, 0.03 mmol) 
was added as an internal standard. NMR yields and deuterium incorporation were determined 
by 1H NMR spectroscopy of the crude reaction mixture. 
Experimental Procedure for Catalyst Inhibition by 2-Methylpyrrole 
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To a 1 dram vial was added Bi(OTf)3 (3.9 mg, 0.006 mmol, 0.100 equiv), 2-
methylpyrrole (6 μL, 0.06 mmol, 1.00 equiv), 3-methyl-2-cyclohexenone (34 μL, 0.30 mmol, 
1.00 equiv), and acetonitrile-d3 and methanol-d4 (10:1)  solution (0.1 mL). The vial was sealed 
with a PFTE/silicone-lined septum cap. The reaction was heated to 60 °C and allowed to stir 
at this temperature for 2 h. The mixture was cooled and internal standard CH2Br2 (2.1 μL, 0.03 
mmol) was added as an internal standard. NMR yields and deuterium incorporation were 
determined by 1H NMR spectroscopy of the crude reaction mixture. 
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CHAPTER 3.                                                                                                             
REGIOSELECTIVE 1,6-ADDITIONS OF ELECTRON-RICH HETEROARENES 
Modified from a paper published in Tetrahedron1 
Tanner L. Metz, Mingwan Leng, and Levi M. Stanley 
Abstract 
The development and optimization of bismuth(III) triflate-promoted regioselective 1,6-
additions of electron-rich heteroarenes to dienones is described. Regioselective 1,6-additions 
of a range of electron-rich heteroarenes, including furan, thiophene, pyrrole, and indole 
nucleophiles to 3-vinyl-2-cyclohexenone occur to produce a variety of d-heteroarylated, b,b-
disubstituted enones in up to 93% yield. The high 1,6-selectivity for these reactions is 
attributed to the increased steric bulk at the b-position relative to the d-position, and no 
competing 1,4-conjugate addition is observed.  
Introduction 
Bismuth(III) triflate has drawn the interest of synthetic organic chemist as an 
inexpensive and environmentally friendly Lewis acid catalyst and easily handled source of 
triflic acid.2 These attractive properties have led to the emergence of bismuth(III) triflate as a 
privileged catalyst that has been utilized in a wide range of organic transformations over the 
past decades.3 Among such transformations, conjugate additions of electron-rich heteroarenes 
to a,b-unsaturated ketones in the presence of bismuth(III) triflate are a valuable set of reactions 
to generate b-heteroarylated ketones. Until recently, these studies were limited to conjugate 
additions of indole nucleophiles to unsubstituted and b-substituted, a,b-unsaturated carbonyl 
compounds and related Michael acceptors.4  
Our group has actively pursued a program aimed at developing catalytic additions of 
aryl and heteroaryl nucleophiles to construct quaternary all-carbon centers and stereocenters. 
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Early efforts from our laboratory focused on developing palladium-catalyzed conjugate 
additions of arylboron nucleophiles to b,b-disubstituted enones.5 However, these processes do 
not encompass additions of heteroarylboron nucleophiles due to the relative instability of these 
reagents.6 To address this issue, we recently reported direct additions of electron-rich 
heteroarenes to b,b-disubstituted enones that are catalyzed by triflic acid generated in situ from 
bismuth(III) triflate.7 These reactions encompass additions of furan, thiophene, pyrrole, and 
indole nucleophiles to a variety of b,b-disubstituted enones to construct heteroarylated all-
carbon quaternary centers. During the course of these studies, we observed that the addition 
reactions are sensitive to the identity of b-substituents present in the b,b-disubstituted enone. 
For example, additions of 2,3-dimethylfuran to cyclic enones containing relatively small alkyl 
substituents, such as methyl, ethyl, and benzyl, at the b-position occur to form the b-
heteroarylated ketone products in good yields. However, additions to cyclic enones with 
sterically demanding substituents, such as isopropyl, cyclohexyl, and phenyl, at the b-position 
do not occur to form the b-heteroarylated ketone products. Based on these results, we 
hypothesized that we could leverage the differences in reactivity and selectivity to develop 
regioselective 1,6-additions of electron-rich heteroarenes to b-vinylenones in the presence of 
bismuth(III) triflate to form d-heteroarylated enones. 
During preliminary studies to develop regioselective 1,6-additions of electron-rich 
heteroarenes, we noted that examples of heteroarenes to para-quinone methides for the 
synthesis of triarylmethanes are established (Scheme 3.1a).8 However, regioselective 1,6-
additions to dienones to synthesize d-heteroarylated, b,b-disubstituted enones are limited to  
would provide one report on additions of furans to steroidal dienones (Scheme 3.1b).9 The 
development of 1,6-addition reactions that encompass additional heteroarenes and dienone 
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electrophiles would provide rapid access to additional classes of d-heteroarylated, b,b-
disubstituted enones with a synthetic handle for further functionalization (Scheme 3.1c)  
Scheme 3.1: Regioselective 1,6-Additions of Electron-Rich Heteroarenes 
 
The impact that identity of the b-substituent has on conjugate additions of heteroarenes 
to cyclic b,b-disubstituted enones led us to hypothesize that regioselective 1,6-additions of 
electron-rich heteroarenes to 3-vinyl-2-cyclohexenone could occur to generate d-
heteroarylated, b,b-disubstituted enones. To test this hypothesis, we examined the model 1,6-
addition of indole 2a to 3-vinyl-2-cyclohexenone 1a.10 These results are summarized in Table 
3.1. 
O
R1R1
R2
OH
R1R1
R2NH
R3
a)previous work: 1,6-additions to para-quinone methides
c)this work:
O
Bi(OTf)3 (2.5 mol %)
Oheteroarene O
or
X
R1
R2
N
R4
R3
R5
▪︎ mild reaction conditions
▪︎ broad scope of heteroarenes
O
H
H
H
HBF3 OEt2 (1.1 equiv)
O O
O
N
H
Bi(OTf)3 (5 mol %)
R3
b)previous work: 1,6-additions to steroidal dienones
+
O
O
独+
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Replicating the reaction conditions described for the conjugate addition of indole to 3-
methyl-2-cyclohexenone in Table 2.1, the addition of indole 2a to 3-vinyl-2-cyclohexenone 1a 
occurred with complete regioselectivity to generate 3-(2-(1H-indol-3-yl)ethyl)cyclohexanone 
3a in 99% yield (entry 1). The ratio between dienone 1a and indole 2a can be lowered from 
5:1 ratio to a 2:1 ratio without significant impact to the yield of enone product 3a (entires 2 
and 3). The yield of 3a does decrease significantly when the model 1,6-addition reaction is 
conducted with a 1:1 ratio between 1a:2a (entry 4), and extended reaction time did not lead to 
higher yield of enone product 3a (entry 5).  
Table 3.1: Evaluation of Substrate Concentration for the Addition of Indole 2a to Dienone 1a 
 
entry ratio 1a:2a time (h) yieldb 3a (%) 
1 5:1 3 99 
2 3:1 3 99 
3 2:1 3 97 
4 1:1 3 75 
5 1:1 24 71 
a Conditions: Reactions were performed with 3-vinyl-2-cyclohexenone 1 (0.25-1.25 mmol), indole 2a 
(0.25 mmol), Bi(OTf)3 (0.0063 mmol), acetonitrile/methanol (10:1, 0.5 mL), 60 °C. b Determined by 
1H NMR spectroscopy using dibromomethane as an internal standard.  
 
 We also conducted control experiments to gain insight into the We also conducted 
control experiments to gain insight into the identity of the active catalyst. Running the model 
1,6-addition reaction in the presence of 10 mol % triflic acid led to the formation of 3a in only 
O
Bi(OTf)3 (2.5 mol %)
60 °C
MeCN:MeOH (10:1)
1a
O
3a
NH
+
N
H
2a
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50% yield (Equation 3.1). We were surprised to observe that the addition of indole 2a to 1a in 
the presence of triflic acid is not regioselective. The 1,4- and 1,6-addition products are formed 
in a nearly 1:1 ratio. We also ran the model reaction in the presence of 2.5 mol % bismuth(III)  
 
triflate and 7.5 mol % 2,6-di-tert-butylpyridine (Equation 3.2).  Under these reaction 
conditions, δ-heteroarylated, β,β-disubstituted enone 3a is formed in a modest 70% yield, but 
the addition occurs with complete regioselectivity for the 1,6-addition product 3a.  Taken 
 
 together these results suggest that both triflic acid and a Lewis acidic bismuth species are 
active catalysts of 1,6-addition.  However, the complete regioselectivity observed for the model 
reactions suggests that the 1,6-addition reaction proceeds through a bismuth-catalyzed 
pathway. Notably, the identification of a bismuth-catalyzed 1,6-addition pathway contrasts our 
previous work on conjugate additions of heteroarenes to construct heteroaryalted all-carbon 
quaternary centers that have been determined to proceed via Brønsted acid catalysis.  
  
After identifying practical reaction conditions for the regioselective 1,6-addition of 
indole 2a to 3-vinyl-2-cyclohexenone 1a (Table 3.1, entry 3), we proceeded to evaluate 1,6-
O
TfOH (10 mol %)
60 °C, 3 h
MeCN:MeOH (10:1)
1a
O
3a 
50% yield
NH
+
N
H
2a
+
O
N
H
4a 50% yield
(1)
O Bi(OTf)3 (2.5 mol %)
2,6-di-tert-butylpyridine (7.5 mol%)
60 °C, 3 h
MeCN:MeOH (10:1)
1a
O
3a 
70% yield
NH
+
N
H
2a
+
O
N
H
4a not observed
(2)
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additions of a variety of electron-rich heteroarene nucleophiles. These results are summarized 
in Scheme 3.2. As shown above, the addition of indole 2a to 1a occurs in in high yield and 
product 3a is isolated in 86% yield. Additions of methylated indoles occur to form the 
corresponding enone products 3b-3g. Additions of N-methyl-, 2-methyl-, 4-methyl-, 5-methyl-
, 6-methyl-, and 7-methylindole to 1a generated enones 3b-3g in 42-93% yield. The reactivity 
of 2-methylindole 2f and 4-methylindole 2g in 1,6-addition reactions contrasts their reactivity 
in conjugate additions to 3-methyl-2-cyclohexenone, which did not occur to form the 
corresponding β-heteroarylated ketones. Additions of indoles containing electron-withdrawing 
substituents at the 5- and 7-positions with 1a occurred to form enone products 3h-3k in 
moderate yields (40-57%). The addition of 5-methoxyindole 2l and 7-methoxyindole 2m to 3-
vinyl-2-cyclohexenone 1a occurred to form the corresponding enones 3l and 3m in 61% and 
64% yield. These 1,6-addition reactions were not limited to the addition of indole nucleophiles, 
and the additions of 2-methylpyrrole 2n, 2-methoxythiophene 2o, and 2,3-dimethylfuran 2p to 
1a occurred to generate the corresponding δ-heteroarylated, β,β-disubstituted enones 3n-3p in 
48-67% yield. Despite the many electron-rich heteroarenes that undergo 1,6-additions to 
construct δ-heteroarylated, b,b-disbustituted enones, there are a number of substrates that did 
not undergo the desired 1,6-addition reaction under our reaction conditions. Additions of less 
nucleophilic heteroarenes, including 2-bromofuran, and 2-methylthiophene, benzothiophene, 
and benzofuran, to 3-vinyl-2-cyclohexenone 1a did not occur. 
 To gain insight into the relative rates of conjugate addition and 1,6-addition reactions 
in our studies, we carried out a competition experiment between 3-methyl-2-cyclohexenone 
1b and 3-vinyl-2-cyclohexenone 1a (Equation 3.3). The addition of indole to an equimolar 
mixture of 1a and 1b in the presence of 2.5 mol % bismuth(III) triflate occurs to form an 8.4:1 
ratio of 1,6-addition:1:4-addition products (3a:4a).  This result clearly indicates that the rate  
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Scheme 3.2: 1,6-Addition of Heteroarenes 2a-2p to Dienone 1aa 
 
a Conditions: Reactions were performed with 3-vinyl-2-cyclohexenone 1 (1.25 mmol), heteroarene 2a-
2p (0.25 mmol), Bi(OTf)3 (0.0063 mmol), acetonitrile/methanol (10:1, 0.5 mL), 60 °C.  
O
Bi(OTf)3 (2.5 mol %)
60 °C, 3 h
MeCN:MeOH (10:1)
O
1a 3a-3m
heteroarene 2a-2p O
3n-3p
or
N R1
X
R4
O
3n
67% yield
H
N
O
3o
49% yield S OMe
O
3p
48% yield O
O
3a 
86% yield NH
O
3c
60% yield NH
O
3d
61% yield NH
O
3e
68% yield NH
O
3f
93% yield NH
O
3g
71% yield NH
R2
R5
O
3b
42% yield N
O
3h
68% yield NH
O
3i
71% yield NH
NC
CN
O
3j
68% yield NH
Br
O
3k
71% yield NH
Br
O
3l
68% yield NH
MeO
O
3m
71% yield NH
OMe
R3
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of 1,6-addition to 3-vinyl-2-cyclohexenone 1a is significantly higher than the rate of 1,4-
addition to 3-methyl-2-cyclohexenone 1b in reactions promoted by bismuth(III) triflate and 
provides further insight into the high preference for 1,6- versus 1,4-selectivity in additions of 
heteroarenes to 3-vinyl-2-cyclohexenone 1a. 
 We also performed competition experiments between a selection of electronically 
distinct indole nucleophiles to gain additional insight into the reactivity of these heteroarenes 
in 1,6-addition reactions. We conducted a series of competition experiments between indole 
2a, 5-bromoindole 2j, and 5-methoxyindole 2l with 3-vinyl-2-cyclohexenone 1a (Scheme 3.3). 
The competition experiment between indole 2a and 5-methoxyindole 2l formed enones 3l and 
3a in a 1.9:1 ratio favoring the addition of 5-methoxyindole. The observed relative rates of 
addition of 5-methoxyindole and indole are consistent with nucleophilicity parameters 
determined for these heterocycles.11 Similar trends are observed for the competition 
experiment between indole 2a and 5-bromoindole 2j and the competition experiment between 
5-bromoindole 2j and 5-methoxyindole 2l. In each of these experiments the observed relative 
rates are consistent with the nucleophilicity parameters for these heterocycles and favor 
addition of the more electron-rich heteroarene. 
Prior to the current study, 1,6-additions of electron-rich heteroarenes to dienones have been 
limited to a select few examples. The most common approach involves heteroarene addition 
to para-quinone methides that do not generate products that retain the electrophilic enone 
O indole 2d (1 equiv)
Bi(OTf)3 (2.5 mol %)
60 °C, 3 h
MeCN:MeOH (10:1)
1a
(2 equiv)
O
3a
NH
+ +
O
N
H
4a
(3)
O
1b
(2 equiv)
3a:4a = 8.4:1
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Scheme 3.3: Competition Experiments Between Indole, 5-Methoxyindole, and 5-Bromoindole 
 
functionality, but instead isomerize to generate triarylmethanes.8 The bismuth-catalyzed 1,6-
addition reactions reported in our study lead to δ-heteroarylated, β,β-disubstituted enones that 
still possess a key enone functional group handle for further functionization. To demonstrate 
the synthetic utility of the δ-heteroarylated, β,β-disubstituted enone products, we sought to 
develop a palladium-catalyzed 1,4-addition of an arylboron nucleophile to enable rapid 
synthesis of β-arylated, δ-heteroarylated ketones that contain a quaternary carbon center at the 
β-position.12  We investigated the reaction of 3-(2-(1H-indol-3-yl)ethyl)cyclohex-2-en-1-one 
O
Bi(OTf)3 (10 mol %)
60 °C, 3 h
MeCN:MeOH (10:1)
O
1a
O
+
NH NH
5l 5a
indole (2.0 equiv)
5-methoxyindole (2.0 equiv)
5l:5a = 1.9:1
O
Bi(OTf)3 (10 mol %)
60 °C, 3 h
MeCN:MeOH (10:1)
O
1a
O
+
NH NH
Br
5a 5j
indole (2.0 equiv)
5-bromoindole (2.0 equiv)
5a:5j = 3.7:1
O
Bi(OTf)3 (10 mol %)
60 °C, 3 h
MeCN:MeOH (10:1)
O
1a
O
+
NH NH
Br
5l 5j
5-methoxyindole (2.0 equiv)
5-bromoindole (2.0 equiv)
5l:5j = 10.3:1
MeO
MeO
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3a with 4-biphenylboronic acid to show proof-of-concept. The addition of 4-biphenylboronic 
acid to 3a forms the corresponding β-arylated, δ-heteroarylated ketone product 5 in 51% yield 
when the reaction is run in the presence of a catalyst prepared in situ from palladium 
trifluoroacetate and 2,2¢-bipyridine (Equation 3.4). 
 
Although we have not investigated the scope of additional nucleophiles that could participate 
in conjugate additions to our δ-heteroarylated, β,β-disubstituted enone products, this result 
clearly demonstrates the potential synthetic utility of these compounds.  
Conclusion 
 In summary, we have developed a regioselective 1,6-additions of electron-rich 
heteroarenes that occur in the presence of   bismuth(III) triflate. These 1,6-additions of 
heteroarenes to 3-vinyl-2-cyclohexenone encompass indole, pyrrole, thiophene, and furan 
nucleophiles and lead to the formation of a variety of δ-heteroarylated, β,β-disubstituted 
enones in up to 93% yield.  Control experiments clearly show that the 1,6-addition reactions 
are bismuth-catalyzed process and that the bismuth catalyst plays a key role in the nearly 
complete selectivity for 1,6-addition. The δ-heteroarylated, β,β-disubstituted enones generated 
from our 1,6-addition reactions have significant potential to serve as valuable synthetic 
building blocks. We have demonstrated one such application through the palladium-catalyzed 
conjugate addition of an arylboronic acid to form a β-arylated, δ-heteroarylated ketone 
containing a quaternary carbon center at the β-position.  
O
Pd(OCOF3)2 (10 mol %)
60 °C, 12 h
1,2-dichloroethane
2,2ʹ-bipyridine (12 mol %)
4-Ph-C6H4B(OH)2 (3 equiv) O
N
H
NH
3a 5
51% yield
(4)
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Experimental 
General Experimental Details. All reactions were performed under air unless 
otherwise noted. Reactions involving air-sensitive procedures were conducted under inert 
atmosphere in a nitrogen-filled drybox or by standard Schlenk techniques. All glassware for 
moisture sensitive reactions was dried at 140 °C in an oven. Dichloromethane, ether, and 
tetrahydrofuran were dried with a solvent purification system by passing through a one-meter 
column of activated alumina. Anhydrous acetonitrile and methanol was purchased from 
Sigma-Aldrich and used as received. Flash column chromatography was performed on 
SiliFlash® P60 silica gel (40-63μm, 60Å) or using a Teledyne Isco Combiflash® Rf system 
with RediSep GoldTM columns using hexanes/ethyl acetate. Reaction products were 
visualized on TLC by UV light or by staining with KMnO4. 
HRMS (ESI) analysis was performed at the Iowa State University Chemical 
Instrumentation Facility on an Agilent 6540 QTOF spectrometer. NMR spectra were acquired 
on Varian MR-400 and Bruker Avance III 600 spectrometers at the Iowa State University 
Chemical Instrumentation Facility. Chemical shifts are reported in ppm relative to a residual 
solvent peak (CDCl3 = 7.26 ppm for 1H and 77.16 ppm. Coupling constants are reported in 
hertz. 
Materials. Indole 2a, 7-methoxyindole 2m, 7-bromoindole 3k, 7-cyanoindole 3i, N-
methylindole 3b, 2-methylpyrrole 3n were purchased from AK Scientific and used without 
further purification. 7-Methylindole 3g, 2-methylindole 3c, and bismuth(III) triflate were 
purchased from Sigma-Aldrich and used without further purification. 6-Methylindole 3f, 5-
methylindole 3e, and 4-methylindole 3d were purchased from Combi-Blocks and used without 
further purification. 2-Methoxythiophene 3o, 3-methyl-2-cyclohexenone 1b were purchased 
from TCI America and used without further purification. Anhydrous acetonitrile and methanol 
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were purchased from Sigma-Aldrich and used as received. 3-Vinyl-2-cyclohexenone 1a was 
prepared according to literature procedure.13 
General Procedure:  1,6-Additions of Heteroarenes 2a-2p to 3-Vinyl-2-Cyclohexenone 1a 
 
To a 1 dram vial was added Bi(OTf)3 (4.2 mg, 0.0063 mmol, 0.025 equiv), heteroarene 2a-2p 
(0.25 mmol, 1.00 equiv), enone 1a (0.75 mmol, 3.00 equiv), and acetonitrile and methanol 
(10:1) solution (0.5 mL). The vial was sealed with a PFTE/silicone-lined septum cap. The 
reaction was heated to 60 °C and allowed to stir at this temperature for 3h. The mixture was 
cooled and concentrated under reduced pressure. The crude reaction mixture was dissolved in 
CDCl3 (0.7 mL) and CH2Br2 (8.9 μL, 0.25 mmol) was added as an internal standard. NMR 
yields were determined by 1H NMR spectroscopy of the crude reaction mixture. The crude 
reaction mixture was purified by flash column chromatography on silica gel (hexane:EtOAc) 
to yield the desired ketones 3a-3p. 
Characterization Data for Enone Products 3a-3p 
3-(2-(1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3a): Synthesized 
according to the General Procedure from 3-vinyl-2-cyclohexenone 1a 
(91.6 mg, 0.75 mmol) and indole 2a (29.3 mg, 0.25 mmol) and purified 
by flash column chromatography (hexanes/ethyl acetate = 80:20 to 70:30) 
to yield 3a as a white solid (82.1 mg, 0.343 mmol, 86%). 1H NMR (600 
MHz, CDCl3): δ 7.98 (br, s, 1H), 7.59 (d, J = 7.8 Hz, 1H), 7.37 (d, J = 7.8 Hz, 1H), 7.21 (dd, 
O
Bi(OTf)3 (2.5 mol %)
O
heteroarene 2a-2p
O
or
X
R1
R2
N
R4
R3
R5
MeCN:MeOH (10:1)
60 °C, 3h
1a
3n-3p 3a-3m
O
3a
NH
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J = 7.8, 7.2 Hz, 1H), 7.13 (dd, J = 7.8, 7.2 Hz, 1H), 6.99 (d, J = 1.2 Hz, 1H), 5.97 (s, 1H), 2.99 
(t, J = 7.8 Hz, 2H), 2.64 (t, J = 7.8 Hz, 2H), 2.37 (dd, J = 6.6, 6.6 Hz, 2H), 2.33 (dd, J = 6.0, 
6.0 Hz, 2H), 1.99 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR (150 MHz, CDCl3): δ 200.1, 
166.3, 136.4, 127.3, 126.1, 122.3, 121.4, 119.5, 118.7, 115.3, 111.4, 38.6, 37.5, 30.0, 23.1, 
22.9. HRMS (ESI) calcd. for C16H18NO+ [M+H]+ 240.1383, found 240.1395. 
3-(2-(1-methyl-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3b): 
Synthesized according to the General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and N-methylindole 2b (32.8 
mg, 0.25 mmol)  and purified by flash column chromatography 
(hexanes/ethyl acetate = 80:20 to 70:30) to yield 3b as a colorless oil 
(43.0 mg, 0.170 mmol, 42%). 1H NMR (600 MHz, CDCl3): δ 7.58 (d, J = 7.8 Hz, 1H), 7.31 
(d, J = 7.8 Hz, 1H), 7.24 (dd, J = 7.8, 7.2 Hz, 1H), 7.12 (dd, J = 7.8, 7.2 Hz, 1H), 6.84 (s, 1H), 
5.98 (s, 1H), 3.75 (s, 3H), 2.98 (t, J =7.8 Hz, 2H), 2.63 (t, J = 7.8 Hz, 2H), 2.38 (dd, J = 6.6, 
6.6 Hz, 2H), 2.34 (dd, J = 6.0, 6.0 Hz, 2H), 2.00 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR 
(100 MHz, CDCl3): δ 200.0, 166.2, 137.1, 127.7, 126.2, 126.0, 121.8, 118.9, 118.8, 113.7, 
109.4, 38.8, 37.5, 32.7, 30.0, 23.0, 22.8. HRMS (ESI) calcd. for C17H20NO+ [M+H]+ 254.1539, 
found 254.1560. 
3-(2-(2-methyl-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3c): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 2-methylindole 2c (32.8 mg, 
0.25 mmol) and purified by flash column chromatography (hexanes/ethyl 
acetate = 80:20 to 70:30) to yield 3c as a white solid (60.0 mg, 0.237 
mmol, 60%). 1H NMR (600 MHz, CDCl3): δ 7.91 (br, s, 1H), 7.47 (d, J = 7.2 Hz, 1H), 7.27 
(d, J = 7.2 Hz, 1H), 7.13 (dd, J = 7.8, 7.2 Hz, 1H), 7.10 (dd, J = 7.8, 7.2 Hz, 1H), 5.95 (s, 1H), 
O
3b
N
O
3c
NH
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2.91 (t, J = 7.8 Hz, 2H), 2.52 (t, J = 7.8 Hz, 2H), 3.37 (dd, J = 6.6, 6.6 Hz, 2H), 2.53 (s, 3H), 
2.31 (dd, J = 6.0, 6.0 Hz, 2H), 1.98 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): δ 200.1, 166.6, 135.4, 131.0, 128.4, 126.0, 121.2, 119.4, 117.8, 110.6, 110.5, 39.0, 
37.5, 30.2, 22.9, 22.5, 11.8. HRMS (ESI) calcd. for C17H20NO+ [M+H]+ 254.1539, found 
254.1561. 
 3-(2-(4-methyl-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3d): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 4-methylindole 2d (32.8 mg, 
0.25 mmol) and purified by flash column chromatography (hexanes/ethyl 
acetate = 80:20 to 70:30) to yield 3d as a white solid (62.0 mg, 0.245 
mmol, 61%). 1H NMR (600 MHz, CDCl3): δ 8.12 (br, s, 1H), 7.19 (d, J = 7.8 Hz, 1H), 7.07 
(dd, J = 7.8, 7.2 Hz, 1H), 6.93 (d, J = 2.4 Hz, 1H), 6.86 (d, J = 7.2 Hz, 1H), 6.01 (s, 1H), 3.15 
(t, J = 7.8 Hz, 2H), 2.72 (s, 3H), 2.62 (t, J = 7.8 Hz, 2H), 2.40 (dd, J = 6.6, 6.6 Hz, 2H), 2.36 
(dd, J = 6.0, 6.0 Hz, 2H), 2.02 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): 
δ 200.1, 166.1, 136.9, 130.8, 126.0, 125.8, 122.4, 121.5, 121.3, 116.3, 109.3, 40.0, 37.5, 30.1, 
25.1, 22.9, 20.5. HRMS (ESI) calcd. for C17H20NO+ [M+H]+ 254.1539, found 254.1558. 
3-(2-(5-methyl-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3e): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 2-methylindole 2e (32.8 mg, 
0.25 mmol)and purified by flash column chromatography (hexanes/ethyl 
acetate = 80:20 to 70:30) to yield 3e as a white solid (68.9 mg, 0.272 
mmol, 68%). 1H NMR (600 MHz, CDCl3): δ 8.07 (br, s, 1H), 7.37 (s, 1H), 7.25 (d, J = 8.4 Hz, 
1H), 7.04 (d, J = 8.4 Hz, 1H), 6.93 (s, 1H), 5.99 (s, 1H), 2.96 (t, J = 7.8 Hz, 2H), 2.64 (t, J = 
7.8 Hz, 2H), 2.48 (s, 3H), 2.38 (dd, J = 6.6, 6.6 Hz, 2H), 2.34 (dd, J = 6.0, 6.0 Hz, 2H), 2.00 
O
3d
NH
O
3e
NH
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(ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 200.1, 166.4, 134.8, 128.7, 
127.5, 126.0, 123.9, 121.5, 118.4, 114.8, 111.0, 38.6, 37.5, 30.0, 23.1, 22.9, 21.7. HRMS (ESI) 
calcd. for C17H20NO+ [M+H]+ 254.1539, found 254.1554. 
3-(2-(6-methyl-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3f): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 6-methylindole 2f (32.8 mg, 
0.25 mmol) and purified by flash column chromatography (hexanes/ethyl 
acetate = 80:20 to 70:30) to yield 3f as a white solid (94.3 mg, 0.372 mmol, 
93%). 1H NMR (600 MHz, CDCl3): δ 8.05 (br, s, 1H), 7.47 (d, J = 7.8 Hz, 1H), 7.15 (s, 1H), 
6.97 (d, J = 7.8 Hz, 1H), 6.89 (s, 1H), 5.99 (s, 1H), 2.97 (t, J = 7.8 Hz, 2H), 2.63 (t, J = 7.8 Hz, 
2H), 2.48 (s, 3H), 2.38 (dd, J = 6.6, 6.6 Hz, 2H), 2.33 (dd, J = 6.0, 6.0 Hz, 2H), 1.99 (ddd, J = 
12.6, 6.6, 6.0 Hz, 2H). 13C NMR (150 MHz, CDCl3): δ 200.2, 166.6, 136.9, 131.9, 125.9, 
125.1, 121.1, 120.8, 118.3, 114.9, 111.3, 38.6, 37.4, 29.9, 23.1, 22.8, 21.8. HRMS (ESI) calcd. 
for C17H20NO+ [M+H]+ 254.1539, found 254.1559. 
3-(2-(7-methyl-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3g): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 2-methylindole 2g (32.8 mg, 
0.25 mmol) and purified by flash column chromatography (hexanes/ethyl 
acetate = 80:20 to 70:30) to yield 3g as a white solid (72.3 mg, 0.285 
mmol, 71%). 1H NMR (600 MHz, CDCl3): δ 8.07 (br, s, 1H), 7.45 (d, J = 7.8 Hz, 1H), 7.07 
(dd, J = 7.8, 7.2 Hz, 1H), 7.02 (d, J = 7.2 Hz, 1H), 6.98 (s, 1H), 5.98 (s, 1H), 2.99 (t, J = 7.8 
Hz, 2H), 2.65 (t, J = 7.8 Hz, 2H), 2.49 (s, 3H), 2.38 (dd, J = 6.6, 6.6 Hz, 2H), 2.34 (dd, J = 6.0, 
6.0 Hz, 2H), 2.00 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR (150 MHz, CDCl3): δ 200.2, 
O
3f
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O
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166.5, 136.0, 126.8, 126.0, 122.7, 121.1, 120.6, 119.6, 116.4, 115.6, 38.6, 37.5, 30.0, 23.2, 
22.8, 16.7. HRMS (ESI) calcd. for C17H20NO+ [M+H]+ 254.1539, found 254.1560. 
3-(2-(5-cyano-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3h): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 5-cyanoindole 2h (35.5 mg, 
0.25 mmol) and purified by flash column chromatography (hexanes/ethyl 
acetate = 60:40 to 50:50) to yield 3h as a white solid (42.0 mg, 0.159 
mmol, 40%). 1H NMR (600 MHz, CDCl3): δ 8.41 (br, s, 1H), 7.93 (s, 1H), 7.44-7.41 (m, 2H), 
7.11 (d, J = 2.4 Hz, 1H), 5.91 (s, 1H), 2.98 (t, J = 7.8 Hz, 2H), 2.63 (t, J = 7.8 Hz, 2H), 2.37 
(dd, J = 6.6, 6.6 Hz, 2H), 2.34 (dd, J = 6.0, 6.0 Hz, 2H), 2.00 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 
13C NMR (150 MHz, CDCl3): δ 200.0, 165.3, 138.1, 127.2, 126.3, 125.3, 124.5, 123.6, 120.8, 
116.2, 112.3, 102.7, 38.3, 37.5, 29.9, 22.8, 22.6. HRMS (ESI) calcd. for C17H17N2O+ [M+H]+ 
265.1335, found 265.1343. 
3-(2-(7-cyano-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3i): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 7-cyanoindole 2i (32.8 
mg, 0.25 mmol) and purified by flash column chromatography 
(hexanes/ethyl acetate = 60:40 to 50:50) to yield 3i as a white solid (49.6 
mg, 0.188 mmol, 47%). 1H NMR (600 MHz, CDCl3): δ 8.27 (br, s, 1H), 7.51 (d, J = 7.8 Hz, 
1H), 7.35 (d, J = 7.8 Hz, 1H), 7.04 (s, 1H), 7.01 (dd, J = 7.8, 7.8 Hz, 1H), 5.96 (s, 1H), 2.96 (t, 
J = 7.8 Hz, 2H), 2.62 (t, J = 7.8 Hz, 2H), 2.37 (dd, J = 6.6, 6.6 Hz, 2H), 2.31 (dd, J = 6.0, 6.0 
Hz, 2H), 1.98 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR (150 MHz, CDCl3): 200.0, 165.9, 
141.2, 135.1, 128.5, 126.1, 124.6, 122.0, 120.6, 118.0, 116.5, 105.0, 38.4, 37.5, 30.0, 23.1, 
22.8. HRMS (ESI) calcd. for C17H17N2O+ [M+H]+ 265.1335, found 265.1355. 
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3-(2-(5-bromo-1H-indol-3-yl)ethyl)cyclohex-2-en-1one (3j): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 2-bromoindole 2j (49.0 mg, 
0.25 mmol) and purified by flash column chromatography (hexanes/ethyl 
acetate = 80:20 to 70:30) to yield 3j as a white solid (72.0 mg, 0.226 mmol, 
57%). 1H NMR (600 MHz, CDCl3): δ 8.24 (br, s, 1H), 7.69 (s, 1H), 7.26 (dd, J = 8.4, 1.2 Hz, 
1H), 7.22 (d, J = 8.4 Hz, 1H), 6.97 (s, 1H), 5.93 (s, 1H), 2.92 (t, J = 7.8 Hz, 2H), 2.60 (t, J = 
7.8 Hz, 2H), 2.37 (dd, J = 6.6, 6.6, Hz, 2H), 2.32 (dd, J = 6.0, 6.0 Hz, 2H), 1.99 (ddd, J = 13.2, 
6.6, 6.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 200.1, 165.9, 135.0, 129.1, 126.2, 125.1, 
122.7, 121.4, 114.9, 112.83, 112.78, 38.4, 37.5, 30.0, 22.84, 22.83. HRMS (ESI) calcd. for 
C16H17BrNO+ [M+H]+ 318.0488, found 318.0506. 
3-(2-(7-bromo-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3k): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 7-bromoindole 2k (49.0 
mg, 0.25 mmol)and purified by flash column chromatography 
(hexanes/ethyl acetate = 80:20 to 70:30) to yield 5k as a white solid (61.8 
mg, 0.194 mmol, 49%). 1H NMR (600 MHz, CDCl3): δ 8.35 (br, s, 1H), 7.68 (s, 1H), 7.25 (d, 
J = 8.4 Hz, 1H), 7.21 (d, J = 8.4 Hz, 1H), 6.96 (s, 1H), 5.93 (s, 1H), 2.91 (t, J = 7.8 Hz, 2H), 
2.59 (t, J = 7.8 Hz, 2H), 2.37 (dd, J = 6.6, 6.6 Hz, 2H), 2.32 (6.0, 6.0 Hz, 2H), 1.98 (ddd, J = 
12.6, 6.6, 6.0 Hz, 2H). 13C NMR (150 MHz, CDCl3): δ 200.2, 166.2, 135.0, 129.0, 126.1, 
124.9, 122.8, 121.3, 114.7, 112.9, 112.6, 38.4, 37.4, 29.9, 22.8, 22.8. HRMS (ESI) calcd. for 
C16H17BrNO+ [M+H]+ 318.0488, found 318.0505. 
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3-(2-(5-methoxy-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3l): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 5-methoxyindole 2l (36.8 
mg, 0.25 mmol) and purified by flash column chromatography 
(hexanes/ethyl acetate = 80:20 to 70:30) to yield 3l as a white solid (68.9 
mg, 0.256 mmol, 64%). 1H NMR (600 MHz, CDCl3): δ 8.13 (br, s, 1H), 7.24 (d, J = 8.4 Hz, 
1H), 7.01 (d, J = 1.8 Hz, 1H), 6.95 (s, 1H), 6.87 (dd, J = 8.4, 1.8 Hz, 1H), 5.98 (s, 1H), 3.87 
(s, 3H), 2.94 (t, J = 7.8 Hz, 2H), 2.63 (t, J = 7.8 Hz, 2H), 2.37 (dd, J = 6.6, 6.6 Hz, 2H), 2.33 
(dd, J = 6.0, 6.0 Hz, 2H), 1.99 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR (150 MHz, CDCl3): 
δ 200.2, 166.5, 154.0, 131.6, 127.6, 126.0, 122.2, 114.7, 122.2, 112.1, 100.7, 56.1, 38.3, 37.4, 
30.0, 23.0, 22.8. HRMS (ESI) calcd. for C17H20NO2+ [M+H]+ 270.1589, found 270.1490. 
3-(2-(7-methoxy-1H-indol-3-yl)ethyl)cyclohex-2-en-1-one (3m): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 7-methoxyindole 2m 
(36.8 mg, 0.25 mmol)and purified by flash column chromatography 
(hexanes/ethyl acetate = 80:20 to 70:30) to yield 3m as a white solid 
(65.4 mg, 0.243 mmol, 61%). 1H NMR (600 MHz, CDCl3): δ 8.30 (br, s, 1H), 7.19 (d, J = 7.8 
Hz, 1H), 7.05 (dd, J = 7.8, 7.8 Hz, 1H), 6.95 (s, 1H), 6.66 (d, J = 7.8 Hz, 1H), 5.98 (s, 1H), 
3.96 (s, 3H), 2.97 (t, J = 7.8 Hz, 2H), 2.63 (t, J = 7.8 Hz, 2H), 2.37 (dd, J = 6.6, 6.6 Hz, 2H), 
2.32 (dd, J = 6.0, 6.0 Hz, 2H), 1.98 (ddd, J = 12.6, 6.6, 6.0 Hz, 2H). 13C NMR (150 MHz, 
CDCl3): δ 200.1, 166.4, 146.3, 128.6, 126.9, 126.0, 121.0, 119.8, 115.5, 111.4, 102.0, 55.4, 
38.6, 37.4, 29.9, 23.2, 22.8. HRMS (ESI) calcd. for C17H20NO2+ [M+H]+ 270.1589, found 
270.1507. 
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3-(2-(5-methyl-1H-pyrrol-2-yl)ethyl)cyclohex-2-en-1-one (3n): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 2-methyl-1H-pyrrole 2n (22 
μL, 0.25 mmol) and purified by flash column chromatography 
(hexanes/ethyl acetate = 80:20 to 70:30) to yield 3n as a yellow solid (54.2 mg, 0.266 mmol, 
67%). 1H NMR (600 MHz, CDCl3): δ 7.78 (br, s, 1H), 5.92 (s, 1H), 5.79-5.78 (m, 1H), 5.76-
5.75 (m, 1H), 2.77 (t, J = 7.8 Hz, 2H), 2.54 (t, J = 7.8 Hz, 2H), 2.37 (dd, J = 6.6, 6.6 Hz, 2H), 
2.30 (dd, J = 6.0, 6.0 Hz, 2H), 2.24 (s, 3H), 2.00 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR 
(150 MHz, CDCl3): δ 200.0, 165.7, 129.4, 126.7, 125.9, 106.0, 105.5, 38.1, 37.5, 30.0, 25.5, 
22.8, 13.1. HRMS (ESI) calcd. for C14H21O2+ [M+H]+ 221.1536, found 221.1539. HRMS (ESI) 
calcd. for C13H18NO+ [M+H]+ 204.1383, found 204.1394 
 3-(2-(5-methoxythiophen-2-yl)ethyl)cyclohex-2-en-1-one (3o): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 2-methoxythiophene 2o 
(25 μL, 0.25 mmol)and purified by flash column chromatography 
(hexanes/ethyl acetate = 80:20 to 70:30) to yield 3o as a yellow oil (46.3 mg, 0.196 mmol, 
49%). 1H NMR (600 MHz, CDCl3): δ 6.37 (d, J = 3.6 Hz, 1H), 5.97 (d, J = 3.6 Hz, 1H), 5.89 
(s, 1H), 3.84 (s, 3H), 2.88 (t, J = 7.8 Hz, 2H), 2.52 (t, J = 7.8 Hz, 2H), 2.35 (dd, J = 6.6, 6.6 
Hz, 2H), 2.29 (dd, J = 6.0, 6.0 Hz, 2H), 1.99 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H). 13C NMR (150 
MHz, CDCl3): δ 199.8, 164.6, 164.5, 129.5, 126.4, 121.7, 103.1, 60.3, 39.8, 37.5, 29.9, 28.1, 
22.8. HRMS (ESI) calcd. for C13H17O2S+ [M+H]+ 237.0944, found 237.0957. 
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 3-(2-(4,5-dimethylfuran-2-yl)ethyl)cyclohex-2-en-1-one (3p): 
Synthesized according to General Procedure from 3-vinyl-2-
cyclohexenone 1a (91.6 mg, 0.75 mmol) and 2,3-dimethylfuran 2p (26 
μL, 0.25 mmol) and purified by flash column chromatography 
(hexanes/ethyl acetate = 80:20 to 70:30) to yield 3p as a colorless oil (41.9 mg, 0.192 mmol, 
48%). 1H NMR (600 MHz, CDCl3): δ 5.88 (s, 1H), 5.76 (s, 1H), 2.74 (t, J = 7.8 Hz, 2H), 2.51 
(t, J = 7.8 Hz, 2H), 2.35 (dd, J = 6.6, 6.6 Hz, 2H), 2.28 (dd, J = 6.0, 6.0 Hz, 2H), 2.14 (s, 3H), 
1.98 (ddd, J = 13.2, 6.6, 6.0 Hz, 2H), 1.87 (s, 3H). 13C NMR (150 MHz, CDCl3): δ 199.9, 
165.2, 151.2, 145.9, 126.1, 114.4, 108.8, 37.5, 36.6, 29.8, 25.7, 22.8, 11.4, 10.0. HRMS (ESI) 
calcd. for C14H19O2+ [M+H]+ 219.1380, found 219.1388. 
Experimental Procedure for Competition Experiment Between 3-Vinyl-2-Cyclohexenone 
1a and 3-Methyl-2-Cyclohexenone 1b 
 
A competition experiment for generating heteroarylated products 3a and 4a was carried 
out by the following procedure. To a 1 dram vial was added Bi(OTf)3 (4.1 mg, 0.0063 mmol, 
0.025 equiv) indole 2a (29.3 mg, 0.25 mmol), 3-methyl-2-cyclohexenone 1b (55.1 mg, 0.500 
mmol), 3-vinyl-2-cyclohexenone  1a (61.3 mg, 0.500 mmol), and acetonitrile/methanol (10:1) 
solution (0.5 mL). The vial was sealed with a PFTE/silicone-lined septum cap. The reaction 
was heated to 60 °C and allowed to stir at this temperature for 3 h. The mixture was cooled 
and concentrated under reduced pressure. The crude reaction mixture was concentrated under 
reduced pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 as the internal 
standard. The ratio of products 3a:4a was determined to be 8.4:1 by 1H NMR spectroscopy. 
The 1H NMR yields of 3a and 4a were determined to be 67% and 8%, respectively. 
Experimental Procedure for Competition Experiment Between Indole 2a and 5-
Methoxyindole 2l 
 
O
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A competition experiment for generating d-heteroarylated enones 3a and 3l was carried 
out by the following procedure. To a 1 dram vial was added Bi(OTf)3 (16.4 mg, 0.0250 mmol, 
0.10 equiv), indole  2a (58.6 mg, 0.50 mmol), 5-methoxyindole  2l (73.6 mg, 0.50 mmol), 3-
vinyl-2-cyclohexenone 1a (30.5 mg, 0.25 mmol), and acetonitrile/methanol (10:1) solution 
(0.5 mL). The vial was sealed with a PFTE/silicone-lined septum cap. The reaction was heated 
to 60 °C and allowed to stir at this temperature for 3 h. The mixture was cooled and 
concentrated under reduced pressure. The crude reaction mixture was concentrated under 
reduced pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 as the internal 
standard. The ratio of products 3l:3a was determined to be 1.9:1 by 1H NMR spectroscopy. 
The 1H NMR yields of 3l and 3a were determined to be 21% and 11%, respectively.  
Experimental Procedure for Competition Experiment Between Indole 2a and 5-
Bromoindole 2j 
 
A competition experiment for generating d-heteroarylated enones 3a and 3j was carried 
out by the following procedure. To a 1 dram vial was added Bi(OTf)3 (16.4 mg, 0.0250 mmol, 
0.10 equiv), indole  2a (58.6 mg, 0.50 mmol), 5-bromoindole 2j (98.0 mg, 0.50 mmol), 3-
vinyl-2-cyclohexenone 1a (30.5 mg, 0.25 mmol), and acetonitrile/methanol (10:1) solution 
(0.5 mL). The vial was sealed with a PFTE/silicone-lined septum cap. The reaction was heated 
to 60 °C and allowed to stir at this temperature for 3 h. The mixture was cooled and 
concentrated under reduced pressure. The crude reaction mixture was concentrated under 
reduced pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 as the internal 
standard. The ratio of products 3a:3j was determined to be 3.7:1 by 1H NMR spectroscopy. 
The 1H NMR yields of 3a and 3j were determined to be 11% and 3%, respectively. 
Experimental Procedure for Competition Experiment Between 5-Methoxyindole 2l and 
5-Bromoindole 2j 
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A competition experiment for generating d-heteroarylated enones 3j and 3l was carried out by 
the following procedure. To a 1 dram vial was added Bi(OTf)3 (16.4 mg, 0.0250 mmol, 0.10 
equiv), 5-bromoindole 2j (98.0 mg, 0.50 mmol), 5-methoxyindole 2l (73.6 mg, 0.50 mmol), 3-
vinyl-2-cyclohexenone 1a (30.5 mg, 0.25 mmol), and acetonitrile/methanol (10:1) solution 
(0.5 mL). The vial was sealed with a PFTE/silicone-lined septum cap. The reaction was heated 
to 60 °C and allowed to stir at this temperature for 3 h. The mixture was cooled and 
concentrated under reduced pressure. The crude reaction mixture was concentrated under 
reduced pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 as the internal 
standard. The ratio of products 3l:3j was determined to be 10.3:1 by 1H NMR spectroscopy. 
The 1H NMR yields of 3l and 3j were determined to be 41% and 4%, respectively. 
Experimental Procedure for Palladium-Catalzyed Conjugatea Addition of 4-
Biphenylboronic Acid to 3-(2-(1H-indol-3-yl)ethyl)cyclohex-2-en-1-one 3a 
 
3-(2-(1H-indol-3-yl)ethyl)-3-phenylcyclohexan-1-one (5): 
Prepared according to a modified literature procedure.12d To a 1 dram 
vial was added Pd(OCOCF3)2 (3.3 mg, 0.010 mmol), 2,2¢-bipyridine 
(1.9 mg, 0.012 mmol), 4-PhC6H4B(OH)2 (59.7 mg, 0.30 mmol), 
enone 3a (23.9 mg, 0.10 mmol, 1.0 equiv) and were dissolved in 
dichloroethane (0.2 mL). The vial was sealed with a PFTE/silicone-lined septum cap. The 
reaction was heated to 60 °C and allowed to stir at this temperature for 10 h. The mixture was 
cooled to room temperature and passed through a short plug of silica gel (eluting with 20 mL 
of ethyl acetate). The crude reaction mixture was purified by flash column chromatography on 
silica gel (hexanes/ethyl acetate = 80:20 to 70:30) to yield 5 as a white solid (19.8 mg, 0.0507 
mmol, 51%). 1H NMR (600 MHz, CDCl3): δ 7.88 (br, s, 1H), 7.63-7.61 (m, 4H), 7.47-7.44 (m, 
4H), 7.38 (d, J = 7.8 Hz, 1H), 7.35 (m, 1H), 7.32 ( d, J = 7.8 Hz, 1H), 7.16 (ddd, J = 7.8, 7.2, 
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1.2 Hz, 1H), 7.07 (ddd, J = 7.8, 7.2, 1.2 Hz, 1H), 6.88 (s, 1H), 3.12 (d, J = 14.4 Hz, 1H), 2.62 
(d, J = 14.4 Hz, 1H), 2.57 (ddd, J = 13.2, 13.2, 4.8 Hz, 1H), 2.40-2.35 (m, 3H), 2.31-2.28 (m, 
1H), 2.18 (ddd, J = 13.2, 13.2, 4.4 Hz, 1H), 2.13-2.04 (m, 2H), 1.93-1.88 (m, 1H), 1.73-1.66 
(m, 1H). 13C NMR (150 MHz, CDCl3): δ 211.5, 144.1, 140.8, 139.2, 136.4, 128.9, 127.4, 127.3, 
127.13, 127.11, 127.10, 122.1, 121.0, 120.9, 118.8, 116.5, 111.2, 51.1, 46.3, 44.0, 41.2, 36.9, 
21.7, 19.5. HRMS (ESI) calcd. for C28H28NO+ [M+H]+ 394.2165, found 394.2169 
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CHAPTER 4.                                                                                                                                                                                                                                                                                          
AN ACID-CATALYZED ADDITION AND DEHYDRATION FOR THE SYNTHESIS 
OF HETEROARYLATED STEROIDAL DIENES 
Modified from a paper published in The Journal of Organic Chemistry1 
Tanner L. Metz, Grace A. Lutovsky, and Levi M. Stanley 
Abstract 
Additions of heteroarenes to hormone steroids containing an a,b-unsaturated ketone 
are reported. Additions of a range of electron-rich heteroarene nucleophiles, including 
indoles, a pyrrole, and a thiophene, to a variety of commercially available steroids and 
subsequent dehydration occur to form 3-heteroarylated steroidal dienes in up to 93% yield. 
This atom-economical reaction sequence occurs under mild reaction conditions in the 
presence of catalytic bismuth triflate. 
Introduction 
Hormone-dependent cancers, including breast and prostate cancers, are the most commonly 
diagnosed cancers and the second most common cause of cancer mortality.2-6 Derivatives of 
sex steroid hormones are key therapeutic agents used to treat hormone-dependent cancers.7-14 
As such, there is strong interest in the synthesis and biological evaluation of new molecular 
architectures based on sex steroid hormones.  
Indole is an important heterocycle that is present in a variety of natural and synthetic 
compounds which possess a wide spectrum of biological activities.15-21 Incorporation of the 
indole nucleus into steroidal frameworks serves as a platform for the synthesis of a potentially 
valuable class of steroid derivatives. Previous methods reported to incorporate indole into the 
C-3 position of steroids include transition metal-catalyzed alkylation,22 cyclizations of 2-
alkynylanilines (Scheme 4.1a),23,24 Stille cross-coupling reactions (Scheme 4.1b),25 and  
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Scheme 4.1: Current Methods to Incorporate Indoles into Steroidal Frameworks 
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Ullmann coupling reactions.26 These reactions require pre-functionalization of the parent 
eroids to their halogenated or pseudo-halogenated derivatives. To date, direct additions of 
indole to steroids containing an a,b-unsaturated ketone are limited to diastereoselective 
conjugate additions in the presence of a Ru(III) catalyst (Scheme 4.1c).27  We sought to develop 
a complementary strategy to directly incorporate heteroarenes at the C-3 position of steroids 
containing an a,b-unsaturated ketone. Recently, we reported a bismuth triflate-promoted 
conjugate addition of electron-rich heteroarenes to b,b-disubstituted enones for the 
construction of all-carbon quaternary centers.28 During studies to assess the scope of these 
conjugate addition reactions, we found that the conjugate addition of indole to a steroid 
containing a b,b-disubstituted enone did not occur. Instead, we observed regioselective 1,2-
addition of indole and subsequent dehydration in the presence of bismuth(III) triflate to form 
3-heteroarylated steroidal dienes.29 We hypothesized that we could leverage this reaction 
manifold to provide rapid access to a variety of 3-heteroarylated steroidal dienes (Scheme 
4.1d). 
Results and Discussion 
To test our hypothesis, we evaluated the model addition and dehydration reaction sequence 
with indole 2a and progesterone 1a in the presence of catalytic bismuth triflate (Table 4.1). 
Upon the addition of indole 2a to progesterone 1a in the presence of catalytic bismuth triflate, 
steroidal diene 3aa is formed as a white precipitate. This precipitate can be filtered and washed 
to provide 3-(1H-indol-3-yl)progesta-3,5-diene 3aa in high purity, eliminating the need to 
purify these 3-heteroarylated steroidal dienes by column chromatography. When the model 
reaction is run in the presence of 2.5 mol % bismuth triflate at 60 °C, product 3aa is isolated 
in 44% yield (entry 1). The yield of 3aa increases to 52-55% when the model reaction is 
conducted at elevated reaction temperatures (entries 2-3). We have previously reported studies 
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that demonstrate nitrogen-containing heteroarenes, including indoles, can inhibit acid 
catalysts.28 When the model reaction is run at lower concentrations of indole, product 3aa is 
generated in 62% yield (entry 4). Running the model reaction in the presence of excess 
progesterone 1a increases the yield of 3aa to 76% yield (entry 5). Despite the increase in yield 
observed in the presence of excess 1a, we proceeded to further optimize the model reaction 
with a 1:1 ratio of substrates to avoid the use of excess steroid. Conducting the model reaction 
with a 1:1 ratio of 1a:2a at increased loadings of bismuth triflate led to the formation of 3aa in 
up to 90% yield (entries 6-7).  
Table 4.1: Optimization of Reaction Conditions for Addition/Dehydration Reaction Sequence 
Between Progesterone 1a and Indole 2aa 
 
entry temp (°C) Bi(OTf)3 (x mol %) ratio 1a:2a yieldb of 3aa (%) 
1 60 2.5 1:2 44 
2 80 2.5 1:2 52 
3 100 2.5 1:2 55 
4 80 2.5 1:1 62 
5 80 2.5 1.5:1 76 
6 80 5 1:1 75 
7 80 10 1:1 90 
a Conditions: Reactions were performed with progesterone 1a (0.25-0.38 mmol), indole 2a (0.25-0.50 
mmol), Bi(OTf)3 (0.0063-0.025 mmol), acetonitrile/methanol (10:1, 0.5 mL), 60-100 °C for 3 h. b 
Isolated yields.  
O
H
H
HN
H
H
Bi(OTf)3 (x mol %)
MeCN:MeOH (10:1)
temp °C, 3 h1a 3aa
N
H
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O
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Based on previously reported studies, we hypothesized that Bi(OTf)3 may be a source 
of triflic acid.30-32 Steroid 3aa is formed in 90% yield when the reaction is conducted in the 
presence of 10 mol % triflic acid (Equation 4.1). To determine whether this transformation is 
 
 catalyzed by the Lewis acidic Bi(OTf)3 or triflic acid generated in situ, we ran the model 
reaction in the presence of catalytic amounts of Bi(OTf)3 and 2,6-di-tert-butylpyridine. Product 
3aa is not formed under these conditions (Equation 4.2). These results suggest that 
 
 triflic acid catalyzes the model reaction. However, we chose to evaluate the scope of this 
reaction using Bi(OTf)3 as a convenient source of triflic acid. 
 We proceeded with studies to evaluate the addition of various substituted indoles to 
progesterone 1a. These results are summarized in Scheme 4.2.  As noted above, the addition 
of indole 2a to 1a occurs to form 3aa in 90% yield under our best reaction conditions. 
Additions of less nucleophilic indoles, such as 7-cyanoindole 2b and 7-bromoindole 2c, to 
progesterone 1a are sluggish and require increased reaction times. The reaction of 7-
cyanoindole 2b with progesterone 1a occurs to form the corresponding steroidal diene 3ab in  
O
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HN
H
H
TfOH (10 mol %)
MeCN:MeOH (10:1)
80 °C, 3 h1a 3aa 
90% yield
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H
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O
O
(4.1)
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H
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H
H
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80 °C, 3 h1a 3aa 
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Scheme 4.2: Catalytic Additions of Indoles 2a-2k to Progesterone 1aa 
 
a Conditions: Reactions were performed with progesterone 1a (0.25 mmol), indole 2a (0.25 mmol), 
Bi(OTf)3 (0.025 mmol), acetonitrile/methanol (10:1, 0.5 mL), 80 °C for 3 h. b Reaction ran for 24 h.  
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36% yield. The reaction of 7-bromoindole 2c with progesterone 1a occurs to generate 3-(7-
bromo-indol-3-yl)progesta-3,5-diene 3ac in 67% yield, and product 3ac contains a functional 
group handle which provides the potential for further functionalization. Reactions of indoles 
containing electron-donating substituents at the 7-position occur to form the corresponding 
heteroarylated steroidal dienes 3ad and 3ae in high yields. Additions of indoles bearing 
electron-donating substituents around the indole core to 1a also occur to form heteroarylated 
steroidal dienes. Reactions of 6-methyl-, 5-methyl-, 4-methyl-, 2-methyl, and 1-methylindole 
to 1a generate the corresponding steroidal dienes 3af-3aj in 50-84% yield. The addition of 2-
phenylindole 2k to progesterone 1a forms product 3ak in 48% yield.  
Scheme 4.3: Addition/Dehydration Reaction Sequences of Heteroarenes 2l and 2m and 
Progesterone Steroids 1a and 1ba 
 
a Conditions: Reactions were performed with steroid 1 (0.25 mmol), heteroarene 2 (0.25 mmol), 
Bi(OTf)3 (0.025 mmol), acetonitrile/methanol (10:1, 0.5 mL), 80 °C for 3 h. b Reaction run in the 
prescence of 2.5 mol % Bi(OTf)3 at 60 °C.  
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These addition/elimination reactions are not limited to substituted indole nucleophiles. The 
addition of 2-methoxythiophene 2l and 2-methylpyrrole 2m to progesterone 1a and 17a-
hyroxyprogesterone acetate 1b occur to generate 3al, 3am, 3bl, and 3bm in up to 79% yield. 
To note, additions with furan nucleophiles to progesterone did not occur.   
To expand the scope of these addition and dehydration processes, we evaluated additions of 
indoles 2a-2d and 2-methylpyrrole 2m to adrenosterone 1c (Scheme 4.4). Addition of indole 
2a to adrenosterone 1c generates 3ca in 93% yield. In contrast, the reaction of 7-cyanoindole 
2b with 1c forms 3cb in 26% yield. Reactions of 7-bromoindole 2c and 7-methoxyindole 2d 
with adrenosternone 1c occur to from steroidal dienes 3cc-3cd in 90-93% yield. Reactions of 
adrenosternone 1c through the addition/dehydration manifold also encompass addition of 
pyrroles. The addition of 2-methylpyrrole 2m to adrenosterone 1c occurs to form the steroidal 
diene 3cm in 89% yield. 
Scheme 4.4: Catalytic Additions of Heteroarenes to Adrenosterone 1ca 
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a Conditions: Reactions were performed with steroid 1c (0.25 mmol), heteroarene 2 (0.25 mmol), 
Bi(OTf)3 (0.025 mmol), acetonitrile/methanol (10:1, 0.5 mL), 80 °C for 3 h. b Reaction run for 24 h.  
To highlight the utility of these addition and subsequent dehydration reactions, we conducted 
our model reaction on gram scale. The reaction of indole 2a with progesterone 1a under 
standard reaction conditions can be conducted on a gram scale to yield 3-(1H-indol-3-
yl)progesta-3,5-diene 3aa in 86% yield. 
Conclusions 
In summary, we have developed an efficient method for the direct incorporation of electron-
rich heteroarenes at the C-3 position of progesterone, 17a-hyroxyprogesterone acetate, and 
adrenosterone. These addition/elimination reactions occur in the presence of catalytic Bi(OTf)3 
under mild reaction conditions. Additions of indole, pyrrole, and thiophene nucleophiles to 
steroids containing an a,b-unsaturated ketone occur to form 3-heteroarylated steroidal dienes 
in up to 93% yield, and these steroidal dienes can be isolated in high purity without column 
chromatography. 
Experimental 
General Reaction Details. All reactions were performed under air unless otherwise 
noted. Anhydrous acetonitrile and methanol were purchased from Sigma-Aldrich and used as 
received. Products were isolated via trituration using hexanes/ethyl acetate (70:30) unless 
otherwise stated. Products that could not be purified via trituration, flash column 
chromatography was performed on SiliFlash® P60 silica gel (40-63μm, 60Å) or using a 
Teledyne Isco Combiflash® Rf system with RediSep GoldTM columns using hexanes/ethyl 
acetate. Reaction products were visualized on TLC under UV light or by staining with KMnO4.  
HRMS (ESI) analysis was performed at the Iowa State University Chemical 
Instrumentation Facility on an Agilent 6540 QTOF spectrometer. Elemental analysis was 
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performed at the Iowa State University Chemical Instrumentation Facility on the Perkin Elmer 
2100 Series II CHN/S Analyzer. NMR spectra were acquired on Varian MR-400 and Bruker 
Avance III 600 spectrometers at the Iowa State University Chemical Instrumentation Facility. 
Chemical shifts are reported in ppm relative to a residual solvent peak (CDCl3 = 7.26 ppm for 
1H and 77.16 ppm for 13C), (DMSO-d6 = 2.50 ppm for 1H and 39.5 ppm for 13C) and (DMF-d7 
= 8.03 ppm, 2.92 ppm, and 2.75 ppm for 1H and 163.2 ppm, 34.9 ppm, 29.8 ppm for 13C) 
Coupling constants are reported in hertz. 
Materials. Indole 2a, 7-methoxyindole 2b, 7-bromoindole 2c, 7-cyanoindole 2d, N-
methylindole 2k, 2-methylpyrrole 2m were purchased from AK Scientific and used without 
further purification. 7-Methylindole 2e, 2-methylindole 2i, and progesterone 1a were 
purchased from Sigma-Aldrich and used without further purification. 6-Methylindole 2f, 5-
methylindole 2g, and 4-methylindole 2h were purchased from Combi-Blocks and used without 
further purification. 2-Phenylindole 2k, 2-methoxythiophene 2l, 17a-hydroxyprogesterone 1b, 
and adrenosterone 1c, were purchased from TCI Amercia and used without further purification. 
Bismuth(III) trifluoromethanesulfonate was purchased from Strem Chemicals and used 
without further purification. 
General Procedure: 1,2-Addition/Dehydration Reaction Sequence Between Heteroarenes 2a-
2m and Steroids 1a-1c 
 
A 1 dram vial was charged with Bi(OTf)3 (16.4 mg, 0.025 mmol, 0.10 equiv), heteroarene 
2a-2m (0.25 mmol, 1.00 equiv), steroid 1a-1c (0.25 mmol, 1.00 equiv), and 
O
H
H
N
H
Hheteroarene 2a-2m
Bi(OTf)3 (10 mol %)
MeCN:MeOH  (10:1)
80 ºC, 3 h
1a-1c 3aa-3ak, 3ca-3cd
R3
R2R1
H
H
3al, 3am, 3bl, 3bm, 3cm
X
R4
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acetonitrile/methanol (10:1) solution (0.5 mL). The vial was sealed with a PFTE/silicone-lined 
septum cap. The reaction was heated to 80 °C and allowed to stir at this temperature for 3 h. 
The completion of the reaction was visible by the generation of a white precipitate in the 
reaction mixture. The mixture was cooled and diluted with hexanes/ethyl acetate (70:30) 
solution. The crude reaction mixture was centrifuged, and the supernatant was removed. The 
remaining solid was washed three additional times with a hexanes/ethyl acetate (70:30) 
solution, or until the supernatant was clear. The remaining precipitate was dried to produce the 
desired heteroarylated steroids 3aa-3am, 3bl, 3bm, 3ca-3cd, 3cm.  
Characterization Data for Steroids 3aa-3am, 3bl, 3bm, 3ca-3cd, 3cm 
 
 3-(1H-indol-3-yl)progesta-3,5-diene (5a): Prepared 
according to the General Procedure from progesterone 2 
(78.6 mg, 0.250 mmol) and 1H-indole 1a (29.3 mg, 0.250 
mmol). The crude product was purified by trituration using 
a solution of hexanes/ethyl acetate (70:30) to yield 5a (93.0 
mg, 0.225 mmol, 90%) as a white solid. 1H NMR (400 MHz, DMF-d7): δ 11.25 (br, s, 1H), 
7.98 (d, J = 8.0 Hz, 1H), 7.56 (d, J = 2.4 Hz, 1H), 7.47 (d, J = 8.0, Hz, 1H), 7.15 (ddd, J = 8.0, 
6.8, 1.2 Hz, 1H), 7.10 (ddd, J = 8.0, 6.8, 1.2 Hz, 1H), 6.64 (s, 1H),  5.56-5.54 (m, 1H), 2.72-
2.52 (m, 3H), 2.30-2.22 (m, 1H), 2.18-2.10 (m, 4H), 2.02-1.98 (m, 1H), 1.84-1.61 (m, 5H), 
1.57-1.11 (m, 7H), 1.06 (s, 3H), 0.65 (m, 3H).  13C NMR (100 MHz, DMF-d7): δ 209.4, 143.4, 
138.8, 130.9, 126.3, 124.6, 123.4, 122.5, 122.4, 121.6, 120.5, 118.0, 112.9, 64.1, 57.9, 49.4, 
44.7, 39.5, 35.8, 35.0, 32.9, 32.8, 31.9, 26.5, 25.2, 23.6, 22.0, 19.9, 13.9. Anal. Calcd. for 
C29H35NO: C, 84.22; H, 8.53; N, 3.39; found: C, 83.88; H, 8.57; N, 3.42. 
HN
H
H
O
5a
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 3-(7-methoxy-1H-indol-3-yl)progesta-3,5-diene 
(5b): Prepared according to the General Procedure from 
progesterone 2 (78.6 mg, 0.250 mmol) and 7-
methoxyindole 1b (37.0 mg, 0.250 mmol). The crude 
product was purified by trituration using a solution of 
hexanes/ethyl acetate (70:30) to yield 5b (93.2 mg, 0.210 mmol, 84%) as a white solid. 1H 
NMR (400 MHz, DMF-d7): δ 11.27 (br, s, 1H), 7.56 (d, J = 8.4 Hz, 1H), 7.48 (d, J = 2.8 Hz, 
1H), 7.03 (m, 1H), 6.74 (d, J = 7.6 Hz, 1H), 5.93 (s, 1H), 5.83-5.81 (m, 1H), 3.96 (s, 3H), 2.72-
2.52 (m, 3H), 2.30-2.22 (m, 1H), 2.18-2.10 (m, 4H), 2.02-1.98 (m, 1H), 1.84-1.61 (m, 5H), 
1.57-1.11 (m, 7H), 1.06 (s, 3H), 0.65 (m, 3H). 13C NMR (100 MHz, DMF-d7): δ 209.4, 143.4, 
138.8, 130.9, 126.3, 124.6, 123.4, 122.5, 122.4, 121.6, 120.5, 118.0, 112.9, 63.1, 56.0, 53.8, 
44.7, 39.5, 35.8, 35.0, 32.9, 32.8, 31.9, 26.5, 25.2, 23.6, 22.0, 19.9, 13.9. Anal. Calcd. for 
C30H37NO2: C, 81.22; H, 8.41; N, 3.16; found: C, 80.86; H, 8.38; N, 3.15. 
 3-(7-bromo-1H-indol-3-yl)progesta-3,5-diene (5c): 
Prepared according to the General Procedure from 
progesterone 2 (78.6 mg, 0.250 mmol) and 7-bromoindole 
1c (49.0 mg, 0.250 mmol). The crude product was 
purified by trituration using a solution of hexanes/ethyl 
acetate (70:30) to yield 5c (82.5 mg, 0.168 mmol, 67%) as a white solid. 1H NMR (400 MHz, 
CDCl3): δ 13C NMR (100 MHz, DMSO-d6): δ 8.30 (br, s, 1H), 7.92 (d, J = 8.0 Hz, 1H), 7.36 
(d, J = 7.6 Hz, 1H), 7.29 (d, J = 2.4 Hz, 1H), 7.04 (d, J = 8.0, 7.6 Hz, 1H), 6.56 (s, 1H), 5.56-
5.54 (m, 1H), 2.59-2.54 (m, 2H), 2.30-2.22 (m, 2H), 2.14 (s, 3H), 2.10-2.08 (m, 1H), 2.01-1.96 
(m, 1H), 1.83-1.65 (m, 5H), 1.52-1.13 (m, 7H), 1.05 (s, 3H), 0.68 (s, 3H). 13C NMR (100 MHz, 
CDCl3): δ 209.8, 142.2, 135.6, 128.9, 126.6, 124.7, 124.6, 123.0, 122.1, 121.3, 120.5, 120.1, 
HN
H
H
O
5b
MeO
HN
H
H
O
5c
Br
  
 
80 
105.1, 63.9, 57.3, 48.4, 44.3, 39.0, 35.1, 34.2, 32.1, 32.0, 31.7, 26.0, 24.6, 23.0, 21.2, 19.3, 
13.5.  HRMS (ESI) calcd. for C29H35BrNO+ [M+H]+ 492.1890, found 492.1690. 
 
 3-(7-cyano-1H-indol-3-yl)progesta-3,5-diene (5d): 
Prepard according to the General Procedure from 
progesterone 2 (78.6 mg, 0.250 mmol) and 7-cyanoindole 
1d (35.5mg, 0.250 mmol). The crude product was 
purified by trituration using a solution of hexanes/ethyl 
acetate (70:30) to yield 5d (39.5 mg, 0.090 mmol, 36%) as a white solid. 1H NMR (400 MHz, 
DMF-d7): δ 12.17 (br, s, 1H), 8.35 (d, J = 8.0 Hz, 1H), 7.75 (s, 1H), 7.66 (d, J = 7.6 Hz, 1H), 
7.28 (dd, J = 8.0, 7.6 Hz, 1H) 6.66 (s, 1H), 5.64-5.62 (m, 1H), 2.72-2.52 (m, 3H), 2.30-2.22 
(m, 1H), 2.18-2.10 (m, 4H), 2.02-1.98 (m, 1H), 1.84-1.61 (m, 5H), 1.57-1.11 (m, 7H), 1.06 (s, 
3H), 0.65 (m, 3H). 13C NMR (100 MHz, DMF-d7): δ 209.9, 143.6, 138.5, 130.0, 127.9, 127.6, 
127.5, 127.0, 126.0, 125.6, 123.7, 120.6, 120.2, 118.1, 64.5, 58.2, 49.9, 44.9, 44.0 36.1, 35.8, 
33.2, 33.0, 31.6, 27.0, 25.3 24.2, 22.2, 19.8, 13.9. Anal. Calcd. for C30H34N2O: C, 82.15; H, 
7.81; N, 6.52; found: C, 81.87; H, 7.79; N, 6.52.  
 3-(7-methyl-1H-indol-3-yl)progesta-3,5-diene (5e): 
Prepared according to the General Procedure from 
progesterone 2 (78.6 mg, 0.250 mmol) and 7-methylindole 
1e (33.5 mg, 0.250 mmol). The crude product was purified 
by trituration using a solution of hexanes/ethyl acetate 
(70:30) to yield 5e (84.5 mg, 0.198 mmol, 79%) as a white solid. 1H NMR (400 MHz, CDCl3): 
δ 8.05 (br, s, 1H), 7.84 (d, J = 8.0 Hz, 1H), 7.26-7.25 (m, 1H), 7.09 (d, J = 8.0, 7.2 Hz, 1H), 
7.02 (d, J = 7.2 Hz, 1H), 6.60 (s, 1H), 5.54-5.52 (m, 1H), 2.60-2.54 (m, 2H), 2.49 (s, 3H), 2.30-
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2.22 (m, 2H), 2.14 (s, 3H), 2.10-2.08 (m, 1H), 2.00-1.96 (m, 1H), 1.83-1.65 (m, 5H), 1.52-1.12 
(m, 7H), 1.06 (s, 3H), 0.68 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 209.8, 142.4, 136.5, 129.4, 
124.9, 124.0, 123.0, 122.3, 121.4, 120.4, 119.4, 119.0, 111.5, 63.9, 57.3, 48.5, 44.4, 39.1, 35.1, 
34.3, 32.1, 32.0, 31.7, 26.0, 24.6, 23.0, 21.3, 19.3, 16.8 13.6. HRMS (ESI) calcd. for 
C30H38NO+ [M+H]+ 428.2948, found 428.2961. 
 3-(6-methyl-1H-indol-3-yl)progesta-3,5-diene (5f): 
Prepared according to the General Procedure from 
progesterone 2 (78.6 mg, 0.250 mmol) and 6-
methylindole 1f (33.5 mg, 0.250 mmol). The crude 
product was purified by trituration using a solution of 
hexanes/ethyl acetate (70:30) to yield 5f (66.3 mg, 0.155 mmol, 62%) as a white solid. 1H 
NMR (400 MHz, CDCl3): δ 7.98 (br, s, 1H), 7.86 (d, J = 8.4 Hz, 1H), 7.17-7.16 (m, 2H), 6.99 
(d, J = 8.0 Hz, 1H), 6.59 (s, 1H), 5.54-5.52 (m, 1H), 2.59-2.54 (m, 2H), 2.46 (s, 3H), 2.30-2.19 
(m, 2H), 2.14 (s, 3H), 2.10-2.07 (m, 1H), 1.99-1.95 (m, 1H), 1.83-1.65 (m, 5H), 1.52-1.12 (m, 
7H), 1.06 (s, 3H), 0.68 (s, 3H). 13C NMR δ 209.9, 142.5, 137.5, 132.2, 129.4, 123.7, 123.2, 
122.2, 122.0, 121.1, 120.9, 118.6, 111.4, 63.9, 57.3, 48.5, 44.3, 39.1, 35.1, 34.3, 32.1, 32.0, 
31.7, 25.9, 24.6, 23.0, 21.7, 21.3, 19.4, 13.5. (100 MHz, CDCl3): δ HRMS (ESI) calcd. for 
C30H38NO+ [M+H]+ 428.2948, found 428.2963. 
 3-(5-methyl-1H-indol-3-yl)progesta-3,5-diene (5g): 
Prepared according to the General Procedure from 
progesterone 2 (78.6 mg, 0.250 mmol) and 5-methylindole 
1g (33.5 mg, 0.250 mmol). The crude product was purified 
by flash column chromatography using a solution of 
hexanes/ethyl acetate (60:40) to yield 5g (53.4 mg, 0.125 mmol, 50%) as a white solid. 1H 
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NMR (600 MHz, CDCl3): δ 8.06 (br, s, 1H), 7.76 (s, 1H), 7.25 (d, J = 8.4 Hz, 1H), 7.19 (d, J 
= 2.4 Hz, 1H), 7.02 (d, J = 8.4 Hz, 1H), 6.59 (s, 1H), 5.56-5.54 (m, 1H), 2.59-2.54 (m, 2H), 
2.48 (s, 3H), 2.31-2.18 (m, 2H), 2.14 (s, 3H), 2.13-2.08 (m, 1H), 1.99-1.96 (m, 1H), 1.83-1.65 
(m, 5H), 1.52-1.12 (m, 7H), 1.07 (s, 3H), 0.69 (s, 3H). 13C NMR (150 MHz, CDCl3): δ 209.8, 
142.5, 135.4, 129.5, 129.4, 125.6, 124.0, 123.7, 122.2, 121.2, 120.9, 118.3, 111.1, 63.4, 57.3, 
48.5, 44.3, 39.1, 35.1, 34.3, 32.1, 32.0, 31.7, 26.1, 24.6, 23.0, 21.9, 21.3, 19.3, 13.5. HRMS 
(ESI) calcd. for C30H38NO+ [M+H]+ 428.2948, found 428.2954 
 3-(4-methyl-1H-indol-3-yl)progesta-3,5-diene (5h): 
Prepared according to the General Procedure from 
progesterone 2 (78.6 mg, 0.250 mmol) and 4-methylindole 
1h (33.5 mg, 0.250 mmol). The crude product was purified 
by trituration using a solution of hexanes/ethyl acetate 
(70:30) to yield 5h (84.5 mg, 0.198 mmol, 79%) as a white solid. 1H NMR (400 MHz, CDCl3): 
δ 8.04 (br, s, 1H), 7.21 (d, J = 8.0 Hz, 1H), 7.09 (dd, J = 8.0, 7.2 Hz, 1H), 7.02 (d, J = 2.4 Hz, 
1H) 6.88 (ddd, J = 7.2, 0.8, 0.8 Hz, 1H), 6.01 (d, J = 2.0 Hz, 1H), 5.43-5.42 (m, 1H), 2.59-2.56 
(m, 4H), 2.49-2.46 (m, 1H), 2.27-2.19 (m, 2H), 2.15 (s, 3H), 2.11-2.08 (m, 1H), 1.96-1.92 (m, 
1H), 1.78-1.65 (m, 5H), 1.52-1.13 (m, 7H), 1.07 (s, 3H), 0.69 (s, 3H).   13C NMR (100 MHz, 
CDCl3): δ 209.8, 142.0, 136.3, 131.2, 131.1, 129.2, 125.5, 122.6, 122.2, 121.9, 121.5, 121.0, 
108.9, 63.8, 57.3, 48.3, 44.3, 39.0, 34.8, 34.6, 32.0, 31.9, 31.7, 30.4, 24.5, 22.9, 21.3, 20.1, 
19.3, 13.6. HRMS (ESI) calcd. for C30H38NO+ [M+H]+ 428.2948, found 428.2956 
 3-(2-methyl-1H-indol-3-yl)progesta-3,5-diene (5i): 
Prepared according to the General Procedure from 
progesterone 2 (78.6 mg, 0.250 mmol) and 2-methylindole 
1i (33.5 mg, 0.250 mmol). The crude product was purified 
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by trituration using a solution of hexanes/ethyl acetate (70:30) to yield 5i (89.8 mg, 0.210 
mmol, 84%) as a white solid. 1H NMR (400 MHz, CDCl3): 7.84 (br, s, 1H), 7.59 (d, J = 7.6 
Hz, 1H), 7.27 (dd, J = 7.6, 0.4 Hz, 1H), 7.11 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 7.06 (ddd, J = 8.4, 
7.2, 1.2 Hz, 1H), 6.05 (s, 1H), 5.56-5.45 (m, 1H), 2.60-2.55 (m, 2H), 2.44 (s, 3H), 2.28-2.19 
(m, 2H), 2.15 (s, 3H), 2.11-2.08 (m, 1H), 1.98-1.93 (m, 1H), 1.82-1.65 (m, 5H), 1.53-1.14 (m, 
7H), 1.10 (s, 3H), 0.69 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 209.8, 142.3, 135.3, 131.1, 
130.3, 128.1, 128.0, 122.3, 121.3, 119.6, 119.5, 115.9, 110.3, 63.9, 57.3, 48.4, 44.4, 39.1, 35.0, 
34.6, 32.1, 32.0, 31.8, 27.6, 24.6, 23.0, 21.3, 19.3, 13.6, 13.5.  HRMS (ESI) calcd. for 
C30H38NO+ [M+H]+ 428.2948, found 428.2953. 
 3-(2-phenyl-1H-indol-3-yl)progesta-3,5-diene (5j): 
Prepared according to the General Procedure from 
progesterone 2 (78.6 mg, 0.250 mmol) and 2-phenylindole 
1j (48.3 mg, 0.250 mmol). The crude product was purified 
by flash column chromatography using a solution of 
hexanes/ethyl acetate (80:20) to yield 5j (58.8 mg, 0.120 mmol, 48%) as a white solid. 1H 
NMR (400 MHz, CDCl3): 8.19 (br, s, 1H), 7.68 (d, J = 8.0 Hz, 1H), 7.62-7.60 (m, 2H), 7.44-
7.39 (m, 2H), 7.38 (d, J = 8.0 Hz, 1H), 7.33 (ddd, J = 7.2, 6.4, 1.2  Hz, 1H), 7.21 (ddd, J = 8.0, 
7.2, 1.2 Hz, 1H), 7.14 (ddd, J = 8.0, 7.2, 1.2 Hz, 1H), 6.28-6.27 (m, 1H), 5.48-5.46 (m, 1H) 
2.59-2.57 (m, 1H), 2.34-2.19 (m, 3H), 2.14 (s, 3H), 2.09-2.05 (m, 1H), 2.09-2.05 (m, 1H), 
1.85-1.66 (m, 5H), 1.50-1.48 (m, 2H), 1.38-1.14 (m, 5H), 1.09 (s, 3H), 0.69 (s, 3H). δ 13C 
NMR (100 MHz, CDCl3): 209.8, 142.3, 136.0, 133.7, 133.5, 129.9, 129.7, 129.0, 128.8, 127.7, 
127.6, 122.8, 122.7, 120.2, 120.1, 116.8, 110.9, 63.9, 57.4, 48.3, 44.3, 39.1, 34.9, 34.6, 32.1, 
31.7, 29.9, 27.1, 24.6, 23.0, 21.3, 19.5, 13.6.  HRMS (ESI) calcd. for C35H40NO+ [M+H]+ 
490.1340, found 490.1342. 
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 3-(1-methylindol-3-yl)progesta-3,5-diene (5k): Prepared 
according to the General Procedure from progesterone 2 
(78.6 mg, 0.250 mmol) and 1-methylindole 1k (33.5 mg, 
0.250 mmol). The crude product was purified by trituration 
using a solution of hexanes/ethyl acetate (70:30) to yield 5k 
(85.5 mg, 0.200 mmol, 80%) as a white solid. 1H NMR (400 MHz, CDCl3): δ 7.98 (d, J = 8.0 
Hz, 1H), 7.31 (d, J = 8.0 Hz, 1H), 7.23 (dd, J = 8.0, 1.2 Hz, 1H), 7.16 (ddd, J = 8.0, 6.8, 1.2 
Hz, 1H), 7.10 (s, 1H), 6.58 (s, 1H), 5.53-5.51 (m, 1H), 3.77 (s, 3H), 2.59-2.54 (m, 2H), 2.31-
2.19 (m, 2H), 2.14 (s, 3H), 2.13-2.08 (m, 1H), 2.00-1.96 (m, 1H), 1.81-1.65 (m, 5H), 1.52-1.12 
(m, 7H), 1.06 (s, 3H), 0.68 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 209.8, 142.5, 137.8, 129.3, 
126.6, 125.9, 123.4, 122.1, 122.0, 121.3, 119.8, 117.1, 109.5, 63.9, 57.3, 48.4, 44.3, 39.1, 35.1, 
34.3, 32.1, 33.0, 32.1, 32.0, 26.0, 24.6, 23.0, 21.3, 19.3, 13.5. HRMS (ESI) calcd. for 
C30H38NO+ [M+H]+ 428.2948, found 428.2959. 
 3-(5-methoxythiophen-2-yl)progesta-3,5-diene (5l): 
Prepared according to the General Procedure from 
progesterone 2 (78.6 mg, 0.250 mmol) and 2-
methoxythiophene 1l (25 μL, 0.250 mmol). The crude 
product was purified by trituration using a solution of 
hexanes/ethyl acetate (70:30) to yield 5l (81.1 mg, 0.198 mmol, 79%) as a white solid. 1H 
NMR (400 MHz, CDCl3): δ 6.61 (d, J = 4.0 Hz, 1H), 6.15 (s, 1H), 6.06 (d, J = 4.0 Hz, 1H), 
5.50-5.48 (m, 1H), 3.87 (s, 3H), 2.57-2.48 (m, 2H), 2.45-2.41 (m, 1H), 2.28-2.17 (m, 2H), 2.13 
(s, 3H), 2.08-2.06 (m, 1H), 1.95-1.90 (m, 1H), 1.77-1.64 (m, 5H), 1.52-1.05 (m, 6H), 0.97 (s, 
3H), 0.66 (m, 3H). 13C NMR (100 MHz, CDCl3): δ 209.8, 164.7, 141.8, 132.6, 128.6, 123.9, 
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122.8, 119.9, 104.1, 63.8, 60.2, 57.2 48.3, 44.3, 39.0, 35.1, 33.9, 32.1, 31.9, 31.7, 24.5, 24.1, 
23.0, 21.3, 19.3, 13.5. HRMS (ESI) calcd. for C26H35O2S+ [M+H]+ 411.2352, found 411.2365. 
 3-(5-methyl-1H-pyrrol-2-yl)progesta-3,5-diene (5m): 
Prepared according to the General Procedure from progesterone 
2 (78.6 mg, 0.250 mmol) and 2-methylpyrrole 1m (22 μL, 0.250 
mmol). The crude product was purified by trituration using a 
solution of hexanes/ethyl acetate (70:30) to yield 5m (41.5 mg, 
0.110 mmol, 44%) as a white solid. 1H NMR (400 MHz, CDCl3): δ 8.01 (br, s, 1H), 6.13-6.12 
(m, 1H), 6.02 (s, 1H), 5.87-5.86 (m, 1H), 5.44-5.43 (m, 1H), 2.58-2.51 (m, 1H), 2.48-2.38 (m, 
2H), 2.28 (s, 3H), 2.24-2.18 (m, 2H), 2.14 (s, 3H), 2.09-2.06 (m, 1H), 1.94-1.89 (m, 1H), 1.80-
1.61 (m, 5H), 1.52-1.08 (m, 6H), 0.97 (s, 3H), 0.66 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 
209.8, 142.0, 132.0, 128.8, 126.3, 122.4, 118.8, 107.4, 106.4, 63.9, 57.3, 48.3, 44.3, 39.0, 35.2, 
33.8, 32.1, 32.0, 31.7, 24.5, 23.5, 23.0, 21.2, 19.3, 13.5, 13.3. HRMS (ESI) calcd. for 
C26H36NO+ [M+H]+ 378.2791, found 378.2811. 
 3-(5-methoxythiophen-2-yl)-17a-hydroxyprogesta-
3,5-diene acetate (6a): Prepared according to the General 
Procedure from 17a-hydroxyprogesterone acetate 3 (92.9 
mg, 0.250 mmol) and 2-methoxythiophene 1l (25 μL, 
0.250 mmol). The crude product was purified by trituration 
using a solution of hexanes/ethyl acetate (70:30) to yield 6a (89.9 mg, 0.193 mmol, 77%) as a 
brown solid. 1H NMR (400 MHz, CDCl3): δ 6.62 (d, J = 4.0 Hz, 1H), 6.16-6.15 (m, 1H), 6.06 
(d, J  = 4.0 Hz, 1H), 5.50-5.49 (m, 1H), 3.87 (s, 3H), 2.99-2.92 (m, 1H), 2.55-2.41 (m, 2H), 
2.29-2.25 (m, 1H), 2.12 (s, 3H), 2.05 (s, 3H), 2.05-1.91 (m, 2H), 1.85-1.72 (m, 6H), 1.60-1.56 
(m, 1H), 1.51-1.40 (m, 1H), 1.34-1.25 (m, 2H), 1.17-1.10 (m, 1H), 0.98 (s, 3H), 0.67 (s, 3H). 
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13C NMR (100 MHz, CDCl3): δ 204.4, 170.9, 164.8, 141.8, 132.5, 128.6, 123.7, 122.8, 120.0, 
104.1, 97.2, 60.2, 52.2, 47.8, 47.1, 35.1, 33.9, 32.1, 32.0, 31.3, 30.6, 29.9, 26.6, 24.1, 21.4, 
20.9, 19.3, 14.6. HRMS (ESI) calcd. for C28H37O4S+ [M+H]+ 469.2407, found 469.2401 
 3-(5-methyl-1H-pyrrol-2-yl)-17a-hydroxyprogesta-3,5-
diene acetate (6b): Prepared according to the General 
Procedure from 17a-hydroxyprogesterone acetate 3 (92.9 mg, 
0.250 mmol) and 2-methylpyrrole 1m (22 μL, 0.250 mmol). 
The crude product was purified by trituration using a solution 
of hexanes/ethyl acetate (70:30) to yield 6b (79.2 mg, 0.183 mmol, 73%) as a brown solid. 1H 
NMR (400 MHz, CDCl3): δ 7.98 (br, s, 1H), 6.13 (dd, J = 3.2, 2.8 Hz, 1H), 6.02 (s, 1H), 5.87 
(ddd, J = 3.2, 2.8, 0.8 Hz, 1H), 5.44-5.43 (m, 1H), 2.99-2.92 (m, 1H), 2.53-2.37 (m, 2H), 2.29-
2.21 (m, 4H), 2.12 (s, 3H), 2.05 (s, 3H), 2.05-2.01 (m, 1H), 1.98-1.90 (m, 1H), 1.83-1.74 (m, 
6H), 1.59-1.57 (m, 1H), 1.51-1.40 (m, 1H), 1.33-1.25 (m, 2H), 1.17-1.11 (m, 1H), 0.97 (s, 3H), 
0.67 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 204.4, 171.0, 142.0, 131.9, 128.8, 126.3, 122.2, 
118.9, 107.4, 106.4, 97.2, 52.3, 47.8, 47.1, 35.2, 33.8, 32.1 (2 carbons), 31.3, 30.6, 26.6, 24.1, 
23.5, 21.5, 20.9, 19.3, 14.6, 13.6. HRMS (ESI) calcd. for C28H38NO3+ [M+H]+ 436.2846, found 
436.2855. 
 3-(1H-indol-3-yl)andrenosta-3,5-diene (7a): Prepared 
according to the General Procedure from andrenosterone 4 
(75.1 mg, 0.250 mmol) and indole 1a (29.3 mg, 0.250 mmol). 
The crude product was purified by trituration using a solution 
of hexanes/ethyl acetate (70:30) to yield 7a (92.9 mg, 0.233 mmol, 93%) as a white solid. 1H 
NMR (600 MHz, DMSO-d6): δ 11.2 (br, s, 1H), 7.87 (d, J = 7.8 Hz, 1H), 7.46 (d, J = 2.4 Hz, 
1H), 7.37 (d, J = 7.8 Hz, 1H), 7.10 (dd, J = 7.8, 7.2 Hz, 1H), 7.04 (dd, J = 7.8, 7.2 Hz, 1H), 
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6.49 (s, 1H), 5.48-5.47 (m, 1H), 2.57-2.41 (m, 4H), 2.36-2.29 (m, 2H), 2.15-1.85 (m, 6H), 
1.75-1.71 (m, 1H), 1.59-1.53 (m, 1H), 1.21-1.16 (m, 1H), 1.12 (s, 3H), 0.69 (s, 3H). 13C NMR 
(100 MHz, DMSO-d6): δ 217.3, 209.4, 141.9, 137.1, 130.1, 125.5, 123.6, 121.3, 122.2, 120.4, 
120.0, 119.4, 116.1, 111.8, 58.2, 50.0, 49.5, 48.6, 35.8, 34.4, 32.3, 31.9, 30.9, 24.8, 21.0, 18.5, 
14.3. HRMS (ESI) calcd. for C27H30NO2+ [M+H]+ 400.2271, found 400.2280. 
 3-(7-methoxy-1H-indol-3-yl)andrenosta-3,5-diene 
(7b): Prepared according to the General Procedure from 
andrenosterone 4 (75.1 mg, 0.250 mmol) and 7-
methoxyindole 1b (37.0 mg, 0.250 mmol). The crude 
product was purified by trituration using a solution of hexanes/ethyl acetate (70:30) to yield 
7b (96.6 mg, 0.225 mmol, 90%) as a brown solid. 1H NMR (600 MHz, DMF-d7): δ 11.29 (br, 
s, 1H), 7.56 (d, J = 7.8 Hz, 1H), 7.49 (d, J = 2.4 Hz, 1H), 7.03 (dd, J = 7.8, 7.8 Hz, 1H), 6.74 
(d, J = 7.8 Hz, 1H), 6.60 (s, 1H), 5.58-5.57 (m, 1H), 3.96 (s, 3H), 2.70-2.67 (m, 1H), 2.63-2.61 
(m, 2H), 2.57-2.45 (m, 3H), 2.30-2.18 (m, 3H), 2.16-2.03 (m, 4H), 1.78-1.72 (m, 1H), 1.31-
1.26 (m, 1H), 1.24 (s, 3H), 0.83 (s, 3H). 13C NMR (100 MHz, DMF-d7): δ 218.4, 210.5, 147.8, 
143.7, 131.9, 128.9, 127.7, 124.2, 122.8, 121.14, 121.13, 118.5, 114.5, 102.9, 60.0, 56.1, 51.4, 
51.0, 50.6, 36.9, 36.0, 34.0, 33.6, 32.4, 26.3, 22.4, 19.5, 15.3. HRMS (ESI) calcd. for 
C28H32NO3+ [M+H]+ 430.2377, found 430.2391. 
 3-(7-bromo-1H-indol-3-yl)andrenosta-3,5-diene (7c): 
Prepared according to the General Procedure from 
andrenosterone 4 (75.1 mg, 0.250 mmol) and 7-
bromoindole 1c (49.0 mg, 0.250 mmol). The crude product 
was purified by trituration using a solution of hexanes/ethyl 
acetate (70:30) to yield 7c (111.2 mg, 0.233 mmol, 93%) as a white solid. 1H NMR (400 MHz, 
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CDCl3): δ 8.33 (br, s, 1H), 7.91 (d, J = 8.0 Hz, 1H), 7.37 (dd, J = 7.6, 0.4 Hz, 1H), 7.32 (d, J 
= 2.4 Hz, 1H), 7.05 (dd, J = 8.0, 8.0 Hz, 1H), 6.54 (s, 1H), 5.54-5.52 (m, 1H), 2.78-2.48 (m, 
6H), 2.39-2.08 (m, 5H), 2.03-1.93 (m, 2H), 1.73-1.66 (m, 1H), 1.36-1.28 (m, 1H), 1.27 (s, 3H), 
0.90 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 217.9, 209.2, 142.9, 135.6, 130.5, 126.5, 124.8, 
123.5, 122.5, 121.4, 120.5, 120.4, 119.7, 105.2, 59.7, 50.70, 50.67, 50.4, 36.4, 35.3, 33.2, 32.9, 
31.8, 25.9, 21.9, 19.0, 14.9. HRMS (ESI) calcd. for C27H29BrNO2+ [M+H]+ 478.1376, found 
478.1366.  
  3-(7-cyano-1H-indol-3-yl)andrenosta-3,5-diene (7d): 
Prepared according to the General Procedure from 
andrenosterone 4 (75.1 mg, 0.250 mmol) and 7-
cyanoindole 1d (35.5mg, 0.250 mmol. The crude product 
was purified by trituration using a solution of hexanes/ethyl acetate (70:30) to yield 7d (27.6 
mg, 0.065 mmol, 26%) as a white solid. 1H NMR (600 MHz, DMF-d7): 12.18 (br, s, 1H), 8.35 
(d, J = 7.8 Hz, 1H), 7.76 (d, J = 2.4 Hz, 1H), 7.67 (d, J = 7.2 Hz, 1H), 7.28 (dd, J = 7.8, 7.2 
Hz, 1H), 6.65 (s, 1H), 5.66-5.65 (m, 1H), 2.73-2.70 (m, 1H), 2.67-2.64 (m, 2H), 2.60-2.55 (m, 
2H), 2.51 (dt, J = 18.0, 4.8 Hz, 1H), 2.31-2.20 (m, 4H), 2.18-2.10 (m, 3H), 1.79-1.75 (m, 1H), 
1.33-1.28 (m, 1H), 1.25 (m, 3H), 0.85 (m, 3H).  13C NMR (100 MHz, DMF-d7): δ 218.3, 210.5, 
143.4, 138.2, 130.7, 127.7, 127.26, 127.25, 127.2, 126.5, 124.3, 120.7, 119.3, 118.3, 59.9, 51.5, 
51.0, 50.6, 36.9, 36.1, 35.9, 33.9, 33.7, 32.4, 26.4, 22.5, 19.5, 15.4. HRMS (ESI) calcd. for 
C28H29N2O2+ [M+H]+ 425.2224, found 425.2228. 
 3-(5-methyl-1H-pyrrol-2-yl)andrnosta-3,5-diene (7e): 
Prepared according to the General Procedure from andrenosterone 
4 (75.1 mg, 0.250 mmol) and 2-methylpyrrole 1m (22 μL, 0.250 
mmol). The crude product was purified by trituration using a 
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solution of hexanes/ethyl acetate (70:30) to yield 7e (80.9 mg, 0.223 mmol, 89%) as a brown 
solid. 1H NMR (400 MHz, CDCl3): δ 7.97 (br, s, 1H), 6.16 (dd, J = 4.8, 4.2 Hz, 1H), 6.00 (s, 
1H), 5.88 (ddd, J = 4.8, 4.2, 1.2 Hz, 1H), 5.43-5.41 (m, 1H), 2.73-2.67 (m, 1H), 2.61-2.47 (m, 
4H), 2.36-2.28 (m, 2H), 2.28 (s, 3H), 2.27-2.06 (m, 4H), 2.01-1.92 (m, 2H), 1.75-1.65 (m, 1H), 
1.24-1.16 (m, 4H), 0.88 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 217.8, 209.1, 142.7, 131.7, 
128.7, 128.9, 127.7, 119.8, 117.9, 107.6, 106.7, 59.5, 50.7, 50.4, 36.3, 35.4, 32.8, 32.7, 31.8, 
23.4, 21.9, 18.9, 14.9, 13.4. HRMS (ESI) calcd. for C24H30NO2+ [M+H]+ 364.2271, found 
364.2301. 
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CHAPTER 5.                                                                                                                           
NI-CATALYZED INTERMOLECULAR, THREE-COMPONENT ALKENE 
CARBOACYLATION INITIATED BY AMIDE C-N BOND ACTIVATION 
Modified from a manuscript in preparation for submission to the Journal of American 
Chemical Society  
Tanner L. Metz, Abhishek A. Kadam, Qian Yiqui, and Levi M. Stanley 
 
Abstract 
The nickel-catalyzed intermolecular carboacylation of alkenes with amides and 
tetraarylborates is presented. Bicyclic alkenes are readily functionalized with a variety of N-
benzoyl-N-phenylbenzamides and triarylboranes, which are generated in situ from the 
corresponding tetraarylborates, to synthesize ketone products in up to 91% yield. This 
reaction manifold is initiated by activation of the amide C-N bond via oxidative addition by 
a Ni(0) catalyst. Preliminary mechanistic studies suggest that migratory insertion precedes 
transmetalation, and that reductive elimination is the turnover-limiting step. These reactions 
occur with excellent chemoselectivity and diastereoselectivity in the absence of a 
directing/chelating group and further demonstrate amides as practical acyl electrophiles for 
alkene functionalization reactions.   
Introduction 
Transition metal-catalyzed cross-coupling reactions constitute an integral toolkit for the 
construction of new C-C bonds.1-6 Recently, cross-coupling reactions involving alkenes as 
ambiphilic conjunctive reagents have emerged as a promising platform for alkene 
dicarbofunctionalization reactions, such as arylalkylation, diarylation, and dialkylation.7-10 
Carboacylation of alkenes is an important subset of these reactions, which resulting in the 
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introduction of an acyl electrophile and an aryl or alkyl nucleophile into readily accessible 
alkene frameworks.  
To date, most alkene carboacylation reactions proceed in an intramolecular fashion, delivering 
cyclized products from preassembled starting materials. As a consequence of their 
intramolecular nature, these processes are restricted to substrates bearing tethered alkenes.11-20 
We envisioned the development of an intermolecular, three-component alkene carboacylation 
reaction, which would enable the synthesis of complex molecular scaffolds from readily 
accessible starting materials. Current approaches to intermolecular alkene carboacylation 
encompass (1) reactions triggered by the directed activation of a C-C bond, and (2) three-
component conjunctive cross-coupling reactions between a carboxylic acid derivative, an alkyl 
radical or organometallic nucleophile, and an alkene.21-23 
Building upon their intramolecular manifold, Douglas and co-workers reported a Rh-catalyzed 
intermolecular alkene carboacylation reaction of 8-acylquinolines with strained bicyclic 
alkenes (Scheme 1a).21 The disadvantage of this approach is that it requires the use of a non-
removable quinoline directing group to facilitate C-C bond scission. 
  An alternative approach to three-component carboacylation of alkenes via Ni-catalyzed 
reductive radical relay was recently reported (Scheme 1b).23 This reaction involves the radical 
addition to an alkene followed by chelating assisted alkyl radical capture of the 
acyl-nickel(II)-chloride intermediate. While this report provides a practical entry into three-
component alkene carboacylation reactions, this method is limited to the addition of 
perfluoroalkyl radicals. Currently, the ability to incorporate a broad range of organometallic 
nucleophiles into these conjunctive three-component cross-coupling reactions is not possible.  
An alternative pathway to intermolecular three-component alkene carboacylation 
proceeds through a Rh-catalyzed three-component conjunctive cross-coupling of an acid 
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anhydride, tetraphenylborate, and norbornene (Scheme 1c).22 This method begins to set the 
stage for highly modular three-component alkene carboacylation; however, this reaction 
suffers from limited substrate scope, 4 examples in 43-55% yield, and poor chemoselectivity. 
In an effort to address these current limitations and simultaneously expand the synthetic utility 
of amides as acyl electrophiles in the context of alkene functionalization reactions, we sought 
to develop a three-component alkene carboacylation reaction initiated by amide C-N bond 
activation (Scheme 1d).20, 24, 25 
Scheme 5.1: Current Strategies for Transition Metal-Catalyzed Intermoleuclar Alkene 
Carboacylation 
 
Initially, we chose to evaluate the reaction of N-glutarimidebenzamide 1a, norbornene 4a, and 
sodium tetraphenylborate 5a as a means to identify an optimal catalyst. We began our  
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Table 5.1: Ligand Studies for the Alkene Carboacylation Reaction Between 1a, 4a, and 5a5 
 
entry ligand 
conversion 
(%)b 
yield (%)b 
6a 7 8 9 10 11 12 
1 SIPr 92 25 16 3 3 0 22 1 
2 IMes 84 8 0 0 2 0 10 7 
3c ICy·HCl 48 18 0 0 2 6 6 2 
4 PCy3 89 15 6 0 0 7 5 4 
5 PtBu3 42 14 0 0 3 7 5 2 
6 dppe 92 3 4 16 0 6 5 4 
7 dppp 99 1 2 7 0 5 10 3 
8 - 80 19 1 2 2 4 8 2 
9d - 70 29 1 9 2 4 8 2 
a Conditions: 1a (0.100 mmol), norbornene 4a (1.00 mmol), NaBPh4 5a (0.200 mmol), Ni(cod)2 (0.010 
mmol), solvent (0.1 M, 1 mL), 16 h. b Determined by 1H NMR spectroscopy of the crude reaction 
mixture using dibromomethane as an internal standard c Run in the presence of 12 mol % NaOtBu. d 
Benzene was used as the solvent. 
 
N
O nbe 4a (10 equiv)
NaBPh4 5a (2 equiv)
Ni(cod)2 (10 mol %)
ligand (12 mol %)
toluene, 95 ºC
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studies by investigating Ni-complex of N-heterocyclic carbenes, monophosphine, and 
bisphosphine ligands that have previously been shown to readily activate amide C-N bonds 
(Table 5.1).26-35 Nickel complexes generated from Ni(cod)2 a variety of N-heterocyclic 
carbenes, monophosphine, or bisphosphine ligands catalyzed the model reaction to form the 
desired cis-diastereomer 6a in 8-25% yield (Table 5.1, entires 1-7). When the alkene 
carboacylation reaction was catalyzed by Ni(cod)2 in the absence of an exogenous ligand, the 
reaction formed the cis-diastereomer 6a in 29% yield with excellent diastereoselectivity (Table 
5.1, entry 9). 
We next investigated the impact additives that have previously been shown to facilitate 
amide activation in amide cross-coupling reactions (Table 5.2). In the presence of boric acid, 
the model reaction formed the carboacylation product 6a in 48% yield (Table 5.2, entry 2). 
While the addition of Mg(OTf)2 and DIEA individually to the model reaction did not impact 
the yield of 6a (Table 5.2, entries 3 and 4); however, these additives in addition to boric acid 
to the model reaction generated the carboacylation 6a product in 66% yield (Table 5.2, entry 
8).  
To improve the yield of the model alkene carboacylation reaction, we investigated the 
impact of amide identity (Table 5.3). The reaction of N-phenyl-N-Boc-benzamide 2a with 
norbornene 4a and sodium tetraphenylborate 5a formed the carboacylation product 6a in 65% 
yield (Table 5.3, entry 2). However, the yield is modest due to the formation of benzanilide in 
20% yield. We initially hypothesized that benzanilide is formed from the acid-catalyzed 
deprotection of the boc carbamate. Several attempts to mitigate the formation of benzanilide 
utilizing a variety of N-aryl-N-carbamate substituted benzamides were unsuccessful, and 
benzanlide formation is likely the result of carbamate C-N bond activation (Table 5.3, entries 
3-7). To mitigate the potential for undesired C-N bond activation we evaluated reactions of  
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Table 5.2:  Investigation of Additives for the Alkene Carboacylation Reaction Between 1a, 4a, 
and 5a5 
 
entry additive(s) 
conversion 
(%)b 
yield (%)b 
6a 7 8 9 10 11 12 
1 none 70 29 1 9 2 4 8 2 
2 1 96 48 0 0 3 7 25 1 
3 2 77 28 0 0 2 6 8 1 
4 3 92 27 2 2 2 3 7 1 
5 1 / 2 98 56 1 1 4 6 33 1 
6 1 / 3 99 59 0 0 2 3 32 3 
7 2 / 3 93 32 2 1 2 4 10 1 
8 1 / 2 / 3 99 66 0 0 6 7 47 1 
a Conditions: 1a (0.100 mmol), norbornene 4a (1.00 mmol), NaBPh4 5a (0.200 mmol), Ni(cod)2 (0.010 
mmol), additive(s) (0.3-2.0 equiv), benzene (0.1 M, 1 mL), 16 h. b Determined by 1H NMR spectroscopy 
of the crude reaction mixture using dibromomethane as an internal standard.  
N
O nbe 4a (10 equiv)
NaBPh4 5a (2 equiv)
Ni(cod)2 (10 mol %)
additive(s) (0.3 - 2.0 equiv)
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11
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2. Mg(OTf)2 (30 mol %)
3. DIEA (3 equiv)
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the symmetrical N-benzoyl-N-phenylbenzamide 3a. The reaction of 3a with norbornene 4a and 
tetraphenylborate 5a generated the alkene carboacylation products in 84% yield with 10.6:1 dr 
(Table 1, entry 8). Utilizing just boric acid as an additive, the carboacylation reaction between 
amide 3a, norbornene 4a, and sodium tetraphenylborate 5a generates ketone product 6a 92% 
yield with 9.2:1 dr (Table 5.3, entry 9).  
When the reaction time was reduced to 8 h, the alkene carboacylation products formed 
in 87% yield with >20:1 dr. However, the reaction formed 6a as a single diastereomer in 85% 
yield when the reaction was conducted at 80 °C for 8 h . We observed that high concentrations 
of norbornene 4a were required to obtain product 6a in high yields. The carboacylation reaction 
between amide 3a, sodium tetraphenylborate 5a and 5 equivalents of norbornene 4a generated 
the carboacylation product 6a in 65% yield. 
With a practical catalyst system identified for the model reaction between amide 3a, 
norbornene 4a, and tetraphenylborate 5a, we evaluated intermolecular alkene carboacylation 
reactions with a variety of N-benzoyl-N-phenylbenzamides and tetraarylborates (Scheme 5.2). 
Carboacylation of norbornene 4a with electron-donating, electron-neutral, or halogentated 
para-substituted N-benzoyl-N-phenylbenzamides 3a-3f and tetraphenylborate 5a formed 
ketone products 6a-6f in 56-91% yield. Reactions of N-benzoyl-N-phenylbenzamides with 
electron-donating and halogenated meta-substituents occur to form the corresponding ketone 
products 6g-6j in moderate-to-good yields (50-74%). Reactions of ortho-methyl amides 
generated the corresponding ketone products 6l in 67%. The reaction of 3,4-dimethoxy 
substituted N-benzoyl-N-phenylbenzamide led to the formation of ketone product 6k in 90% 
yield. A heteroaromatic amides, N-phenyl-N-(thiophen-2-carbonyl)thiophene-2-carboxamide 
underwent alkene carboacylation to form ketone product 6m in 20% yield. Although we 
focused on developing alkene carboacylation reactions using N-benzoyl-N-phenylbenzamides, 
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Table 5.2:  Investigation of Additives for the Model Alkene Carboacylation Reactiona 
entry amide 
conversion 
(%)b 
yield (%)b 
6a 7 8 9 10 11 12 13 
1 1a 70 48 0 0 3 7 25 1 - 
2 2a 99 66 0 0 6 7 47 1 20 
3 2b 99 60 6 0 6 6 54 2 25 
4 2c 99 55 6 0 6 0 47 2 25 
5 2d 99 43 26 0 8 6 57 3 44 
6 2e 81 10 0 0 5 9 38 3 26 
7 2f 99 23 9 0 3 1 40 3 80 
8 3a 99 74 7 0 6 6 21 0 84 
9c 3a 99 83 9 0 4 4 20 0 90 
a Conditions: 1a (0.100 mmol), norbornene 4a (1.00 mmol), NaBPh4 5a (0.200 mmol), Ni(cod)2 (0.010 
mmol), additive(s) (0.3-2.0 equiv), benzene (0.1 M, 1 mL), 16 h. b Determined by 1H NMR spectroscopy 
of the crude reaction mixture using dibromomethane as an internal standard. c Run in the absence of 
Mg(OTf)2 and DIEA.   
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Scheme 5.2: Scope of Amides and Sodium Tetraarylboratesa,c 
 
a  Reaction conditions: 3 (0.100 mmol), 2a (1.00 mmol), 3 (0.200 mmol), Ni(cod)2 (0.010 mmol), H3BO3 
(0.200 mmol), benzene, 80 °C, 8-16 h. b Reaction run in the presence of Mg(OTf)2 (0.030 mmol) and 
DIEA (0.300 mmol). c Reaction Conditions: 1 (0.100 mmol), 2a (1.00 mmol), 3 (0.200 mmol), Ni(cod)2 
(0.010 mmol), H3BO3 (0.200 mmol), Mg(OTf)2 (0.030 mmol), and DIEA (0.300 mmol), benzene, 80 
°C, 16 h 
 
the reactions of amides derived from glutarimide were also successful. For example, the 
reaction of 1-(2-naphthoyl)piperidine-2,6-dione formed  ketone product 6n in 88% yield when 
run in the presence of 15 mol % catalyst. We next evaluated reactions of a range of 
electronically diverse sodium tetraarylborates 5a-5c with N-benzoyl-N-phenylbenzamide 3a 
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and norbornene 4a. Sodium tetraphenylborates with electron-donating and halogenated 
substituents reacted with N-benzoyl-N-phenylbenzamide 3a and norbornene 4a to form the 
corresponding ketone products 6o and 6p in 55-69% yields.  
With the scope of benzamide substrates and tetraarylborates established, we sought to 
evaluate Ni-catalyzed alkene carboacylation with a range of bicyclic alkenes 4a-4h (Scheme 
5.3). Carboacylations of benzonorbornadienes with amide 3a and tetraphenylborate 5a 
generate ketone products 6q and 6s in 68% and 48% yield. Reactions of dimethyl-(exo,exo)-
5-nobornene-2,3-dicarboxylate and dimethyl-(endo,endo)-5-nobornene-2,3-dicarboxylate 
generated carboacylation products 6v and 6w in 75% and 53% yield. We recognized the 
impracticality of establishing an alkene scope which requires a large excess of non-
commercially available alkene coupling partners.36-38 We discovered that the concentration of 
norbornene 4a can be lowered to 4 equivalents in the presence of 1 equivalent of p-F-styrene 
without impacting the yield of ketone product 6a. Encouraged by this result, we continued our 
substrate scope using 4 equivalents of alkene in the presence of 1 equivalent of p-F-styrene. 
Carboacylation reactions of benzonorbornadienes formed ketone products 6r and 6s in 40-51% 
yield. In addition, reactions of dialkyl (exo,exo)-5-nobornene-2,3-dicarboxylates and dimethyl 
(endo,endo)-5-nobornene-2,3-dicarboxylate generated carboacylation products 6t-6w in 44-
68% yield. 
To gain insight into the mechanism of the intermolecular alkene carboacylation 
reaction, we conducted a series of control experiments (Scheme 5.4). The carboacylation 
reactions with unsymmetrical amides, N-benzoyl-4-methoxy-N-phenylbenzamide 3o or 
pheny-4-(trifluoromethyl)lbenzamide 3p, generated a mixture of ketone products 6a and 6b or 
-6a and 6x in nearly a 1:1 ratio (Scheme 5.4a and 5.4b). These results suggest that oxidative 
addition is not the turnover-limiting step in these catalytic reactions. As we have noted in our 
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discussion of alkene scope (Scheme 5.3), the concentration of alkene can be significantly 
reduced when running the model reaction in the presence of p-F-styrene (Scheme 5.4c). The 
addition of p-F-styrene has been reported to facilitate reductive elimination between sp2 and 
sp3 hybridized carbon centers for nickel-catalyzed cross-coupling reactions.36-38 Based on this 
result, our working hypothesis is that reductive elimination is the turnover-limiting step for the 
intermolecular alkene carboacylation reaction. 
Scheme 5.3: Alkene Scopea 
 
a  Reaction conditions A: 3a (0.100 mmol), 4 (1.00 mmol), 5a (0.200 mmol), Ni(cod)2 (0.010 mmol), 
H3BO3 (0.200 mmol), benzene, 95 °C, 8 h. Reaction conditions B: 3a (0.100 mmol), 2 (0.400 mmol), 
5a (0.200 mmol), Ni(cod)2 (0.010 mmol), H3BO3 (0.200 mmol), p-F-styrene (0.100 mmol) benzene, 95 
°C, 8 h. 
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After oxidative addition, we envisioned two potential pathways for our model reaction 
to proceed depending on the order for the subsequent transmetalation and migratory insertion 
steps. If transmetalation with triphenylborane occurs first, the corresponding acyl-nickel(II)-
aryl complex would be generated as an on cycle intermediate. However, if migratory insertion 
precedes transmetalation, an alkyl-nickel(II)-amido complex would be formed. In this 
scenario, the acyl-nickel(II)-aryl complex would be a an off-cycle intermediate that leads to 
the formation of benzophenone 10, the product of Suzuki-Miyaura cross-coupling. In effort to 
determine the order of elementary steps we compared the three-component alkene 
carboacylation reactions of norbornene 4a, amide 3a, and diphenylzinc or dimehtylzinc as the 
organometallic nucleophile (Scheme 5.4d). The carboacylation reaction with diphenylzinc 
generated benzophenone 10, the product of Negishi coupling, in 89% yield and the desired 
carboacylation product 6a was formed in 11% yield. We postulate that in the presence of an 
diphenylzinc, transmetalation proceeds migratory insertion and selectivity generates the acyl- 
nickel(II)-aryl intermediate. The observed formation of benzophenone 10 as the major product 
suggests that the acyl-nickel(II)-aryl complex is an off cycle intermediate and that migratory 
insertion precedes transmetalation for our model reaction. It has been established that nickel 
catalysts undergo faster rates of transmetalation with arylzinc nucleophiles compared to 
alkylzinc nucleophiles.39 We hypothesized that in the presence of dimethylzinc, migratory 
insertion would proceed the slower transmetalation, and carboacylation of norbornene 4a, 
amide 3a, and dimethylzinc occurred to form the carboacylation product 6y in 37% yield and 
no competing Negishi coupling product was observed. This result provides further evidence 
that migratory insertion precedes transmetalation for our model reaction. 
Building upon the observations derived from our control experiments, we propose the 
following catalytic cycle (Scheme 5.5). Oxidative addition of the active Ni(0) catalyst to amide 
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Scheme 5.4: Control Experiments 
 
3a affords acyl-Ni(II)-amido intermediate B. Migratory insertion of bicyclic alkene 4a into 
the Ni-C(acyl) bond generates alkyl-Ni(II)-amido complex C. Subsequent transmetalation 
with triphenylborane forms the alkyl-Ni(II)-aryl intermediate D, which undergoes reductive 
elimination to form the carboacylation product 6a and regenerates the active Ni(0) catalyst A. 
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Scheme 5.5: Plausible Catalytic Cycle 
 
Conclusions 
In summary, we have developed a nickel-catalyzed intermolecular, three-component 
alkene carboacylation reaction triggered by activation of an amide C-N bond. This nickel-
catalyzed conjunctive cross-coupling encompasses reactions of a variety of bicyclic alkenes, 
amides, and tetraarylborates to generate highly functionalized ketone products high yields and 
excellent diastereoselectivity. In addition, preliminary mechanistic studies suggest that 
reductive elimination is the turnover-limiting step, and that migratory insertion precedes 
transmetalation. Studies to further leverage the synthetic potential of amides as acyl 
electrophiles in three-component conjunctive cross-coupling reactions are ongoing in our 
laboratory. 
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Experimental 
General Reaction Details. All air-senstive procedures were conducted under inert 
atmosphere in a nitrogen-filled dry box or by standard Schlenk techniques. All reactions were 
performed under nitrogen unless otherwise stated. Benzene, Toluene, DCM, Et2O, and THF 
were degassed by purging with argon for 45 minutes and dried with a solvent purification 
system by passing through a one-meter column of activated alumina. Anhydrous dioxane and 
DMF were purchased from Sigma-Aldrich and used as received. Flash column 
chromatography was performed on SiliFlash® P60 silica gel (40-63μm, 60Å) or using a 
Teledyne Isco Combiflash® Rf system with RediSep GoldTM columns using hexanes/ethyl 
acetate. Reaction products were visualized on TLC under UV light or by staining with KMnO4.  
HRMS (ESI) analysis was performed at the Iowa State University Chemical Instrumentation 
Facility on an Agilent 6540 QTOF spectrometer. Elemental analysis was performed at the Iowa 
State University Chemical Instrumentation Facility on the Perkin Elmer 2100 Series II CHN/S 
Analyzer. NMR spectra were acquired on Varian MR-400 and Bruker Avance III 600 
spectrometers at the Iowa State University Chemical Instrumentation Facility. Chemical shifts 
are reported in ppm relative to a residual solvent peak (CDCl3 = 7.26 ppm for 1H and 77.16 
ppm for 13C) Coupling constants are reported in hertz. 
Materials.  
Sodium tetraphenylborate, norbornene, Methylchloroformate, ethylchloroformate, 
isopropylchloroformate, phenylchloroformate, benzylchloroformate, 4-methoxybenzoic acid, 
4-methylbenzoic acid , 4-phenylbenzoic acid, 4-chlorobenzoic acid, 4-fluorobenzoic acid, 3-
chlorobenzoic acid, 3-fluorobenzoic acid, 2-thiophenecarboxylic acid, 2-furoic acid, 
magnesium triflate, DIEA, anhydrous methanol, anhydrous ethanol, anhydrous n-butanol, 
dimethylzinc, benzoyl chloride, , 2.0 M oxayl chloride solution in DCM,  and 2.5 M n-BuLi 
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solution in hexanes were purchased from Sigma Aldrich. 3-Methylbenzoic acid was purchased 
from Lancaster Synthesis. 3-Methoxybenzoic acid was purchased from Eastman Organic 
Chemicals. Dicyclopentandiene and triphenylborane were purchased from Alfa Aesar. 4-
Methoxybenzoyl chloride, and 4-(trifluoromethyl)benzoyl chloride where purchased from TCI 
America. Carbic anhydride and benzanilide were purchased from AK Scientific. Ni(cod)2 was 
purchased from Strem Chemcial. Amides 1a,25 2a,40 and 3a41 were synthesized according to 
literature procedures. Alkene 4b,42 4c,43 4d,44 4e,45 4f, 45 4g, 45 and 4h45 were synthesized 
according to literature procedures. Tetraaarylborates 2b46 and 2c46 where prepared according 
to literature procedures.  
General Procedure A for synthesis of carbamates amides 2b-2f: 
 
An oven dried flask was charged with a solution of NaH (1.4 equiv) in THF (0.6 M) at 0 °C 
under N2. A solution of benzanilide (1.2 equiv) in THF (0.25 M) was added to the reaction 
flask. The resulting mixture was then stirred at 0 °C for 1 h. A solution of alkyl or aryl 
chloroformate (1.0 equiv) in THF (0.42 M) was added slowly to the reaction flask. The 
resulting mixture was stirred at room temperature for 5 h. The reaction mixture was then 
quenched with sat. NH4Cl. The aqueous layer was separated and extracted with DCM (15 mL 
X 3). The combined organic layer was washed with brine, dried over MgSO4 and concentrated 
under vacuum. The crude reaction mixture was then purified by flash column chromatography 
to give amides 2b-2f in 61-99% yield.      
Characterization data for amides 2b-2f 
Ph N
H
O
Ph
O Cl
O
R
NaH (1.4 equiv)
THF, rt, 5 h
R = Me, Et, iPr, Bn, Ph
Ph N
O
Ph
O O R
R = Me, Et, iPr, Bn, Ph
(1.2 equiv)
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isopropyl benzoyl(phenyl)carbamate 2b: Prepared according to the General 
Procedure A from benzanilide. 1H NMR (400 MHz, CDCl3): d 1.04 (d, J = 6.4 Hz, 6H), 
4.88 (sep, J = 6.4 Hz, 1H), 7.27 (dd, J = 7.6, 1.2 Hz, 2H), 7.35 (tt, J = 7.6, 1.2 Hz, 1H), 
7.40-7.46 (m, 4H), 7.52 (tt, J = 7.6, 1.2 Hz, 1H), 7.72-7.74 (m,  2H). 13C NMR (100 
MHz, CDCl3): 21.4, 71.55, 71.62, 128.0, 128.3, 128.4, 129.3, 131.9, 136.6, 139.0, 154.4, 172.6. HRMS 
(ESI): Calcd. for C17H18NO3+ ([M+H]+): 284.1281, Found: 284.1279. 
ethyl benzoyl(phenyl)carbamate 2c: Prepared according to the General Procedure A 
from benzanilide. 1H NMR (400 MHz, CDCl3): d 1.03 (t, J = 7.2 Hz, 3H), 4.12 (q, J = 7.2 
Hz, 2H), 7.27 (dd, J = 7.6, 1.2 Hz, 2H), 7.35 (tt, J = 7.6, 1.2 Hz, 1H), 7.40-7.45 (m, 4H), 
7.52 (tt, J = 7.6, 1.2 Hz, 1H), 7.71-7.73 (m, 2H). 13C NMR (100 MHz, CDCl3): 13.9, 63.3, 
128.1, 128.1, 128.3, 128.4, 129.4, 132.0, 136.2, 138.9, 154.9, 172.4. HRMS (ESI): Calcd. for 
C16H16NO3+ ([M+H]+): 270.1125, Found: 270.1129. 
benzyl benzoyl(phenyl)carbamate 2d: Prepared according to the General 
Procedure A from benzanilide. 1H NMR (400 MHz, CDCl3): d 5.10 (s, 2H), 7.03 (dd, 
J = 7.6, 1.6 Hz, 2H), 7.24-7.29 (m, 5H), 7.33-7.44 (m, 5H), 7.50 (77, J = 7.6, 1.2 Hz, 
1H), 7.68-7.71 (m, 2H). 13C NMR (100 MHz, CDCl3): 68.8, 128.1, 128.2, 128.46, 
128.50, 128.52, 128.54, 128.57, 129.4, 132.2, 134.8, 135.9, 138.8, 154.8, 172.3. HRMS (ESI): Calcd. 
for C21H18NO3+ ([M+H]+): 332.1281, Found: 332.1281. 
methyl benzoyl(phenyl)carbamate 2e: Prepared according to the General Procedure 
A from benzanilide. 1H NMR (400 MHz, CDCl3): d 3.68 (s, 3H), 7.24-7.27 (m, 2H), 7.36 
(tt, J = 7.6, 1.2 Hz, 1H), 7.40-7.44 (m, 4H), 7.51 (tt, J = 7.6, 1.2 Hz, 1H), 7.70-7.73 (m, 
2H). 13C NMR (100 MHz, CDCl3): 53.9, 128.1, 128.2, 128.4, 128.5, 129.4, 132.1, 135.7, 
138.7, 155.3, 172.2. HRMS (ESI): Calcd. for C15H13NO3+ ([M+H]+): 256.0968, Found: 256.0972. 
phenyl benzoyl(phenyl)carbamate 2f: Prepared according to the General Procedure 
A from benzanilide. 1H NMR (400 MHz, CDCl3): d 6.95-6.98 (m, 2H), 7.18 (tt, 7.6, 1.2 
Hz, 1H), 7.30 (tt, 8.0, 2.0 Hz, 2H), 7.37-7.42 (m, 3H), 7.45-7.50 (m, 4H), 7.55 (tt, J = 
7.6, 1.2 Hz, 1H), 7.84-7.87 (m, 2H).13C NMR (100 MHz, CDCl3): 121.0, 126.2, 128.0, 
Ph N
O
Ph
O O
2b
Ph N
O
Ph
O O
2c
Ph N
O
Ph
O O
2d Ph
Ph N
O
Ph
O O
2e
Ph N
O
Ph
O O
Ph
2f
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128.4, 128.7, 128.7, 129.5, 132.5, 135.6, 138.6, 150.5, 153.2, 172.2. HRMS (ESI): Calcd. for 
C20H16NO3+ ([M+H]+): 318.1125, Found: 318.1127. 
General Procedure B for synthesis of amides 3a-3p: 
 
To the appropriate benzoic acid in anhydrous DCM (0.3 M) at 0 °C under N2 was added 2.0 M 
solution of oxalyl chloride in DCM (1.2 equiv) dropwise and a catalytic amount of DMF (1-2 
drops). The reaction was allowed to warm to room temperature and stirred overnight. The 
solvent was removed under vacuum to afford the corresponding acid chloride. The acid 
chloride was used in the next step without further purification.  
To a dry flask, aniline (1.1 equiv), triethylamine (2.0 equiv) and N,N-dimethylaminopyridine 
(0.25 equiv) were added in DCM (1.5 M). A solution of acid chloride in DCM (0.30 M) was 
added slowly to the reaction flask at 0 °C under N2. The reaction was allowed to warm to room 
temperature and stirred overnight. The reaction mixture was then quenched with 1N HCl and 
layers were separated. The aqueous layer was extracted with EtOAc (15 mL X 3). The organic 
layers were combined, washed with brine, dried over MgSO4, and concentrated under vacuum 
to yield corresponding benzanilide. The benzanilide was used in the next step without further 
purification. 
(Het)Ar
O
OH (Het)Ar
O
Cl (Het)Ar
O
N
H
(COCl)2 (1.5 equiv)
DMF (cat.)
DCM, rt, overnight
Aniline (1.1 equiv)
Et3N (2.0 equiv)
DMAP (0.25 equiv)
DCM, rt, overnight
Ph
Ar = C6H5
Ar = 4-OCH3C6H4
Ar = 4-CH3C6H4
Ar = biphenyl
Ar = 4-ClC6H4
Ar = 4-FC6H4
Ar = 4-CF3C6H4
Ar = 3-OCH3C6H4
Ar = 3-CH3C6H4
Ar = 3-ClC6H4
Ar = 3-FC6H4
Ar = 3,4-(OCH3)2C6H3
Ar = 2-CH3C6H4
Ar = 2-FC6H4
HetAr = 2-thiophene
Ar = C6H5
Ar = 4-OCH3C6H4
Ar = 4-CH3C6H4
Ar = biphenyl
Ar = 4-ClC6H4
Ar = 4-FC6H4
Ar = 4-CF3C6H4
Ar = 3-OCH3C6H4
Ar = 3-CH3C6H4
Ar = 3-ClC6H4
Ar = 3-FC6H4
Ar = 3,4-(OCH3)2C6H3
Ar = 2-CH3C6H4
Ar = 2-FC6H4
HetAr = 2-thiophene
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To an oven dried flask, a cold solution of benzanilide in THF (0.30 M) at -50 °C under N2 was 
added. A solution of 2.5 M nBuLi in hexane (1.1 equiv) was added dropwise to the reaction 
flask. The resulting mixture was stirred at room temperature for 1 h. Acid chloride (4.0 equiv) 
was then added slowly under vigorous stirring. The resulting mixture was then refluxed for 4 
h. The reaction mixture was then quenched with 1 N HCl and layers were separated. The 
aqueous layer was then extracted with EtOAc (20 mL X 3). The combined organic layer was 
then washed with brine, dried over MgSO4, and concentrated under vacuum. The crude 
reaction mixture was then purified by flash column chromatography using Hexane:EtOAc to 
afford corresponding amides. All the amides were then recrystallized from methanol or 
methanol:chloroform (1:1) to give pure amides 3a-3p in 31-75% yields.   
Characterization data for amides 3a-3o 
4-methoxy-N-(4-methoxybenzoyl)-N-phenylbenzamide 3b: 
Prepared according to General Procedure B from 4-
methoxybenzoyl chloride. 1H NMR (400 MHz, CDCl3): δ 
3.81 (s, 3H), 6.82 (ddd, J = 8.8, 2.8, 2.0 Hz, 4H), 7.16 (d, J = 7.2 Hz, 2H), 7.25 (dd, J = 7.6, 
(Het)Ar
O
N
H
Ph nBuLi (1.1 equiv)THF, -50 °C to reflux, 4 h(Het)Ar
O
Cl
(Het)Ar
O
N Ph
O (Het)Ar
Ar = C6H5
Ar = 4-OCH3C6H4
Ar = 4-CH3C6H4
Ar = biphenyl
Ar = 4-ClC6H4
Ar = 4-FC6H4
Ar = 4-CF3C6H4
Ar = 3-OCH3C6H4
Ar = 3-CH3C6H4
Ar = 3-ClC6H4
Ar = 3-FC6H4
Ar = 3,4-(OCH3)2C6H3
Ar = 2-CH3C6H4
Ar = 2-FC6H4
HetAr = 2-thiophene
Ar = C6H5
Ar = 4-OCH3C6H4
Ar = 4-CH3C6H4
Ar = biphenyl
Ar = 4-ClC6H4
Ar = 4-FC6H4
Ar = 4-CF3C6H4
Ar = 3-OCH3C6H4
Ar = 3-CH3C6H4
Ar = 3-ClC6H4
Ar = 3-FC6H4
Ar = 3,4-(OCH3)2C6H3
Ar = 2-CH3C6H4
Ar = 2-FC6H4
HetAr = 2-thiophene
(4.0 equiv)
N
O
Ph
O
O
O
3b
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7.2 Hz, 1H), 7.35 (ddd, J = 8.8, 2.8, 2.0 Hz, 4H). 13C NMR (100 MHz, CDCl3): δ 55.6, 113.9, 
127.2, 127.4, 127.7, 129.6, 131.8, 141.0, 163.0, 173.1. HRMS (ESI): Calcd. for C22H20NO4+ 
([M+H] +): 362.1387, Found: 362.1385. 
4-methyl-N-(4-methylbenzoyl)-N-phenylbenzamide 3c: Prepared 
according to General Procedure B from 4-methylbenzoyl chloride. 
1H NMR (400 MHz, CDCl3): δ 2.34 (s, 6H), 7.13 (d, J = 8.0 Hz, 
4H), 7.17 (d, J = 8.4 Hz, 2H), 7.25 (t, J = 7.2 Hz, 1H), 7.34 (d, J = 8 Hz, 2H), 7.64 (d, J = 8.0 
Hz, 4H). 13C NMR (100 MHz, CDCl3): δ 21.8, 127.5, 127.8, 129.3, 129.61, 129.64, 132.1, 
140.7, 143.2, 173.6. HRMS (ESI): Calcd. for C22H20NO2+ ([M+H] +): 330.1489, Found: 
330.1466. 
N-([1,1'-biphenyl]-4-carbonyl)-N-phenyl-[1,1'-biphenyl]-4-
carboxamide 3d: Prepared according to General Procedure B 
from 4-phenylbenzoyl chloride. 1H NMR (400 MHz, CDCl3): δ 
7.23-7.26 (m, 2H), 7.29 (tt, J = 7.4, 1.29 Hz, 1H), 7.35-7.41 (m, 4H), 7.44 (tdd, J = 7.1, 1.8, 1. 
2 Hz, 4H), 7.55-7.60 (m, 4H), 7.85 (ddd, J = 8.6, 1.9, 1.8 Hz, 4H). 13C NMR (100 MHz, 
CDCl3): δ 127.3, 127.4, 127.8, 127.9, 128.3, 129.1, 129.8, 130.1, 133.5, 139.9, 140.4, 145.3, 
173.4. HRMS (ESI): Calcd. for C32H24NO2+ ([M+H] +): 454.1802, Found: 454.1808. 
4-chloro-N-(4-chlorobenzoyl)-N-phenylbenzamide 3e: 
Prepared according to General Procedure B from 4-
chlorobenzoyl chloride.  1H NMR (400 MHz, CDCl3): δ 7.14 
(ddd, J = 7.6, 1.6, 1.2 Hz, 2H), 7.26-7.39 (m, 7H), 7.67 (ddd, J = 8.0, 2.0, 2.0 Hz, 4H). 13C 
NMR (100 MHz, CDCl3): δ 127.8, 128.1, 129.1, 129.9, 130.8, 132.9, 139.0, 139.8, 172.4. 
HRMS (ESI): Calcd. for C22H14Cl2NO2+ ([M+H] +): 370.0396, Found: 370.0387.  
N
O
Ph
O
3c
N
O
Ph
O
Ph
Ph
3d
N
O
Ph
O
Cl
Cl
3e
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4-fluoro-N-(4-fluorobenzoyl)-N-phenylbenzamide 3f: Prepared 
according to General Procedure B from 4-fluorobenzoyl chloride.  
1H NMR (400 MHz, CDCl3): δ 7.03 (dd, J = 7.6, 5.2 Hz, 4H), 7.16 
(d, J = 8.0 Hz, 2H), 7.29 (t, J = 8.0 Hz, 1H), 7.37 (t, J = 8.0 Hz, 2H), 7.77 (dd, J = 7.6, 5.2 Hz, 
4H). 13C NMR (100 MHz, CDCl3): δ 116.0 (d, J = 22.0 Hz, 4C), 127.8, 128.0, 129.8, 130.8 
(d, J = 3.1 Hz, 2C), 132.0 (d, J = 9.2 Hz, 4C), 140.1, 165.2 (d, J = 253.5 Hz, 2C), 172.3. 19F 
NMR (376 MHz, CDCl3): δ HRMS (ESI): Calcd. for C22H14F2NO2+ ([M+H] +): 338.0987, 
Found: 338.0995. 
3-methoxy-N-(3-methoxybenzoyl)-N-phenylbenzamide 3g: 
Prepared according to General Procedure B from 3-
methoxybenzoyl chloride.  1H NMR (400 MHz, CDCl3): δ 3.76 (s, 
6H), 6.98 (dt, J = 7.1, 2.4 Hz, 2H), 7.17-7.39 (m, 11H). 13C NMR (100 MHz, CDCl3): δ 55.5, 
114.2, 118.9, 121.7, 127.76, 127.78, 129.6, 129.7, 136.2, 140.3, 159.7, 173.4. HRMS (ESI): 
Calcd. for C22H20NO4+ ([M+H] +): 362.1387, Found: 362.1381. 
3-methyl-N-(3-methylbenzoyl)-N-phenylbenzamide 3h: 
Prepared according to General Procedure B from 3-methylbenzoyl 
chloride.  1H NMR (400 MHz, CDCl3): δ 2.31 (s, 6H), 7.17 -7.28 
(m, 7H), 7.36 (t, J = 7.4 Hz, 2H), 7.50 (d, J = 7.4 Hz, 2H), 7.55 (s, 2H).  13C NMR (100 MHz, 
CDCl3): δ 21.4, 126.4, 127.7, 127.9, 128.4, 129.6, 130.1, 133.2, 135.0, 138.5, 140.4, 173.8. 
HRMS (ESI): Calcd. for C22H20NO2+ ([M+H] +): 330.1489, Found: 330.1476. 
3-chloro-N-(3-chlorobenzoyl)-N-phenylbenzamide 3i: 
Prepared according to General Procedure B from 3-
chlorobenzoyl chloride.  1H NMR (400 MHz, CDCl3): δ 7.16 (d, 
J = 8.1 Hz, 2H), 7.26-7.33 (m, 3H), 7.37-7.44 (m, 4H), 7.58 (d, J = 7.8 Hz, 2H), 7.71 (s, 2H). 
N
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13C NMR (100 MHz, CDCl3): δ 127.3, 127.9, 128.3, 129.5, 129.95, 129.96, 132.6, 134.9, 
136.3, 139.5, 172.0. HRMS (ESI): Calcd. for C22H14Cl2NO2+ ([M+H] +): 370.0396, Found: 
370.0395.  
3-fluoro-N-(3-fluorobenzoyl)-N-phenylbenzamide 3j: Prepared 
according to General Procedure B from 3-fluorobenzoyl chloride. 
1H NMR (400 MHz, CDCl3): δ 7.14-7.19 (m, 4H), 7.28-7.40 (m, 
5H), 7.42 (dt, J = 8.9, 2.5 Hz, 2H), 7.51 (dt, J = 7.8, 1.5 Hz, 2H). 13C NMR (100 MHz, CDCl3): 
δ 116.4 (d, J = 23.2 Hz, 2C), 119.7 (d, J = 21.2 Hz, 2C), 125.0 (d, J = 3.2 Hz, 2C), 127.9, 
128.3, 129.9, 130.4 (d, J = 7.8 Hz, 2C), 136.7 (d, J = 6.9 Hz, 2C), 139.6,  162.6 (d, J = 247.2 
Hz, 2C), 172.1 (d, J = 2.9 Hz, 2C). 19F NMR (376 MHz, CDCl3): δ HRMS (ESI): Calcd. for 
C22H14F2NO2+ ([M+H] +): 338.0987, Found: 338.0989. 
N-(3,4-dimethoxybenzoyl)-3,4-dimethoxy-N-phenylbenzamide 
3k: Prepared according to General Procedure B from 3,4-
dimethoxybenzoyl chloride. 1H NMR (400 MHz, CDCl3): δ 3.82 
(s, 6H), 3.88 (s, 6H), 6.77 (d, J = 8.5 Hz, 2H), 7.18 (d, J = 7.3 Hz, 
2H), 7.26 (t, J = 8.3 Hz, 1H), 7.32 (d, J = 2.0 Hz, 2H), 7.36 (t, J = 8.0 Hz, 2H), 7.40 (dd, J = 
8.4, 2.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 56.0, 56.1, 110.3, 112.4, 123.8, 127.2, 127.4, 
127.5, 129.7, 141.2, 148.9, 152.7, 173.1. δ HRMS (ESI): Calcd. for C24H24NO6+ ([M+H] +): 
422.1598, Found: 422.1601. 
2-methyl-N-(2-methylbenzoyl)-N-phenylbenzamide 3l: Prepared 
according to General Procedure B from 2-methylbenzoyl chloride.  1H 
NMR (400 MHz, CDCl3): 2.40 (s, 6H), 7.05-7.13 (m, 4H), 7.20 (td, J 
= 7.6, 1.2 Hz, 2H), 7.27-7.32 (m, 3H), 7.38-7.43 (m, 2H), 7.50 (dd, J = 7.6, 1.2 Hz, 2H). 13C 
NMR (100 MHz, CDCl3): 20.1, 125.5, 127.7, 127.95, 129.96, 128.01, 129.6, 130.9, 131.3, 
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136.0, 138.0, 139.6, 173.5. HRMS (ESI): Calcd. for C22H20NO3+ ([M+H]+): 330.1489, Found: 
330.1488. 
 N-phenyl-N-(thiophene-2-carbonyl)thiophene-2-carboxamide 3m: 
Prepared according to General Procedure B from thiophene-2-carbonyl 
chloride.  1H NMR (400 MHz, CDCl3): δ 7.00 (dd, J = 5.0, 3.9 Hz, 2H), 
7.21-7.31 (m, 2H), 7.34-7.44 (m, 3H), 7.50 (dd, J = 3.8, 1.2 Hz, 2H), 7.55 (dd, J = 5.0, 1.2 Hz, 
2H).  13C NMR (100 MHz, CDCl3): δ 127.8, 128.4, 128.5, 129.8, 133.6, 134.0, 138.3, 139.9, 
166.2. HRMS (ESI): Calcd. for C16H12NO2S2+ ([M+H] +): 314.0304, Found: 314.0299.   
N-benzoyl-4-methoxy-N-phenylbenzamide 3o: Prepared 
according to General Procedure B from benzanilide and 4-
methoxybenzoyl chloride. 1H NMR (400 MHz, CDCl3): 3.81 (s, 
3H), 6.82-6.84 (ddd, J = 9.6, 4.8, 2.8 Hz, 2H), 7.17 (ddd, J = 7.6, 3.6, 1.2 Hz, 2H), 7.26 (tt, J 
= 7.6, 1.2 Hz, 1H),  7.31-7.38 (m, 4H), 7.44 (tt, J = 7.6, 1.2 Hz, 1H), 7.74 (ddd, J = 9.6, 4.8, 
2.8 Hz, 4H). 13C NMR (100 MHz, CDCl3): 55.6, 114.0, 126.8, 127.6, 127.8, 128.6, 129.2, 
132.1, 132.3, 135.3, 140.7, 163.2, 172.9, 173.7. HRMS (ESI): Calcd. for C21H18NO3+ 
([M+H]+):  
N-benzoyl-N-phenyl-4-(trifluoromethyl)benzamide 3p: 
Prepared according to General Procedure B from benzanilide and 
4-(trifluoromethyl)benzoyl chloride. 1H NMR (400 MHz, 
CDCl3): 7.16-7.20 (m, 2H), 7.27-7.40 (m, 5H), 7.47 tt (J = 7.6, 1.2 Hz, 1H), 7.62 (d, J = 8.0 
Hz, 2H), 7.73-7.75 (m, 2H), 7.85 (d, J = 8.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): 125.7 (q, 
J = 3.8 Hz, 1C), 127.9, 128.1, 128.8, 129.4, 129.6, 129.7, 129.9, 130.7, 132.9, 172.4, 173.3. 
19F NMR (376 MHz, CDCl3): -63.16 (s, 3F). HRMS (ESI): Calcd. for C22H20NO3+ ([M+H]+): 
318.1125, Found: 318.1127. 
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General Procedure C: Synthesis of Carboacylation Products 6a-6q, 6s, 6v, 6w 
 
An oven dried 1-dram vial was charged with 0.100 mmol of the appropriate amide 3a-3p, 
Ni(cod)2 (2.8 mg, 0.010 mmol), H3BO3 (12.4 mg, 0.200 mmol), NaBAr4 (0.200 mmol), alkene 
4a, 4b, 4d, 4g, 4h (1.00 mmol), and benzene (1.0 mL, 0.1 M). The resulting solution was stirred 
at 80-95 °C for 8-16 hours. Upon completion of the reaction, the reaction was cooled to room 
temperature and was flirted through a short plug of silica gel eluting with 50:50 hexanes:EtOAc 
and concentrated under reduced pressure. The crude product was purified by flash column 
chromatography.  
 
 
General Procedure D: Synthesis of Carboacylation Products 6a, 6r-6w 
 
An oven dried 1-dram vial was charged with 0.100 mmol of the appropriate amide 3a, Ni(cod)2 
(2.8 mg, 0.010 mmol), H3BO3 (12.4 mg, 0.200 mmol), NaBPh4 (68.4 mg, 0.200 mmol), alkene 
4a, 4c-4h (0.400 mmol), p-F-styrene (11.9 µL, 0.100 mmol) and benzene (1.0 mL, 0.1 M). The 
resulting solution was stirred at 80-95 °C for 8-16 hours. Upon completion of the reaction, the 
reaction was cooled to room temperature and was flirted through a short plug of silica gel 
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eluting with 50:50 hexanes:EtOAc and concentrated under reduced pressure. The crude 
product was purified by flash column chromatography.  
Characterization of Carboacylation Products 6a-6w 
phenyl(3-phenylbicyclo[2.2.1]heptan-2-yl)methanone 6a: Prepared 
according to general procedure C from N-benzoyl-N-phenylbenzamide 3a 
(30.1 mg, 0.100 mmol, 1.00 equiv), norbornene 4a (94.2 mg, 1.00 mmol, 
10.0 equiv), and sodium tetraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 80°C in 8 
h. The crude reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc) to (91:9 hexanes:EtOAc) to yield 6a as a white solid in 85% yield (25.5 mg, 
0.085 mmol). Or prepared according to general procedure D from N-benzoyl-N-
phenylbenzamide 3a (30.1 mg, 0.100 mmol, 1.00 equiv), norbornene 4a (37.7 mg, 1.00 mmol, 
10.0 equiv), and sodium tetraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 80°C in 8 
h. The crude reaction mixture was purified by flash column chromatography (100:0®91:9 
hexanes:EtOAc) to yield 6a as a white solid in 85% yield (25.5 mg, 0.085 mmol).1H NMR 
(400 MHz, CDCl3): d 1.36-1.75 (m, 5H), 2.43-2.50 (m, 2H), 2.71 (m, 1H), 3.29 (d, J = 10.4 
Hz, 1H), 3.85 (d, J = 10.4 Hz, 1H), 6.88-6.97 (m, 5H), 7.21 (t, J = 7.6 Hz, 2H) 7.32-7.36 (m, 
1H), 7.53-7.56 (m, 2H),  13C NMR (100 MHz, CDCl3): 29.1, 31.3, 37.6, 39.3, 54.0, 56.4, 
126.0, 127.8, 128.0, 128.5, 132.1, 138.6, 141.9, 201.8. HRMS (ESI): Calcd. for C20H21O+ ([M 
+H]+): 277.1587, Found: 277.2202. 
 (4-methoxyphenyl)(3-phenylbicyclo[2.2.1]heptan-2-
yl)methanone 6b: Prepared from general procedure C from 4-
methoxy-N-(4-methoxybenzoyl)-N-phenylbenzamide 3b (36.1 mg, 
0.100 mmol, 1.00 equiv), norbornene 4a (94.2 mg, 1.00 mmol, 10.0 equiv), and sodium 
tertraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 80°C in 8 h. The crude reaction 
O
PhO
6b
Ph
O
6a
  
 
117 
mixture was purified by flash column chromatography (100:0®91:1 hexane:EtOAc) to give 
6b as a white solid in 91% yield (27.9 mg, 0.091 mmol). 1H NMR (400 MHz, CDCl3): δ 1.36-
1.51 (m, 3H), 1.66-176 (m, 2H), 2.42 (app. s, 1H), 2.48 (dp, J = 10.2, 1.7 Hz, 1H), 2.67 (app. 
s, 1H), 3.28 (d, J = 9.9 Hz, 1H), 3.78 (s, 3H), 3.79 (d, J = 9.9 Hz, 1H), 6. 70 (ddd, J = 9.0, 2.8, 
2.1 Hz, 2H), 6.88-6.99 (m, 5H), 7.57 (ddd, J = 9.0, 2.8, 2.1 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): δ 29.2, 31.3, 37.5, 39.4, 43.6, 54.2, 55.4, 55.9, 113.2, 125.9, 127.7, 128.5, 130.4, 
131.7, 142.1, 162.7, 200.2. HRMS (ESI): Calcd. for C21H23O2+ ([M+H] +): 307.1693, Found: 
307.1697. 
 (3-phenylbicyclo[2.2.1]heptan-2-yl)(p-tolyl)methanone 6c: Prepared 
from general procedure C from 4-methyl-N-(4-methylbenzoyl)-N-
phenylbenzamide 3c (32.9 mg, 0.100 mmol, 1.00 equiv), norbornene 4a 
(94.2 mg, 1.00 mmol, 10.0 equiv), and sodium tertraphenylborate 5a (68.4 mg, 0.200 mmol, 
2.00 equiv) at 80°C in 8 h. The crude reaction mixture was purified by flash column 
chromatography (100:0®96:4 hexane: EtOAc) to give 6c as a white solid in 82% yield (23.8 
mg, 0.082 mmol). 1H NMR (400 MHz, CDCl3): δ 1.37-1.51 (m, 3H), 1.66-1.76 (m, 2H), 2.30 
(s, 3H), 2.43 (app. s, 1H), 2.48 (dp, J = 10.2, 1.8 Hz, 1H), 2.68 (app. s, 1H), 3.29 (d, J = 10.1 
Hz, 1H), 3.81 (d, J = 10.1 Hz, 1H), 6.88-6.99 (m, 5H), 7.02 (d, J = 8.0 Hz, 2H), 7.48 (d, J = 
8.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 21.6, 29.2, 31.3, 37.5, 39.5, 43.6, 54.1, 56.1, 
125.9, 127.7, 128.3, 128.5, 128.7, 136.1, 142.0, 142.7, 201.4. HRMS (ESI): Calcd. for 
C21H23O+ ([M+H] +): 291.1743, Found: 291.1746. 
 [1,1'-biphenyl]-4-yl(3-phenylbicyclo[2.2.1]heptan-2-yl)methanone 
6d: Prepared from general procedure C from N-([1,1'-biphenyl]-4-
carbonyl)-N-phenyl-[1,1'-biphenyl]-4-carboxamide 3d (45.3 mg, 0.100 
mmol, 1.00 equiv), norbornene 4a (94.2 mg, 1.00 mmol, 10.0 equiv), and sodium 
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tertraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 95°C in 8 h. The crude reaction 
mixture was purified by flash column chromatography (100:0®94:6 pentane:Et2O) to give 6d 
as a white solid in 66% yield (23.3 mg, 0.066 mmol). 1H NMR (400 MHz, CDCl3): δ 1.38-
1.54 (m, 3H), 1.69-1.79 (m, 2H), 2.46 (app. s, 1H), 2.51 (dt, J = 10.2, 1.8 Hz, 1H), 2.73 (app. 
s, 1H), 3.33 (d, J = 10.2 Hz, 1H), 3.88 (d, J = 10.2 Hz, 1H), 6.89-7.01 (m, 5H), 7.31 (t, J = 7.1 
Hz, 1H), 7.42-7.46 (m, 4H), 7.55-7.57 (m, 2H), 7.63 (d, J = 8.4 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): δ 29.1, 31.3, 37.6, 39.4, 43.6, 54.1, 56.4, 126.0, 126.7, 127.3, 127.8, 128.1, 128.6, 
128.7, 129.0, 137.4, 140.2, 142.0, 144.6, 201.5. HRMS (ESI): Calcd. for C26H25O+ ([M+H] +): 
353.1900, Found: 353.1900. 
 (4-chlorophenyl)(3-phenylbicyclo[2.2.1]heptan-2-yl)methanone 
6e: Prepared from general procedure C from 4-chloro-N-(4-
chlorobenzoyl)-N-phenylbenzamide 3e (37.0 mg, 0.100 mmol, 1.00 
equiv), norbornene 4a (94.2 mg, 1.00 mmol, 10.0 equiv), and sodium tertraphenylborate 5a 
(68.4 mg, 0.200 mmol, 2.00 equiv) at 95°C in 8 h. The crude reaction mixture was purified by 
flash column chromatography (100:0®94:6 pentane:Et2O) to give 6e as a white solid in 56% 
yield (17.4 mg, 0.056 mmol). 1H NMR (400 MHz, CDCl3): δ 1.37-1.53 (m, 3H), 1.66-1.74 
(m, 2H), 2.42-2.47 (m, 2H), 2.70 (app. s, 1H), 3.28 (dd, J = 10.3, 0.5 Hz, 1H), 3.77 (dd, J = 
10.3, 1.0 Hz, 1H), 6.90-6.98 (m, 5H), 7.18 (ddd, J = 8.7, 2.4, 2.0 Hz, 2H), 7.47 (ddd, J = 8.7, 
2.4, 2.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 29.0, 31.3, 37.6, 39.2, 43.8, 54.0, 56.5, 126.2, 
127.9, 128.3, 128.5, 129.5, 136.9, 138.4, 141.8, 200.7. HRMS (ESI): Calcd. for C20H19ClO+ 
([M+H] +): 311.1197, Found:311.1194. 
 (4-fluorophenyl)(3-phenylbicyclo[2.2.1]heptan-2-yl)methanone 6f: 
Prepared from general procedure C from 4-fluoro-N-(4-fluorobenzoyl)-
N-phenylbenzamide 3f (33.7 mg, 0.100 mmol, 1.00 equiv), norbornene 
O
PhF
6f
O
PhCl
6e
  
 
119 
4a (94.2 mg, 1.00 mmol, 10.0 equiv), and sodium tertraphenylborate 5a (68.4 mg, 0.200 mmol, 
2.00 equiv) at 95°C in 8 h. The crude reaction mixture was purified by flash column 
chromatography (100:0®96:4 hexane:EtOAc) to give 6f as a white solid in 78% yield (23.0 
mg, 0.078 mmol). 1H NMR (400 MHz, CDCl3): δ 1.37-1.53 (m, 3H), 1.66-1.78 (m, 2H), 2.42-
2.47 (m, 2H), 2.70 (d, J = 1.2 Hz, 1H), 3.28 (dd, J = 10.2, 0.8 Hz, 1H), 3.78 (dd, J = 10.2, 1.2 
Hz, 1H), 6.85-6.97 (m, 7H), 7.54-7.59 (m, 2H).  13C NMR (100 MHz, CDCl3): δ 29.0, 31.3, 
37.6, 39.1, 43.8, 54.1, 56.4, 115.0 (d, J = 21.6 Hz, 2C), 126.1, 127.8, 128.5, 130.6 (d, J = 9.2 
Hz, 2C), 135.0 (d, J = 3.0 Hz, 1C), 142.8, 165.1 (d, J = 252.0 Hz, 1C), 200.2. 19F NMR (376 
MHz, CDCl3): δ -107.02 (m, 1F). HRMS (ESI): Calcd. for C20H19FO+ ([M+H] +): 295.1493, 
Found: 295.1491. 
 (3-methoxyphenyl)(3-phenylbicyclo[2.2.1]heptan-2-
yl)methanone 6g: Prepared from general procedure C from 3-
methoxy-N-(3-methoxybenzoyl)-N-phenylbenzamide 3h (36.1 mg, 
0.100 mmol, 1.00 equiv), norbornene 4a (94.2 mg, 1.00 mmol, 10.0 equiv), and sodium 
tertraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 95°C in 8 h. The crude reaction 
mixture was purified by flash column chromatography (100:0®96:4 hexane:Et2O) to give 6g 
as a white solid in 63% yield (19.3 mg, 0.063 mmol). 1H NMR (400 MHz, CDCl3): δ 1.35-
1.53 (m, 3H), 1.65-1.78 (m, 2H), 2.44-2.49 (m, 2H), 2.69 (d, J = 1.5 Hz, 1H), 3.28 (dd, J = 
10.2, 0.7 Hz, 1H), 3.71 (s, 3H), 3.82 (dd, J = 10.2, 1.5 Hz, 1H), 6.88-6.97 (m, 7H), 7.15 (t, J = 
7.8 Hz, 1H), 7.22 (dt, J = 7.8, 1.4 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 29.1, 31.3, 37.5, 
39.4, 43.5, 54.0, 55.4, 56.6, 112.2, 118.8, 120.8, 125.9, 127.8, 128.6, 128.9, 140.3, 142.0, 
159.4, 201.8. HRMS (ESI): Calcd. For C21H23O2+ ([M+H] +): 307.1693, Found: 307.1695. 
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 (3-phenylbicyclo[2.2.1]heptan-2-yl)(m-tolyl)methanone 6h: Prepared 
from general procedure C from 3-methyl-N-(3-methylbenzoyl)-N-
phenylbenzamide 3i (32.9 mg, 0.100 mmol, 1.00 equiv), norbornene 4a 
(94.2 mg, 1.00 mmol, 10.0 equiv), and sodium tertraphenylborate 5a (68.4 mg, 0.200 mmol, 
2.00 equiv) at 80°C in 8 h. The crude reaction mixture was purified by flash column 
chromatography (100:0®96:4 hexane:EtOAc) to give 6h as a white solid in 69% yield (20.0 
mg, 0.069 mmol). 1H NMR (400 MHz, CDCl3): δ 1.38-1.52 (m, 3H), 1.65-1.79 (m, 2H), 2.26 
(s, 3H), 2.44-2.50 (m, 2H), 2.69 (d, J = 1.3 Hz, 1H), 3.29 (d, J = 10.2 Hz, 1H),  3.83 (dd, J = 
10.2, 1.3 Hz, 1H), 6.89-6.97 (m, 5H), 7.09-7.16 (m, 2H), 7.28 (s, 1H), 7.37 (d, J = 7.4 Hz, 1H). 
13C NMR (100 MHz, CDCl3): δ 21.3, 29.1, 31.3, 37.6, 39.4, 43.6, 54.0, 56.5, 125.3, 125.9, 
127.7, 127.8, 128.5, 128.7, 132.8, 137.6, 138.8, 142.0, 202.2. HRMS (ESI): Calcd. for 
C21H23O+ ([M+H] +): 291.1743, Found: 291.1746. 
 (3-chlorophenyl)(3-phenylbicyclo[2.2.1]heptan-2-yl)methanone 6i: 
Prepared from general procedure C from 3-chloro-N-(3-
chlorobenzoyl)-N-phenylbenzamide 3i(37.0 mg, 0.100 mmol, 1.00 
equiv), norbornene 4a (94.2 mg, 1.00 mmol, 10.0 equiv), and sodium tertraphenylborate 5a 
(68.4 mg, 0.200 mmol, 2.00 equiv) at 95°C in 11 h. The crude reaction mixture was purified 
by flash column chromatography (100:0®98:2 hexane:EtOAc) to give 6j as a white solid in 
50% yield (15.5 mg, 0.050 mmol). 1H NMR (400 MHz, CDCl3): δ 1.38-1.53 (m, 3H), 1.66-
1.78 (m, 2H), 2.41-2.44 (m, 2H), 2.71 (app. s, 1H), 3.28 (d, J = 10.2 Hz, 1H),  3.76 (d, J = 10.2 
Hz, 1H), 6.90-6.98 (m, 5H), 7.14 (t, J = 7.9 Hz, 1H), 7.30 (d, J = 7.9 Hz, 1H), 7.39 (d, J = 7.9 
Hz, 1H), 7.43 (s, 1H). 13C NMR (100 MHz, CDCl3): δ 28.9, 31.3, 37.6, 39.1, 43.8, 53.9, 56.8, 
126.1, 126.2, 127.9, 128.3, 128.5, 129.3, 131.9, 134.2, 140.2, 141.7, 200.7. HRMS (ESI): 
Calcd. for C20H19ClO+ ([M+H] +): 311.1197, Found:311.1198. 
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 (3-fluorophenyl)(3-phenylbicyclo[2.2.1]heptan-2-yl)methanone 6j: 
Prepared from general procedure C from 3-fluoro-N-(3-fluorobenzoyl)-
N-phenylbenzamide 3j (33.7 mg, 0.100 mmol, 1.00 equiv), norbornene 
4a (94.2 mg, 1.00 mmol, 10.0 equiv), and sodium tertraphenylborate 5a (68.4 mg, 0.200 mmol, 
2.00 equiv) at 95°C in 11 h. The crude reaction mixture was purified by flash column 
chromatography (100:0®98:2 hexane:EtOAc) to give 6k as a white solid in 74% yield (21.8 
mg, 0.074 mmol).  1H NMR (400 MHz, CDCl3): δ 1.38-1.1.54 (m, 3H), 1.67-1.78 (m, 2H), 
2.42-2.47 (m, 2H), 2.71-2.72 (m, 1H), 3.29 (d, J = 10.3, 1.0 Hz, 1H), 3.78 (d, J = 10.3, 1.2 Hz, 
1H), 6.90-6.97 (m, 5H), 7.03 (tdd, J = 8.2, 2.6, 0.9 Hz, 1H), 7.14-7.22 (m, 2H), 7.35 (dt, J = 
7.8, 1.2 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 28.9, 31.3, 37.6, 39.1, 43.8, 54.0, 56.7, 114.8 
(d, J = 22.2 Hz, 1C), 119.0 (d, J = 21.4 Hz, 1C), 123.8 (d, J = 2.9 Hz, 1C), 126.1, 127.9, 128.5, 
129.6 (d, J = 7.6 Hz, 1C), 140.8 (d, J = 6.0 Hz, 1C), 141.7, 162.5 (d, J = 245.6 Hz, 1C), 200.6 
(d, J = 2.0 Hz, 1C). 19F NMR (376 MHz, CDCl3): δ -113.01 (m, 1F). HRMS (ESI): Calcd. for 
C20H19FO+ ([M+H] +): 295.1493, Found: 295.1493. 
 (3,4-dimethoxyphenyl)(3-phenylbicyclo[2.2.1]heptan-2-
yl)methanone 6k: Prepared from general procedure C from N-(3,4-
dimethoxybenzoyl)-3,4-dimethoxy-N-phenylbenzamide 3l (42.1 mg, 
0.100 mmol, 1.00 equiv), norbornene 4a (94.2 mg, 1.00 mmol, 10.0 equiv), and sodium 
tertraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 80°C in 8 h. The crude reaction 
mixture was purified by flash column chromatography (100:0®90:10 hexane:EtOAc) to give 
6k as a white solid in 90% yield (30.3 mg, 0.090 mmol). 1H NMR (400 MHz, CDCl3): δ 1.37-
1.51 (m, 3H), 1.66-1.75 (m, 2H), 2.43 (app. s, 1H), 2.48 (dt, J = 10.2, 1.7 Hz, 1H), 2.67 (app. 
s, 1H), 3.26 (d, J = 10.0 Hz, 1H), 3.76 (s, 3H), 3.79 (d, J = 10.0 Hz, 1H), 3.87 (s, 3H), 6.71 (d, 
J = 8.4 Hz, 1H), 6.89-6.97 (m, 6H), 7.35 (dd, J = 8.4, 1.9 Hz, 1H). 13C NMR (100 MHz, 
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CDCl3): δ 29.1, 31.2, 37.5, 39.5, 43.5, 54.2, 54.88, 54.94, 55.0, 109.4, 110.3, 122.6, 125.9, 
127.7, 128.5, 132.2, 142.1, 148.5, 152.5, 200.5. HRMS (ESI): Calcd. for ([M+H] +): 295.1493, 
Found: 295.1491. HRMS (ESI): Calcd. for C22H25O3+ ([M+H] +): 337.1798, Found: 337.1811. 
 (3-phenylbicyclo[2.2.1]heptan-2-yl)(o-tolyl)methanone 6l: Prepared 
according to general procedure A: from 2-methyl-N-(2-methylbenzoyl-N-
phenylbenzamide 3l (32.9 mg, 0.100 mmol, 1.00 equiv), norbornene 4a 
(94.2 mg, 1.00 mmol, 10.0 equiv), and sodium tetraphenylborate 5a (68.4 mg, 0.200 mmol, 
2.00 equiv) at 80°C in 8 h. The crude reaction mixture was purified by flash column 
chromatography (100:0®96:4 hexanes:EtOAc) to yield 6m as a white solid in 67% yield (19.4 
mg, 0.067 mmol). 1H NMR (400 MHz, CDCl3): d 1.36-1.75 (m, 5H), 1.86 (s, 3H), 2.49 (m, 
2H), 2.69 (m, 1H), 3.23 (d, J = 10.0 Hz, 1H), 3.84 (d, J = 10.0 Hz, 1H), 6.93-7.02 (m, 5H), 
7.15 (td, J  = 7.6, 0.8 Hz, 1H), 7.21 (td, J = 7.6, 1.2 Hz, 1H), 7.25-7.29 (m, 1H), 7.52 (dd, J = 
7.6, 1.2 Hz, 1H). 13C NMR (100 MHz, CDCl3): 20.8, 29.2, 31.2, 37.5, 40.0, 42.9, 53.5, 57.7, 
125.2, 126.0, 127.9, 128.5, 128.8, 130.8, 131.8, 139.0, 139.3, 141.8, 204.9. HRMS (ESI): 
Calcd. for C21H23O+ ([M+H]+): 291.1743, Found: 291.1744. 
 (3-phenylbicyclo[2.2.1]heptan-2-yl)(thiophen-2-yl)methanone 6m: 
Prepared from general procedure C from N-phenyl-N-(thiophene-2-
carbonyl)thiophene-2-carboxamide 3 (31.3 mg, 0.100 mmol, 1.00 equiv), 
norbornene 4a (94.2 mg, 1.00 mmol, 10.0 equiv), and sodium tertraphenylborate 5a (68.4 mg, 
0.200 mmol, 2.00 equiv) at 95°C in 16 h. The crude reaction mixture was purified by flash 
column chromatography (100:0®95:5 hexane:EtOAc) to give 6q as a white solid in 20% yield 
(5.61 mg, 0.020 mmol). 1H NMR (400 MHz, CDCl3): δ 1.37-1.52 (m, 3H), 1.67-1.76 (m, 2H), 
2.48-2.53 (m, 2H), 2.67-2.68 (m, 1H), 3.30 (dd, J = 10.08, 1.20 Hz, 1H), (dd, J = 10.08, 1.28 
Hz, 1H), 6.93-7.03 (m, 6H), 741 (dd, J = 5.0, 1.1 Hz, 1H), 7.46 (dd, J = 5.0, 1.1 Hz, 1H). 13C 
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NMR (100 MHz, CDCl3): δ 29.1, 31.2, 37.6, 39.8, 43.0, 54.1, 57.8, 126.0, 127.6, 127.8, 128.5, 
131.4, 133.0, 141.7, 146.2, 194.1. HRMS (ESI): Calcd. for C18H19SO+ ([M+H] +): 283.1151, 
Found: 283.1149.  
naphthalen-2-yl(3-phenylbicyclo[2.2.1]heptan-2-yl)methanone 
6n: Prepared from general procedure C from 1-(2-
naphthoyl)piperidine-2,6-dione 1b (26.7 mg, 0.100 mmol, 1.00 equiv), 
norbornene 4a (94.2 mg, 1.00 mmol, 10.0 equiv), and sodium tertraphenylborate 5a (68.4 mg, 
0.200 mmol, 2.00 equiv) at 95°C in 16 h. The crude reaction mixture was purified by flash 
column chromatography (100:0®94:6 pentane:Et2O) to give 6o as a white solid in 80% yield 
(26.1 mg, 0.080 mmol). 1H NMR (400 MHz, CDCl3): δ 1.45-1.57 (m, 3H), 1.69-1.82 (m, 2H), 
2.48 (app. s, 1H), 2.54 (dp, J = 10.0, 1.8 Hz, 1H), 2.76 (app. s, 1H), 3.38 (d, J = 10.3, 1H), 4.01 
(d, J = 10.3, 1H), 6.80-6.88 (m, 3H), 6.94-6.98 (m, 2H), 7.47-7.56 (m, 3H), 7.64 (d, J = 8.7 
Hz, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.87 (d, J = 7.8 Hz, 1H), 8.15 (s, 1H). 13C NMR (100 MHz, 
CDCl3): δ 29.2, 31.3, 37.6, 39.5, 43.6, 54.2, 56.4, 124.3, 126.0, 126.5, 127.7, 127.8, 127.9, 
128.0, 128.5, 129.50, 129.53, 132.4, 135.1, 136.1, 142.0, 201.8. HRMS (ESI): Calcd. for 
C24H23O+ ([M+H] +): 327.1743, Found: 327.1748.   
phenyl(3-(p-tolyl)bicyclo[2.2.1]heptan-2-yl)methanone 6r: Prepared 
according to general procedure A: from N-benzoyl-N-phenylbenzamide 3a  
(30.1 mg, 0.100 mmol, 1.00 equiv), norbornene 4a (94.2 mg, 1.00 mmol, 
10.0 equiv), and sodium tetra-p-tolylborate 5c (79.6 mg, 0.200 mmol, 2.00 
equiv) at 80°C in 8 h. The crude reaction mixture was purified by flash column 
chromatography (100:0®96:4 hexanes:EtOAc) to yield 6o as a white solid in 69% yield (20.0 
mg, 0.069 mmol). 1H NMR (400 MHz, CDCl3): d 1.38-1.73 (m, 5H), 2.12 (s, 3H), 2.41 (m, 
1H), 2.44-2.49 (m, 1H), 2.68 (m, 1H), 3.27 (d, J = 10.4 Hz, 1H), 3.82 (d, J = 10.4 Hz, 1H), 
O
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6.74 (d, J = 8.0 Hz, 2H), 6.85 (d, J = 8.0 Hz, 2H), 7.23 (t, J = 7.6, 2H), 7.35 (tt, J = 7.6, 1.2, 
1H),  7.56 (m, 2H). 13C NMR (100 MHz, CDCl3): 20.9, 29.2, 31.2, 37.5, 39.4, 43.7, 53.7, 56.4, 
128.0, 128.1, 128.3, 128.4, 132.1, 135.3, 138.7, 138.9, 202.0. HRMS (ESI): Calcd. for 
C21H23O+ ([M+H]+): 291.1743, Found: 291.1745. 
 (3-(4-fluorophenyl)bicyclo[2.2.1]heptan-2-yl)(phenyl)methanone 6p: 
Prepared from general procedure C from N-benzoyl-N-phenylbenzamide 
3a (30.1 mg, 0.100 mmol, 1.00 equiv), norbornene 4a (94.2 mg, 1.00 mmol, 
10.0 equiv), and sodium tetrakis(4-fluorophenyl)borate 5d (94.5 mg, 0.200 
mmol, 2.00 equiv) at 80°C in 8 h. The crude reaction mixture was purified by flash column 
chromatography (100:0®95:5 hexane:EtOAc) to give 6p as a white solid in 55% yield (16.2 
mg, 0.055 mmol).  1H NMR (400 MHz, CDCl3): δ 1.35-1.52 (m, 3H), 1.65-177 (m, 2H), 2.39 
(app. s, 1H), 2.43 (d, J = 10.3 Hz, 1H), 2.70 (app. s, 1H), 3.27 (d, J = 10.1 Hz, 1H), 3.84 (d, J 
= 10.1 Hz, 1H), 6.61 (t, J = 8.6 Hz, 2H), 6.90 (dd, J = 8.6, 5.7 Hz, 2H), 7.24 (t, J = 7.8 Hz, 
2H), 7.37 (t, J = 7.8 Hz, 1H), 7.55 (d, J = 7.8 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 29.0, 
31.3, 37.4, 39.3, 43.7, 53.2, 56.2, 114.5 (d, J = 20.9 Hz, 2C), 128.06, 128.14, 129.9 (d, J = 7.74 
Hz, 2C), 132.3, 137.6 (d, J = 3.2 Hz, 1C), 138.5, 161.1 (d, J = 243.1 Hz, 1C), 201.8. 19F NMR 
(376 MHz, CDCl3): δ -117.44 (m, 1F). HRMS (ESI): Calcd. for C20H19FO+ ([M+H] +): 
295.1493, Found: 295.1494.  
phenyl(3-phenyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-2-
yl)methanone 6q: Prepared according to general procedure C: from 
N-benzoyl-N-phenylbenzamide 3a  (30.1 mg, 0.100 mmol, 1.00 
equiv), Benzonorbornadiene 4b (142.2 mg, 1.00 mmol, 10.0 equiv), and sodium 
tetraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 95°C in 12 h. The crude reaction 
mixture was purified by flash column chromatography (100:0®90:10 hexanes:EtOAc) to yield 
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6q as a white solid in 68% yield (22.0 mg, 0.068 mmol). 1H NMR (400 MHz, CDCl3): d 2.06-
2.10 (m, 1H), 2.90 (dt, J = 9.6, 1.2 Hz, 1H), 3.36 (dd, 10.0, 1.2 Hz, 1H), 3.49 (m, 1H), 3.73 
(m, 1H), 3.86 (dd, J = 10.0, 1.2 Hz, 1H), 6.96-7.01 (m, 5H), 7.16-7.23 (m, 4H), 7.27-7.32 (m, 
2H), 7.36 (tt, J = 7.2, 1.2 Hz, 1H), 7.52 (m, 2H). 13C NMR (100 MHz, CDCl3): 46.8, 47.5, 
50.8, 52.0, 52.8, 120.8, 121.4, 126.1, 126.2, 126.4, 128.0, 128.1, 128.7, 132.4, 138.4, 140.7, 
148.6, 150.6, 202.6. HRMS (ESI): Calcd. for C24H21O+ ([M+H]+): 325.1587, Found: 
325.1592. 
 5,8-dimethoxy-3-phenyl-1,2,3,4-tetrahydro-1,4-
methanonaphthalen-2-yl)(phenyl)methanone 6w: Prepared 
according to general procedure D: from N-benzoyl-N-
phenylbenzamide 3a  (30.1 mg, 0.100 mmol, 1.00 equiv), 5,8-dimethoxy-1,4-dihydro-1,4-
methanonaphthalene 4c (80.9 mg, 0.400 mmol, 4.0 equiv), and sodium tetraphenylborate 5a 
(68.4 mg, 0.200 mmol, 2.00 equiv) at 95°C in 12 h. The crude reaction mixture was purified 
by flash column chromatography (100:0®90:10 hexanes:EtOAc) to yield 6r as a white solid 
in 40% yield (15.4 mg, 0.040 mmol). 1H NMR (600 MHz, CDCl3): d 2.01 (dt, J = 9.6, 1.8 Hz, 
1H), 2.84 (dt, 9.6, 1.8 Hz, 1H), 3.34 (dd, J = 10.0, 1.2 Hz, 1H), 3.71 (d, J = 1.2 Hz, 1H), 3.78 
(s, 3H), 3.81 (s, 3H), 3.84 (dd, J = 10.0, 1.2 Hz, 1H), 3.93 (d, 1.2 Hz, 1H), 6.67 (s, 2H), 6.94-
7.00 (m, 5H), 7.19-7.21 (m, 2H), 7.34 (tt, J = 7.2, 1.2 Hz, 1H), 7.53 (dd, J = 8.4, 1.2 Hz, 2H). 
13C NMR (150 MHz, CDCl3): 43.4, 47.0, 47.2, 51.5, 52.1, 56.18, 56.20, 109.7, 109.9, 126.3, 
127.9, 128.1, 128.2, 128.8, 132.3, 137.6, 138.5, 139.7, 140.8, 147.7, 148.2, 202.6. HRMS 
(ESI): Calcd. for C26H24O3+ ([M+H]+): 385.1798, Found: 385.1799. 
phenyl(7-phenyl-5,6,7,8-tetrahydro-5,8-
methanonaphtho[2,3-d][1,3]dioxol-6-yl)methanone 6s: 
Prepared according to general procedure C: from N-benzoyl-N-
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phenylbenzamide 3a  (30.1 mg, 0.100 mmol, 1.00 equiv), 5,8-dihydro-5,8-
methanonaphtho[2,3-d][1,3]dioxole 4d (186.2 mg, 1.00 mmol, 10.0 equiv), and sodium 
tetraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 95°C in 12 h. The crude reaction 
mixture was purified by flash column chromatography (100:0®90:10 hexanes:EtOAc) to yield 
6s as a white solid in 48% yield (17.7 mg, 0.048 mmol). Or prepared according to general 
procedure D: from N-benzoyl-N-phenylbenzamide 3a (30.1 mg, 0.100 mmol, 1.00 equiv), 5,8-
dihydro-5,8-methanonaphtho[2,3-d][1,3]dioxole 4c (74.5 mg, 0.400 mmol, 4.00 equiv), and 
sodium tetraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 95°C in 12 h. The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc) to 
(90:10 hexanes:EtOAc) to yield 6s as a white solid in 51% yield (18.8 mg, 0.051 mmol). 1H 
NMR (400 MHz, CDCl3): d 2.03-2.07 (m, 1H), 2.85 (dt, J = 9.6, 1.6 Hz, 1H), 3.30 (d, J = 9.6, 
1.2 Hz, 1H), 3.39 (m, 1H), 3.63 (m, 1H), 3.80 (dd, J = 10.0, 1.2 Hz, 1H), 5.93 (d, J = 1.2 Hz, 
1H), 5.95 (d, J = 1.2 Hz, 1H), 6.81 (s, 1H), 6.83 (s, 1H), 6.95-6.99 (m, 5H), 7.21 (t, J = 7.6 Hz, 
1H), 7.36 (tt, J = 7.6, 1.2 Hz, 1H), 7.52 (m, 2H). 13C NMR (100 MHz, CDCl3): 37.3, 22.9, 
37.3, 46.9, 47.7, 50.9, 52.4, 53.2, 100.8, 103.3, 103.7, 126.4, 128.0, 128.10, 128.14, 128.6, 
132.4, 138.4, 140.7, 141.9, 144.0, 145.68, 145.72, 202.7. HRMS (ESI): Calcd. for C25H22O3+ 
([M+H]+): 371.1642, Found: 371.1645. 
 diethyl-5-benzoyl-6-phenylbicyclo[2.2.1]heptane-2,3-
dicarboxylate 6t: Prepared according to general procedure D: 
from N-benzoyl-N-phenylbenzamide 3a  (30.1 mg, 0.100 mmol, 
1.00 equiv), diethyl-(exo,exo)-5-nobornene-2,3-dicarboxylate 4e (117.8 mg, 0.400 mmol, 4.00 
equiv), and sodium tetraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 95°C in 12 h. 
The crude reaction mixture was purified by flash column chromatography (90:10®70:30 
hexanes:EtOAc) to yield 6t as a white solid in 57% yield (24.0 mg, 0.057 mmol). 1H NMR 
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(400 MHz, CDCl3): 1.22-1.29 (m, 6H), 2.38 (dt, J = 11.2, 1.2 Hz, 1H), 2.52 (dt, J = 11.2, 1.2 
Hz, 1H), 2.76-2.80 (m, 1H), 2.97 (qd, J = 10.0, 1.6 Hz, 2 H), 3.03-3.06 (m, 1H), 3.30 (dd, J = 
10.0, 0.8 Hz, 1H), 3.85 (dd, J = 10.0, 0.8 Hz, 1H), 4.07-4.17 (m, 4H), 6.89-6.96 (m, 5H), 7.22 
(t, 7.6 Hz, 2H), 7.35 (tt, J = 7.6, 1.2 Hz, 1H), 7.51 (m, 2H).  13C NMR (100 MHz, CDCl3): 
14.29, 14.31, 35.5, 43.0, 46.8, 50.6, 52.5, 53.2, 55.1, 60.8, 60.9, 126.5, 128.0, 128.1, 128.2, 
128.5, 132.5, 138.2, 140.3, 172.5, 172.7, 200.5. HRMS (ESI): Calcd. for C26H28O5+ ([M+H]+): 
421.2010, Found: 421.2011. 
 dibutyl-5-benzoyl-6-phenylbicyclo[2.2.1]heptane-2,3-
dicarboxylate 6u: Prepared according to general procedure 
D: from N-benzoyl-N-phenylbenzamide 3a  (30.1 mg, 
0.100 mmol, 1.00 equiv), dibutyl-(exo,exo)-5-nobornene-2,3-dicarboxylate 4f (117.8 mg, 
0.400 mmol, 4.00 equiv), and sodium tetraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) 
at 95°C in 12 h. The crude reaction mixture was purified by flash column chromatography 
(90:10®70:30 hexanes:EtOAc) to yield 6u as a white solid in 68% yield (32.4 mg, 0.068 
mmol). 1H NMR (400 MHz, CDCl3): 0.90-0.96 (m, 6H), 1.32-1.44 (m, 4H), 1.55-1.65 (m, 
4H), 2.37 (dt, J = 11.2, 1.6 Hz, 1H), 2.52 (dt, J = 11.2, 1.5 Hz, 1H), 2.78 (m, 1H), 2.93-3.01 
(m, 2H), 3.03 (m, 1H), 3.31 (d, J = 10.0 Hz, 1H), 3.85 (d, J = 10.0 Hz, 1H), 3.96-4.12 (m, 4H), 
6.90-6.95 (m, 5H), 7.21 (t, J = 7.6 Hz, 1H), 7.36 (tt, J = 7.6, 1.2 Hz, 1H), 7.52 (m, 2H). 13C 
NMR (100 MHz, CDCl3): 13.9, 19.3, 19.4, 30.7, 35.4, 43.0, 46.8, 50.7, 52.6, 53.2, 53.3, 55.1, 
55.2, 64.8, 64.9, 126.5, 128.0, 128.1, 128.2, 128.5, 138.2, 140.3, 172.6, 172.7, 200.5. HRMS 
(ESI): Calcd. for C30H26O5+ ([M+H]+): 477.2636, Found: 477.2633. 
methyl-5-benzoyl-6-phenylbicyclo[2.2.1]heptane-2,3-
dicarboxylate 6v: Prepared according to general procedure C: from 
N-benzoyl-N-phenylbenzamide 3a  (30.1 mg, 0.100 mmol, 1.00 
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equiv), dimethyl-(exo,exo)-5-nobornene-2,3-dicarboxylate 4g (210.2 mg, 1.00 mmol, 10.0 
equiv), and sodium tetraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 95°C in 8 h. 
The crude reaction mixture was purified by flash column chromatography (90:10®70:30 
hexanes:EtOAc) to yield 6v as a white solid in 75% yield (29.4 mg, 0.075 mmol). Or Prepared 
according to general procedure D: from N-benzoyl-N-phenylbenzamide 3a  (30.1 mg, 0.100 
mmol, 1.00 equiv), dimethyl-(exo,exo)-5-nobornene-2,3-dicarboxylate 4g (84.1 mg, 0.400 
mmol, 4.00 equiv), and sodium tetraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv). The 
crude reaction mixture was purified by flash column chromatography (90:10 hexanes:EtOAc) 
to (70:30 hexanes:EtOAc) to yield 6v as a white solid in 60% yield (23.5 mg, 0.060 mmol). 1H 
NMR (400 MHz, CDCl3): 2.35 (dt, J = 11.2, 1.6 Hz, 1H), 2.53 (dd, J = 11.2, 1.6 Hz, 1H), 2.95-
3.05 (m, 2H), 3.05 (m, 1H), 3.31 (d, J = 10.4 Hz, 1H), 3.65 (s, 3H), 3.68 (s, 3H), 3.85 (d, J = 
10.4 Hz, 1H), 7.22 (t, J = 7.6 Hz, 2H), 7.36 (tt, J = 7.6, 1.2 Hz, 1H), 7.51 (m, 2H).13C NMR 
(100 MHz, CDCl3): 33.5, 42.9, 46.8, 50.4, 52.0, 52.1, 52.4, 53.1, 55.0, 126.5, 128.0, 128.1, 
128.2, 128.4, 132.5, 138.1, 140.2, 172.9, 173.1, 200.4. HRMS (ESI): Calcd. for C24H24O5+ ([M 
+H]+): 393.1697, Found: 393.1698. 
methyl-5-benzoyl-6-phenylbicyclo[2.2.1]heptane-2,3-
dicarboxylate 6w: Prepared according to general procedure C: 
from N-benzoyl-N-phenylbenzamide 3a  (30.1 mg, 0.100 mmol, 
1.00 equiv), dimethyl-(endo,endo)-5-nobornene-2,3-dicarboxylate 4h (210.2 mg, 1.00 mmol, 
10.0 equiv), and sodium tetraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv) at 95°C in 
12 h. The crude reaction mixture was purified by flash column chromatography (90:10®70:30 
hexanes:EtOAc) to yield 6w as a white solid in 53% yield (20.8 mg, 0.053 mmol). Or Prepared 
according to general procedure D: from N-benzoyl-N-phenylbenzamide 3a (30.1 mg, 0.100 
mmol, 1.00 equiv), dimethyl-(endo,endo)-5-nobornene-2,3-dicarboxylate 4h (84.1 mg, 0.400 
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mmol, 4.00 equiv), and sodium tetraphenylborate 5a (68.4 mg, 0.200 mmol, 2.00 equiv). The 
crude reaction mixture was purified by flash column chromatography (90:10®70:30 
hexanes:EtOAc)  to yield 6w as a white solid in 44% yield (17.2 mg, 0.044 mmol). 1H NMR 
(400 MHz, CDCl3): 1.66 (dt, J = 10.8, 1.6 Hz, 1H), 2.68 (dd, J = 10.8, 1.6 Hz, 1H), 2.72-2.76 
(m, 1H), 2.99-3.02 (m, 1H), 3.19-3.21 (m, 2H), 3.71 (s, 3H), 3.72 (s, 3H), 3.94 (dd, J = 10.4, 
1.6 Hz, 1H), 4.63 (dd, J = 10.4, 1.6 Hz, 1H), 6.93-6.96 (m, 5H), 7.22 (t, J = 7.6 Hz, 2H), 7.35 
(tt, J = 7.6, 1.2 Hz, 1H), 7.59 (m, 2H). 13C NMR (100 MHz, CDCl3): 38.8, 42.9, 46.2, 46.9, 
47.0, 48.3, 49.3, 51.82, 51.84, 126.3, 128.0, 128.1, 128.4, 128.7, 132.4, 138.4, 141.0, 172.7, 
173.2, 201.6. HRMS (ESI): Calcd. for C24H24O5+ ([M 
+H]+): 393.1697, Found: 393.1700. 
 
 
General Procedure E: Synthesis of Carboacylation Products 6a and 6y Using Organozinc 
Nucleophiles 
 
An oven dried 1-dram vial was charged with 0.100 mmol of the appropriate amide 3a, Ni(cod)2 
(2.8 mg, 0.010 mmol), ZnR2 (0.200 mmol), norbornene 4a (1.00 mmol), and benzene (1.0 mL, 
0.1 M). The resulting solution was stirred at 80 °C for 8 hours. Upon completion of the reaction, 
the reaction was cooled to room temperature and was flirted through a short plug of silica gel 
eluting with 50:50 hexanes:EtOAc and concentrated under reduced pressure.   1H NMR yields 
N
O nbe 4a (10 equiv)Ni(cod)2 (10 mol%)
ZnR2  (2 equiv)Ph
R
O
Ph
3a
Ph
Ph
O
R = Ph, 6a, 11% yield 10, 89% yield
R = Me, 6y, 37% yield 10ʹ, not detected
benzene (0.1 M)
80 °C, 8 h
+
Ph R
O
6 10
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were determined for the correspond crude reaction mixtures using dibromomethane as an 
internal standard. 
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CHAPTER 6.    CONCLUSIONS 
The bismuth(III) triflate-promoted conjugate addition of electron-rich heteroarenes to 
b,b-disubstituted enones generates heteroarylated all-carbon quaternary centers. These 
reactions encompass the addition of furan, thiophene, pyrrole, and indole nucleophiles to a 
variety a cyclic b,b-disubstituted enones. Control experiments suggest that these conjugate 
addition reactions are catalyzed by triflic acid, which is generated upon hydrolysis of 
bismuth(III) triflate in the presence of advantageous water. During studies to assess the 
substrate scope we observed that: (1) additions of electron-rich heteroarenes to b,b-
disubstituted enones was exceptionally sensitive to the size of the b-substituent and (2) under 
the guise of applying our model conjugate addition reactions to include biologically active 
enones, such as progesterone, no conjugate addition reaction was observed. Serendipitously, 
we discovered that this reaction manifold promoted a sequential 1,2-addition and dehydration 
pathway to generate heteroarylated steroidal dienes. 
 Regioselective 1,6-additions of electron-rich heteroarenes occur in the presence of   
bismuth(III) triflate. These 1,6-additions encompass indole, pyrrole, thiophene, and furan 
nucleophiles to 3-vinyl-2-cyclohexenone and lead to the formation of a variety of δ-
heteroarylated, β,β-disubstituted enones.  Control experiments suggest that the 1,6-addition 
reactions are bismuth-catalyzed process and that the bismuth catalyst plays a key role in the 
nearly complete selectivity for 1,6-addition. The δ-heteroarylated, β,β-disubstituted enones 
generated from our 1,6-addition reactions have significant potential to serve as valuable 
synthetic building blocks. We have demonstrated one such application through the palladium-
catalyzed conjugate addition of an arylboronic acid to form a β-arylated, δ-heteroarylated 
ketone containing a quaternary carbon center at the β-position. 
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 The serendipitous discovery of an efficient method for the direct incorporation of 
electron-rich heteroarenes at the C-3 position of progesterone, 17a-hyroxyprogesterone 
acetate, and adrenosterone. These addition/elimination reactions occur in the presence of 
catalytic bismuth(III) triflate under mild reaction conditions. Additions of indole, pyrrole, and 
thiophene nucleophiles to steroids containing an a,b-unsaturated ketone occur to form 3-
heteroarylated steroidal dienes, and these steroidal dienes can be isolated in high purity without 
column chromatography. 
Finally, we have developed a protocol for three-component, intermolecular nickel-catalyzed 
alkene carboacylation reaction triggered by amide C-N bond activation. These conjunctive 
cross-coupling encompasses reactions of a variety of bicyclic alkenes, amides, and 
tetraarylborates to generate highly functionalized ketone products high yields. Preliminary 
mechanistic studies suggest that reductive elimination is the turnover-limiting step, and that 
migratory insertion precedes transmetalation. These reactions occur with excellent 
chemoselectivity and diastereoselectivity in the absence of a directing/chelating group and 
further demonstrate amides as practical acyl electrophiles for alkene functionalization 
reactions.   
 
 
